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Abstract 
Tumour-associated macrophages (TAM) represent a prominent component of the 
leukocytic infiltrate of human tumours and their accumulation in oral squamous cell 
carcinoma (OSCC) has been shown to be a predictor of poor prognosis.  Evidence suggests 
that the tumour microenvironment drives TAM into a pro-tumour phenotype which 
exacerbates tumour growth.  Three-dimensional (3D) models are gaining in popularity as 
they can replicate complex in vivo environments without the regulatory or financial barriers 
presented by in vivo experiments, whilst improving clinical relevance.   
The research described in this thesis addresses a lack of oral mucosa models containing 
human macrophages or tools with which to analyse cells cultured within 3D models by 
developing (i) a 3D model of the oral mucosa containing primary human macrophages, and 
(ii) an optimised multi-colour flow cytometry panel to quantitatively measure the 
expression of CD14, CD36, CD45, CD80, CD86, CD163 and CD206 on macrophages cultured 
within the tissue-engineered oral mucosa.    
An oral mucosa model containing FNB6 epithelial cells and monocyte-derived macrophages 
(MDM) was developed and characterised using immunohistochemistry; E-cadherin, AE1/3 
and Ki67 were visualised in the epithelium and CD68 staining was visualised in the 
connective tissue.  The expression of vimentin and collagen IV was also analysed.  In 
addition, flow cytometry confirmed the viability of MDM cultured within this model, and 
ELISA detected a significant increase in IL-6 release following LPS challenge. 
The use of 8-colour flow cytometry and rheometry provided preliminary results to 
demonstrate that models containing the OSCC cell line, H357, contained an increased 
number of CD163+ MDM and a stiffer extracellular matrix compared to those models 
cultured with normal oral keratinocytes or immortalised keratinocyte cell line, FNB6.  These 
results demonstrate that the macrophage-containing oral mucosa model and molecular 
tools presented in this thesis will be useful in improving understanding of the role 
macrophages play in oral cancer progression. 
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Chapter Summaries 
Chapter 1 
The literature review presented in this chapter provides an overview of oral cancer, 
including its clinical and molecular pathogenesis.  In addition, it details the known roles that 
macrophages play in health and disease, with a particular focus on their involvement in oral 
cancer.  Finally, the range of pre-clinical models currently available for research is described.  
This review leads into the problems this thesis aims to address. 
Chapter 2 
In this chapter, a comprehensive description of the materials and methods used for this 
research is provided.   
Chapter 3 
Firstly, this chapter explores and optimises the isolation and 2D culture of primary and cell 
line monocytes and macrophages, including the stimulation of monocyte to macrophage 
differentiation.  This leads into a preliminary comparison between primary and cell line 
monocytes and macrophages using single-colour flow cytometry.   
Chapter 4 
At first, this chapter develops methods for the 3D culture of monocytes and macrophages, 
and analysis of cell viability using flow cytometry using THP-1 monocytes.  Optimised 
methods are then applied to primary and alternative cell line monocytes and macrophages.  
Consequently, monocyte-derived macrophages (MDM) are selected for incorporation 
within the tissue-engineered model of oral mucosa presented in chapter 5.  This chapter 
ends with data showing that 3D-cultured MDM are viable and respond to stimulation with 
LPS by releasing inflammatory cytokine, IL-6.   
Chapter 5 
The results presented in chapter 5 describe the development of an oral mucosa model 
containing an immune component.  At first, THP-1 monocytes are used to optimise methods 
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which are later applied to generate an optimised 3D in vitro model of the oral mucosa 
containing MDM.  In this chapter, MDM are shown to be viable and responsive to LPS when 
cultured within this 3D co-culture model.  This chapter concludes with the optimisation of 
rheometry to analyse the stiffness of the engineered oral mucosa.   
Chapter 6 
Chapter 6 describes the development of a fully optimised multi-colour flow cytometry panel 
(OMIP) to analyse the expression of key macrophage polarization markers, CD36, CD80, 
CD86, CD163 and CD206.  The results in this chapter detail the selection of reagents used in 
the panel, stimulation of macrophages to express selected polarisation markers and the 
optimisation of controls required.  
Chapter 7 
This chapter begins by optimising the multi-colour flow cytometry panel, described in 
chapter 6, for use on macrophages cultured within a tissue-engineered oral mucosa model.  
In addition, tissue-engineered models containing MDM in the presence of normal oral 
keratinocytes (NOK), immortalised ‘normal’ (FNB6) and OSCC cell line (H357), or polarised 
MDM in the presence of FNB6 cells, begin to be explored using histology, rheometry, the 
OMIP and contraction assays. 
Chapter 8 
The conclusion of this thesis, and proposed future work are presented in this chapter.   
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 Chapter 1: Literature Review 
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1.1 Oral Cancer 
 An overview of oral cancer 
Seventy five per cent of oral cancers are preventable by simple lifestyle changes, such as 
tobacco smoking cessation and reduced alcohol consumption (Warnakulasuriya, 2009).  
Head and neck cancer is defined as cancer arising in the head and neck, including the nasal 
cavity, sinuses, lips, mouth, salivary glands, throat and larynx.  Oral cancer however is 
limited to those cancers found in the oral cavity and oropharynx (National Cancer Institute, 
UK).  Globally, lip and oral cavity cancers account for 2.7 % of cancers, excluding non-
melanoma skin cancer, and are most commonly found in North America, Europe and 
Australasia.  These cancers amounted to 2.1 % of mortalities due to cancer in 2012 (Ferlay 
et al., 2013).  Around 90 % of oral cancers are classified as oral squamous cell carcinoma 
(OSCC, Chen et al., 1999) which tend to primarily affect the tongue (British Association of 
Otorhinolaryngology of Head and Neck Surgery (ENT.UK), 2011).  Oral cancer arises from a 
series of genetic mutations in response to various mutagens, that lead to excessive 
proliferation of oral keratinocytes.  These typically progress through stages of dysplastic 
epithelial lesions leading to malignant cancers which characteristically penetrate the 
epithelial basement membrane (Scully and Bagan, 2009a).   
Oral cancer incidence and epidemiology 
Whilst oral cancer is relatively rare compared to other cancers, its incidence is increasing 
particularly in young people (less than 45 years old) and this trend has previously been 
reviewed in detail (Majchrzak et al., 2014).  Data published in January 2014 shows oral 
cancer to be the 11th most common cancer in the UK, with nearly 6000 people diagnosed in 
2011 alone (Figure 1.1).  Oral cancer has a 27 % mortality rate, with more than double the 
number of men affected than women (Cancer Research UK, 2014).  In the rest of the world, 
Papua New Guinea shows the highest incidence of lip and oral cavity cancers globally with 
24.95 people per 100 000 of the population affected, and Nicaragua the lowest with 0.55 
cases per 100 000 (Figure 1.2) and this is reflected in mortality statistics where Papua New 
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Guinea also shows the highest mortality rates due to lip and oral cavity cancers, and 
Nicaragua the lowest with 0.26 cases per 100 000 of the population (Ferlay et al., 2013, 
Figure 1.2).   
 
Figure 1.1. Incidence and mortality rates for cancers in the UK in 2011.   Age-standardised 
incidence (blue) and mortality (black) rates for cancers in the UK in 2011.  Data from Cancer 
Research UK. 
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Figure 1.2. Incidence and mortality rates for cancers of the lip and oral cavity globally in 
2012.   Age-standardised incidence (A) and mortality (B) rates of lip and oral cavity cancers 
in 2012.  Data is shown as rates per 100,000 of the global population for both males and 
females.  Modified from Ferlay J, Globocan 2012 (IACR). 
In England, the 27 % mortality and 56 % five-year survival rate (Oxford Cancer Intelligence 
Unit) of oral cancer can be largely attributed to late diagnosis by which time the cancer is 
A 
B 
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so advanced, that prognosis is poor (Sargeran et al., 2008).  Oral cancer caught in the early 
stages has survival rates as high as 90 %, so development of methods for early diagnosis are 
key.  However, early cancer is often over-looked as the disease is often asymptomatic until 
the cancer has progressed to advanced stages (Bagan et al., 2010) and diagnostic delays of 
even just one month have a huge impact on prognosis (Allison et al., 1998).  In addition, 
patients generally wait more than three months from the onset of potential oral cancer 
symptoms before seeking professional advice (Scott et al., 2006).  With the number of oral 
cancer cases set to rise to between 30-40 % by 2020 (Moller et al., 2007) new methods must 
be developed to understand, then prevent and treat oral cancer.  The World Health 
Organisation (WHO) aims to ‘ensure that prevention of oral cancer is an integral part of 
national cancer-control programmes’ but for this to be successful, risk factors need to be 
determined (Petersen, 2008).   
Oral cancer risk factors 
Many studies have investigated the risk factors for the continuing rise in the incidence of 
oral cancer (Saman, 2012).  Currently, known risk factors include tobacco and alcohol which 
have been strongly implicated in more than 75 % of oral and pharyngeal cancer cases with 
a synergistic effect observed (Blot et al., 1988).   
Tobacco releases tobacco-specific nitrosamines and free radicals which have been 
implicated in carcinogenesis in both smoked and chewed tobacco (Scully and Bagan, 
2009b).  Alcohol dehydrogenases convert ethanol to acetaldehyde which promotes DNA 
damage leading to carcinogenesis and an increase in the risk of oral cancer by five-fold 
(Scully and Bagan, 2009b).  Many studies have also sought to determine whether alcohol in 
mouthwashes make a contribution to oral cancer risk, however evidence is conflicting as 
the effects of mouthwash use cannot be segregated from other independent risk factors 
(Ahrens et al., 2014).  
Betel quid is a preparation of tobacco, areca nut and betel leaf which is regularly chewed 
by around 10 % of the world’s population and is the leading risk factor for oral cancer in 
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developing countries (Joshi et al., 2014).  Areca nut is the main ingredient of betel quid 
which contains arecoline, a known carcinogen.  Arecoline blocks tumour suppressor genes, 
including p53, to repress DNA repair responses (Scully and Bagan, 2009a).  The areca nut is 
also linked with oral sub-mucous fibrosis (OSMF), a pre-malignant condition which causes 
trismus (Gupta et al., 1998). 
Unbalanced diets are found in both developed and undeveloped countries, with both 
showing a shift to high fat and sugar diets (Petti, 2009) which have many health 
implications, including an increased risk of oral cancer. A study has shown that high meat 
intake and low fruit and vegetable consumption may account for between 49-65 % of oral 
and pharyngeal cancers (Levi et al., 1998).  The protective effect of fruits and vegetables 
could be at least a 25 % reduction in oral cancer risk (Warnakulasuriya, 2010).  The WHO 
have made recommendations for the global population to achieve a balanced diet and 
lifestyle which they believe is ‘most likely to protect against cancer’ (Wiseman, 2008).   
Other risk factors for oral cancer include human papilloma virus (HPV) infection which was 
found in almost 4 % of oral cavity cancers.  Nearly 95 % of these cases were due to HPV16 
which also causes cervical cancer (Herrero et al., 2003).  Infection of the oral mucosa from 
oral pathogens such as Porphyromonas gingivalis disrupts the immune system, creating a 
pro-inflammatory environment which dysregulates proliferation of oral epithelial cells, 
contributing to oral cancer development (Whitmore and Lamont, 2014).  Sun exposure has 
also been linked to oral cancer, in particular to lip cancer, due to ultra-violet (UV) radiation 
damage to DNA (Scully and Bagan, 2009b).  These risk factors have been further reviewed 
in detail previously (Radoi and Luce, 2013). 
 Clinical pathogenesis of oral cancer 
Pre-malignant lesions 
The first sign of a potential malignancy is the appearance of leukoplakia or erythroplakia, 
which are white and red patches respectively which cannot be ‘characterised clinically or 
pathologically as any other disease’ (WHO).  Whilst erythroplakia is well demarcated, often 
  
 
7 | P a g e  
 
asymptomatic and less common than leukoplakia, it is more likely to show signs of dysplasia 
or carcinoma (Shafer and Waldron, 1975).  Another form of leukoplakia, known as 
proliferative verrucous leukoplakia (PVL) is rare, but occurs at multiple sites on the oral 
mucosa and has a high recurrence rate, with a 70 % risk of progressing into an aggressive 
OSCC (Silverman and Gorsky, 1997).   
Early malignant leukoplakia or erythroplakia may then progress into a non-healing ulcer 
followed by bleeding, tooth loosening and dysphagia.  However by this time, 65 % of oral 
carcinomas have progressed to stage 3 or 4 (Brandizzi et al., 2008).  Delays in diagnosis make 
a large contribution to the overall low (50-55 %) five-year survival rates of OSCC which have 
not improved in 30 years (Neville and Day, 2002). 
Histologically, dysplasia can range from mild to severe and is described as a disruption of 
the stratification of the oral mucosa.  Dysplasia is characterised by drop-shaped rete ridges, 
cellular and nuclear pleomorphisms with an increase in nuclear to cytoplasmic ratio of 
epithelial cells and loss of keratinocyte differentiation compared to normal epithelium 
(WHO, Figure 1.3).  With progression of lesions from dysplasia to carcinoma in situ comes 
an increased risk of invasive carcinoma development (Bradley et al., 2010). 
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Figure 1.3.  Changes in the structure of the oral mucosa during oral cancer development.   Differences in the epithelium are 
diagrammatically represented for normal oral mucosa, dysplasia and invasive carcinoma. 
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Carcinoma in situ 
Carcinoma in situ, as first described by Ackerman and McGavran (Ackerman and McGavran, 
1958), is considered to be an extreme form of dysplasia and only differs from invasive 
carcinoma by a lack of stromal invasion (WHO).  There is extensive epithelial disruption 
which is full thickness and many nuclear and cellular pleomorphisms can be observed.  With 
current treatments, head and neck carcinoma in situ has a 98 % five-year survival rate with 
a 20 % recurrence rate (Christensen et al., 2013).  As with invasive oral carcinoma, the 
number of diagnoses of oral carcinoma in situ are also increasing, and when left untreated, 
carcinoma in situ has a high transition rate to invasive carcinoma (Reid et al., 2000). 
Invasive carcinoma 
By the time an oral lesion is described as invasive carcinoma, the epithelial structure has 
been completely lost; there is little keratinocyte differentiation and hence little 
keratinisation, destruction of the basement membrane, rapid proliferation of cells and 
therefore many multi-nucleated cells which can be observed histologically (Figure 1.3).  This 
is due to many abnormal mitoses resulting in most cells containing either cellular or nuclear 
pleomorphisms or both.  The first malignancy to be classified was squamous cell carcinoma, 
which can be graded from grade 1 to 3 using Broders’ method for histological grading 
(Broders, 1927).  Alternatively, Anneroth’s malignancy grading can be used (Anneroth et al., 
1987) however the tumour-node-metastasis (TNM) staging is now the most commonly used 
tumour classification system and can be applied universally to a range of malignancies.  This 
was originally developed by Professor Pierre Denoix between 1943 and 1952, but has since 
been revised several times by the Union Internationale Contre le Cancer (IUCC).  TNM 
staging takes into account tumour (extent of primary tumour), node (presence or absence 
of lymph node metastasis) and metastasis (distant to the primary tumour).  Grading is used 
to predict aggressiveness of the cancer, patient prognosis and to determine treatment 
strategy. 
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Oral squamous cell carcinoma 
OSCC arises from a malignancy in the basal cells of a stratified squamous epithelium.  These 
cells are highly proliferative in order to maintain the structure and integrity of the oral 
mucosa.  Invasive carcinomas include basaloid squamous cell carcinoma, spindle cell 
carcinoma and verrucous carcinoma, however OSCC is the most common, accounting for 
90 % of all oral cancer cases (Bagan et al., 2010).   
Current treatments for OSCC primarily involve surgery and radiotherapy, but these have 
debilitating side effects which have a huge detrimental impact on the quality of life of 
patients  (Funk et al., 2002).  Radiotherapy has a 90 % success rate with stage 1 oral cancers, 
however oral cancers are rarely diagnosed before stage 3 or 4, by which time surgery is 
usually required to remove the malignancy (Sargeran et al., 2008).  Side effects of 
radiotherapy include oral mucositis which is severe in 50 % of patients, xerostomia which is 
moderate to severe in 60 % of patients, and also dysphagia, dermatitis, thyroid dysfunction, 
trismus and osteoradionecrosis (Argiris et al., 2008).  Radiotherapy side effects can be either 
temporary or permanent (Foulkes, 2013).  Adverse side effects of surgery include loss of 
oral function and devastating disfigurement.  Often, treatment of OSCC becomes palliative 
to restore some oral function and ease discomfort. 
 Molecular pathogenesis of oral cancer 
In the development of oral cancer, there are a number of specific cellular changes at the 
molecular level which are propagated into the development of disease.  Carcinogens or 
mutagens, such as tobacco, alcohol and poor diet can damage DNA in oral keratinocytes on 
the surface of the oral mucosa which, if left un-repaired, may lead to uncontrolled cell 
proliferation and become the starting point for OSCC (Blot et al., 1988; Levi et al., 1998; 
Petti, 2009; Scully and Bagan, 2009b).  Increased exposure to mutagens leads to 
accumulation of genetic changes which develop into premalignant lesions.  Often in oral 
cancer there is loss of heterozygosity of the 17p chromosome region, the CDKN2A locus is 
missing, there is increased expression of epidermal growth factor receptor (EGFR) and C-
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met receptor tyrosine kinase (RTK) is overexpressed or mutated.  This is discussed in further 
detail below. 
P53 tumour suppressor gene 
The 17p chromosome region encodes many genes, including p53 tumour suppressor gene 
which encodes a protein with a critical role in cell cycle regulation and apoptosis (Zilfou and 
Lowe, 2009).  P53 is the most commonly mutated gene in cancer, often due to tobacco and 
alcohol consumption in the case of oral cancer, and is implicated in around 50 % of oral 
cancer cases (Baral et al., 1998; Boyle et al., 1993; Caamano et al., 1993).  Presence of 
mutated p53 is associated with the transition from dysplasia to invasive carcinoma (Choi 
and Myers, 2008) and poor prognosis, due to a reduced sensitivity of the tumour to 
chemotherapy (Cabelguenne et al., 2000). 
CDKN2A locus 
CDKN2A locus contains CDKN2A/ARF, two tumour suppressor genes which encode INK4A 
and ARF cell cycle regulatory proteins (Berggren et al., 2003).  This locus is found in the 9p21 
chromosomal region which is missing in 71 % of dysplastic lesions in head and neck cancer 
(Vanderriet et al., 1994).  Typically, tumour suppressor genes have a role in containing cell 
proliferation, but with these missing or mutated, there is uncontrolled cell proliferation, 
leading to tumour formation. 
Epidermal growth factor receptor  
EGFR binds a total of seven ligands to promote cell proliferation as well as migration, DNA 
synthesis and adhesion (Schneider and Wolf, 2009).  Mutations in EGFR, such as EGFRvIII 
variant in 42 % of oral cancer, contribute to tumour formation (Pidone Ribeiro et al., 2014).  
EGFR is overexpressed in 72 % of OSCC and thus is an attractive therapeutic target 
(Forastiere et al., 2006) which has been explored through anti-EGFR antibodies which have 
so far produced mixed results (Thomas et al., 2012).  
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C-met receptor tyrosine kinase 
Hepatocyte growth factor (HGF) ligand binds c-met RTK encoded by c-met proto-oncogene 
(Bottaro et al., 1991).  The receptor is often overexpressed or mutated in cancer, leading to 
an increase in matrix metalloproteinase expression (Hasina et al., 1999).  These enzymes 
have a role in degradation of connective tissue and the basement membrane, and are 
thought to enable cancer epithelial invasion of the basement membrane for increased 
metastasis by malignant keratinocytes.  The potential therapeutic benefits of using c-met 
RTK have been reviewed (Ma et al., 2003). 
Despite what is currently known about oral cancer, therapeutics have not changed in a long 
time, and there is a real need for further understanding how this disease progresses.  
Therefore, improved pre-clinical models are required. 
 
1.2 Macrophages in Health and Disease 
Macrophages are a highly specialised leukocyte, with roles in development and disease.  
Their primary role in the innate immune system is in the identification and elimination of 
invading micro-organisms, using highly sensitive receptors on their cell surface, and 
phagocytosis.  In addition, release of a large variety of cytokines during pathogen 
elimination results in macrophages tuning the adaptive immune response.  Whilst the 
inflammatory response of macrophages to invading pathogens is key for host survival of an 
immune challenge, the same arsenal has been shown to play a role in the initiation of 
cancer. 
 The role of macrophages in the immune system 
Origin and development of macrophages 
Monocytes are macrophage pre-cursors which originate from hematopoietic stem cells 
(HSCs) in the bone marrow and spleen.  During development to mature monocytes, HSCs 
proceed through several stages (including a common myeloid progenitor, a myeloblast, 
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monoblast and finally, a pro-monocyte) before finally maturing into a monocyte.  
Monocytes are small, spherical cells with a reniform nucleus and very few granules (Auffray 
et al., 2009; Geissmann, 2010; Ginhoux and Jung, 2014; Terry and Miller, 2014).   
During the acute inflammatory response, neutrophils are the first to be recruited to a site 
of injury or infection and through a cytokine signalling cascade which ends with epithelial 
and stromal cell secretion of MCP-1, monocytes are recruited.  Here, they extravasate from 
the blood stream into tissues and quickly differentiate into macrophages, promoted by the 
presence of GM-CSF and M-CSF, among other cytokines (Sheel and Engwerda, 2012; Shi and 
Pamer, 2011; Wrigley et al., 2011; Yang et al., 2014b).  Monocyte to macrophage 
differentiation is characterised by a morphological change as cells increase in size, 
cytoplasmic to nuclear ratio and number of cytoplasmic granules to increase production of 
hydrolytic enzymes (Chang et al., 2012).  
Macrophages in innate immunity 
Macrophages possess a large array of pattern recognition receptors (PRRs) including 
scavenger receptors, integrins and toll-like receptors which readily bind pathogen-
associated molecular patterns (PAMPs) such as lipopolysaccharide (LPS) on gram-negative 
bacteria.  Binding of PAMPs to these receptors results in the initiation of inflammation 
characterised by redness, swelling, heat and pain as macrophages become activated (Sheel 
and Engwerda, 2012; Shi and Pamer, 2011; Wrigley et al., 2011; Yang et al., 2014b). 
Activated macrophages become the main secretors of growth factors, chemokines and 
cytokines to create an inflammatory environment; increased integrin expression on 
endothelial cells enables additional monocytes and neutrophils to extravasate into the 
affected tissue; CXCL1, 2 and 5 attract additional neutrophils; and TNF induces vasodilation 
to increase the permeability of blood vessels for increased flow of lymph containing 
antigen-presenting cells (APCs) into tissues (Porcheray et al., 2005).  Additionally, 
macrophages can engage with the adaptive immune system through release of IL-6 
resulting in differentiation of B cells into plasma cells for antibody production, and antigen 
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presentation of PAMPs, following phagocytosis, activates T lymphocytes.   An anti-microbial 
environment is further promoted by the production of reactive oxygen and nitrogen species 
(ROS and RNS) to fight infection (Coussens and Werb, 2002).   
 From inflammation to cancer initiation 
The same mechanisms that enable macrophages to defend the host against invading 
pathogens are increasingly shown to have major roles in the initiation of cancer.  The 
chronic inflammation caused by infection is thought to lead to 15 % of all tumours (Kuper 
et al., 2000).  Inflammation due to oral lichen planus and gingivitis is associated with OSCC; 
sialadentitis has been linked to salivary gland carcinoma; Sjögren’s syndrome is associated 
with mucosa-associated lymphoma tissue (MALT) lymphoma which commonly affects the 
oral cavity; and inflammation due to oral HPV infection is strongly associated with 
carcinomas of the oral cavity and oropharynx (Balkwill et al., 2005; Coussens and Werb, 
2002).  Macrophage migration inhibitory factor (MIF) is thought to provide the link between 
chronic inflammation and cancer due to its role in leukocyte accumulation which is one of 
the hallmarks of cancer-associated inflammation (Mitchell, 2004; Pollard, 2004).  
Macrophages release many pro-inflammatory cytokines, including tumour necrosis factor 
(TNF), interleukin-1 (IL-1), IL-6 and IL-8 during inflammation.  In acute inflammation, 
secretion of anti-inflammatory cytokines closely follows the secretion of pro-inflammatory 
cytokines, however in chronic inflammation leading to cancer, pro-inflammatory cytokines 
persist long term, in the absence of anti-inflammatory signals.  Under the influence of 
persistent pro-inflammatory signals, macrophages can switch from an M1 to an M2 
phenotype (Shapiro et al., 2011). 
DNA damage 
At sites of inflammation, macrophage inducible nitric oxide synthase (iNOS) enzymes 
produce reactive nitrogen and oxygen species free radicals to fight infection which react 
together to form peroxynitrite which is highly reactive with DNA.  Whilst the inflammatory 
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response is short-lived, ROS and RNS cause DNA damage in proliferating cells, thus 
accelerating mutagenesis (Maeda and Akaike, 1998).   
In addition to DNA damage, nitric oxide (NO) released by iNOS enables more efficient supply 
of nutrients to tumour tissues, through vasodilation, to facilitate tumour growth (Maeda 
and Akaike, 1998).  Through this process, chronic inflammation can lead to cancer by 
enabling cells to undergo malignant transformation, or ‘cancer initiation’, and continue to 
proliferate in the growth-supportive inflammatory environment.  High expression of iNOS 
is often observed in oral cancer and pre-malignant lesions (Choudhari et al., 2014).   
Faulty DNA repair mechanisms 
During pathogen challenge, MIF is released by leukocytes, such as macrophages and 
neutrophils, to further attract leukocytes to the site of inflammation.  MIF has a variety of 
roles in both the innate and adaptive immune systems, including regulation of cytokine 
secretion through extracellular signalling, or inhibition of p53 through intracellular 
signalling (Bach et al., 2008).   
Tumour suppressor protein, p53, plays a key role in cell cycle regulation.  MIF has been 
shown to suppress the transcriptional activity of TP53 gene in proliferating cells, leading to 
a lack of DNA damage response and repair mechanisms.  This results in an accumulation of 
mutations and chromosome abnormalities (Hudson et al., 1999).  Several studies have 
shown a strong positive correlation between an increase in the expression of MIF and 
increased tumour growth, cell survival, metastasis and angiogenesis in oral carcinomas, 
especially those of the lip which have a high infiltration of CD68+ cells (Franca et al., 2013).  
This is in direct contrast with gastric carcinomas where a high level of MIF is associated with 
a more favourable prognosis; here, patients whose tumours do not express MIF had a worse 
prognosis than patients with tumours that did express MIF (Xia et al., 2009).   
 Tissue-resident macrophages 
Whilst the majority of macrophages residing within the oral mucosa originate from blood 
monocytes recruited following inflammation, other tissues have been shown to be 
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populated with tissue-resident macrophages during foetal development, which persist 
throughout life and are independent of recruited monocyte-derived macrophages (Davies 
et al., 2013).  Tissue-resident macrophages such as, peritoneal, alveolar and cardiac 
macrophages as well as microglia and Langerhans cells play a role in homeostasis (such as 
immune surveillance, clearing of cellular debris and iron processing) in addition to 
supplementing the numbers of macrophages during inflammation (Davies et al., 2015).  As 
with monocyte-derived macrophages recruited during inflammation, tissue-resident 
macrophages are highly plastic and alter their phenotype in response to environmental 
stimuli and can be associated with M1 or M2 phenotypes (Lavin et al., 2014).  However, in 
contrast with recruited monocyte-derived macrophages which are typically considered 
terminally differentiated, tissue-resident macrophages have been observed to proliferate 
to maintain cell numbers (Chorro et al., 2009).  Monocyte-derived macrophages recruited 
during inflammation can persist in tissues for up to 60 days following resolution of 
inflammation, therefore it can be challenging to distinguish between these and tissue-
resident macrophages.  Specific markers have been sought to distinguish between the two, 
with CD64 identified as a marker which has been shown to be universally associated with 
mature tissue macrophages in a murine model (Gautier et al., 2012).  Within the tumour 
microenvironment however, a study of a murine model of breast carcinoma demonstrated 
that tumour-associated macrophages are derived from blood monocytes rather than 
originating from the tissue-resident population of macrophages (Franklin et al., 2014).  It is 
yet to be shown whether these findings can be translated into studies of human tissues as 
well as those of other tissues. 
 Tumour-supportive stroma 
Tumour-associated macrophages (TAM) display many pro-tumour effector functions; they 
secrete TNF for cell proliferation, release matrix metalloproteinases (MMPs) and tumour 
growth factor β (TGFβ) to promote matrix deposition and remodelling, and promote 
angiogenesis through secretion of vascular endothelial growth factor (VEGF), fibroblast 
growth factor 2 (FGF2) and TNF.  TNF and MMPs released by TAM also promote metastasis 
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and secretion of IL-10 and TGFβ to create an immunosuppressive environment (Quatromoni 
and Eruslanov, 2012).  Fibroblasts are the most abundant cell type in the connective tissue 
and their interaction with macrophages is key in developing a tumour-supportive stroma.  
They play a role in TAM recruitment which propagates wound healing responses of 
fibroblasts to further promote invasion, metastasis and matrix deposition.  Hence, the 
cross-talk between fibroblasts, epithelial cells, malignant cells and immune cells is crucial 
for the maintenance of a tumour microenvironment (MaasSzabowski and Fusenig, 1996).   
Tumour-associated macrophage recruitment 
Stromal cells, such as fibroblasts, as well as tumour cells drive monocyte recruitment 
through chemokines such as monocyte chemotactic protein 1 (MCP-1) and chemokine 
ligands 3 and 5 (CCL3 and CCL5, Murdoch et al., 2008).  These have been observed at 
increased levels in tumours, and implicated in oral cancer with roles including promotion of 
metastasis and cell migration (Bektas-Kayhan et al., 2012; Chuang et al., 2009; Silva et al., 
2007).  Increased TAM infiltration between malignant tumour cells in the connective tissue 
stroma and at the invasive front of the tumour is associated with higher histopathological 
grades in oral cancer (El-Rouby, 2010). 
The role of tumour-associated macrophages in cancer invasion 
Granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-
stimulating factor (G-CSF) play a key role in the differentiation of monocytes to 
macrophages and in the maintenance of homeostasis (Rosas et al., 2007).  These are 
secreted by stromal and epithelial cells, and have been observed to upregulate the 
expression of MMPs 1 and 2 in head and neck squamous cell carcinoma (HNSCC, Gutschalk 
et al., 2006).  These MMPs degrade collagenase IV in the basement membrane, facilitating 
tumour invasion and metastasis (Sugimoto et al., 2001).  Blocking the effects of GM-CSF 
with antibodies resulted in an inhibition of tumour cell invasion in both three-dimensional 
(3D) organotypic cultures and in nude mice (Gutschalk et al., 2006).  Concerns have 
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therefore been raised regarding the use of GM-CSF and G-CSF to prevent chemotherapy-
induced neutropenia (Dale, 2002).  
Among other roles in tumour promotion, TGFβ secreted by macrophages plays a leading 
role in promoting epithelial-mesenchymal transition (EMT) that promotes cancer invasion 
and metastasis.  EMT describes the process in which epithelial cells reduce their expression 
of cell-to-cell adhesion proteins, such as E-cadherin, and begin to migrate away from the 
epithelium and acquire properties associated with mesenchymal cells, such as matrix 
deposition (Heldin et al., 2012; Lamouille et al., 2014; Xu et al., 2009).  The addition of TGFβ 
to in vitro cultured OSCC cell lines has been shown to induce EMT and promote bone 
invasion (Quan et al., 2013).  TGFβ has also been reported to activate macrophages to an 
M2 phenotype (Gong et al., 2012). 
The role of tumour-associated macrophages in tumour metastasis 
In the first evidence for synergy between tumour cells and macrophages, macrophage 
colony-stimulating factor (M-CSF, known to stimulate CD163 expression in macrophages) 
was shown to stimulate chemotaxis and migration of tumour cells to promote metastasis 
(Wyckoff et al., 2004).  This was confirmed by a study using genetic and chemical ablation 
of macrophages to reduce the efficiency of cancer cell metastasis in an in vivo breast cancer 
model (Qian et al., 2009).  In oral cavity squamous cell carcinoma, a higher percentage of 
macrophages was found in metastatic patients, which correlated with reduced patient 
survival times, compared to non-metastatic cancers (Costa et al., 2013).  These 
macrophages were found to be IL10+ TGFβ+ and those in non-metastatic patients were 
IFNγhigh (Costa et al., 2013). 
Whilst TNF typically plays a role in promoting inflammation, this macrophage-secreted 
cytokine has displayed immune-suppressing functions and a number of tumour-promoting 
roles.  High levels of TNF have previously been measured in serum from HNSCC patients and 
in OSCC cell lines (Koontongkaew, 2013).  TNF secretion has been linked to a reduction in E-
cadherin expression on tumour cells, stimulating EMT, and increased expression of TGFβ 
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and MMPs (Smith and Kang, 2013).  Treatment of human oral cancer cells with TNF 
promoted expression of CD163 by macrophages and resulted in increased epithelial 
invasion into a myoma model (Pirila et al., 2015).  Lung and liver metastases in mouse 
models of carcinoma could both be prevented by blocking TNF binding to its receptor 
(Balkwill, 2006).  The TNF-dependent metastasis of cancer cells is likely due to activation of 
the NF-κB signalling pathway that results in activation of MMPs, particularly MMPs 2 and 9 
(Hagemann et al., 2005).   
MMPs are proteases essential for extracellular matrix (ECM) turnover; in tumour 
progression, their role of matrix degradation enables malignant cell invasion and 
metastasis.  Macrophages secrete large amounts of MMPs, and in particular, MMPs 2 and 
9 have been implicated in oral cancer metastasis as they can degrade collagen IV, a major 
component of the basement membrane (Patel et al., 2005).  A published study found 
significantly higher levels of both macrophages and MMP9 in OSCC patients correlating with 
lymph-node metastasis (Dai et al., 2007).  In addition, plasma MMP9 levels were found to 
be significantly lower in patients responding to treatment (Patel et al., 2007).  These authors 
also found that the activation of MMP2 was higher than MMP9 in malignant tissues and 
suggest these enzymes may be used as prognostic markers. 
The role of tumour-associated macrophages in angiogenesis 
TAM have been shown to accumulate in hypoxic areas of tumours through chemoattraction 
by endothelin-2 (Grimshaw et al., 2002).  Within the hypoxic region, they promote 
angiogenesis through the release of angiogenic factors such as VEGF, FGF and TGFβ in a 
positive feedback loop (Bingle et al., 2002).  A strong correlation was found between TAM 
accumulation and microvessel density in oral cancer, in agreement with similar studies on 
breast and cervical cancer (El-Rouby, 2010).  However, a later study showed that whilst 
there were high numbers of TAM in oral cancer, their role in angiogenesis may be more due 
to macrophage phenotype than numbers of cells infiltrating (Boas et al., 2013).    
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VEGF mediates the ‘angiogenic switch’ in order to promote angiogenesis.  This ‘switch’ 
results in an increase in the number of blood vessels which provides the growing tumour 
with additional nutrients, and facilitates metastasis (Carmeliet, 2005; Hicklin and Ellis, 
2005).  In a small study, expression of VEGF was higher in OSCC samples compared to 
normal tissues and correlated with tumour grading (Kim et al., 2015).  In contrast, Kukreja 
et al., found that VEGF expression and MVD were independent of tumour grade, however 
this study also found that OSCC samples expressed high levels of VEGF (Kukreja et al., 2013).  
Additional angiogenic factors, such as FGFs, are involved in the cross-talk between epithelial 
and stromal cells to promote angiogenesis.  In particular, FGF2 has been shown to play a 
role in EMT and migration as well as angiogenesis (Hasina et al., 2008) and has been 
identified as a potential prognostic marker for malignant transformation of leukoplakia to 
OSCC (Nayak et al., 2015).  Several studies have indicated that VEGF and FGF may act 
synergistically to promote angiogenesis (Korc and Friesel, 2009). 
The role of tumour-associated macrophages in immunosuppression   
To promote tumour progression, TAM take an active role in immune suppression, due to 
their secretion of IL-10 and TGFβ.  Both these cytokines promote the polarisation of 
macrophages to an M2 phenotype, that has been found to be immunosuppressive by 
reducing the antigen presentation capabilities of immune cells (Hao et al., 2012; Noy and 
Pollard, 2014).  An additional immunosuppressive mechanism employed by cancer cells 
involves the recruitment of myeloid-derived suppressor cells (MDSC), including monocytic-
MDSCs, that prevent dendritic cell maturation, suppress T cell responses and secrete high 
levels of TGFβ to further promote immunosuppression (Noy and Pollard, 2014). 
IL-10 is an anti-inflammatory cytokine, and thus downregulates the expression of pro-
inflammatory cytokines, such as TNF, IL-6 and IL-12, as part of the innate immune response.  
It prevents antigen presentation by downregulating the expression of major 
histocompatibility complex II (MHCII) and co-stimulatory molecules (Martinez et al., 2008).  
In addition, IL-10 prevents maturation of dendritic cells (further reducing antigen 
presentation) and promotes differentiation of macrophages, specifically to an M2 
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phenotype (Hao et al., 2012).  Meanwhile, TGFβ may inhibit cytolytic activity of natural killer 
cells and T lymphocytes whilst simultaneously preventing dendritic cell migration and 
promoting apoptosis (Hao et al., 2012).  This further reduces antigen presentation and 
subsequent attack of cancer cells by the immune system.  TGFβ also promotes 
differentiation of T lymphocytes to Th2 cells, further promoting M2 polarisation of 
macrophages and stimulates Treg differentiation for peripheral tolerance of malignant cells 
(Hao et al., 2012; Mori et al., 2011; Noy and Pollard, 2014). 
 Tumour-associated macrophages in oral cancer 
TAM have been widely implicated in the development of a tumour microenvironment and 
can form up to 65 % of the tumour mass (Liu et al., 2008).  A high number of TAM is 
associated with a favourable prognosis in colorectal and prostate cancer, however they are 
considered a poor prognostic indicator in glioma, lymphoma, melanoma, sarcomas, breast 
carcinoma, lung carcinoma and HNSCC (Balermpas et al., 2014; Costa et al., 2013).  
Macrophages are highly plastic, responding to environmental cues to adopt various 
activation states.  Whilst macrophages in vivo tend to fit along a spectrum of activation 
states, in vitro the polarisation status of macrophages has been simplified to classically or 
alternatively activated macrophages.  It has recently been observed that TAM do not fit into 
either polarisation category, and instead express features of both activation states in 
response to micro environmental cues (Martinez and Gordon, 2014; Qian and Pollard, 
2010). 
Tumour-associated macrophage phenotype  
In 2000, two distinct subsets of macrophages were described and termed M1 and M2 due 
to their differential metabolism of arginine (Mills et al., 2000).  During differentiation from 
monocytes, macrophages were found to become either classically or alternatively activated 
and termed M1 or M2 respectively to reflect the Th1 and Th2 subsets of T lymphocytes that 
secreted the cytokines thought to be responsible for this polarisation (Mantovani et al., 
2002; Stein et al., 1992; Steinman and Idoyaga, 2010; Murray et al., 2014).  Additionally, 
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depending on whether macrophages were cultured in GM-CSF (M1) or M-CSF (M2) they 
displayed very different transcriptomes (Fleetwood et al., 2009; Joshi et al., 2014) that could 
not be categorized as M1 or M2 (Murray et al., 2014).   
Classically activated macrophages (M1) are considered pro-inflammatory as they are 
activated by pro-inflammatory cytokines such as interferon-γ (IFNγ), TNF and GM-CSF, or 
PAMPS such as LPS, to which they respond by secreting further inflammatory cytokines such 
as IL-1β, IL-12, TNF and IL-6.  They express high levels of CD80 and CD86, MHCII co-
stimulatory molecules and low levels of CD206.  M1 macrophages display microbicidal 
properties, promote tissue destruction and display anti-tumour functions for the effective 
depletion of cancer cells (Mills et al., 2000).  In vitro, M1 macrophages can be induced using 
various combinations of LPS, IFNγ, GM-CSF and TNF (Chanput et al., 2013; Goerdt and 
Orfanos, 1999; Mantovani et al., 2005; Mantovani et al., 2002; Martinez and Gordon, 2014; 
Martinez et al., 2008; Mosser, 2003; Muraille et al., 2014; Murray et al., 2014).     
On the other hand, alternatively activated macrophages (M2) typically respond to IL-4, IL-
10, IL-13 and immune complexes to release anti-inflammatory cytokines such as IL-10 and 
TGFβ.  These typically express high levels of CD36, CD163 and CD206 and display pro-
tumour functions such as promotion of angiogenesis, tissue remodelling and 
immunosuppression as well as resolution of inflammation and parasite encapsulation 
(Goerdt and Orfanos, 1999; Mantovani et al., 2005; Mantovani et al., 2002; Martinez and 
Gordon, 2014; Martinez et al., 2008; Muraille et al., 2014; Murray et al., 2014).  
Macrophages are a heterogeneous population and it has been proposed that they are 
further categorised as M1a-M1b and M2a-M2d (Martinez et al., 2008); M1a and M1b may 
distinguish between classically and alternatively activated macrophages, with M2a used to 
describe macrophages activated by IL-4 or IL-13, M2b used to describe macrophages 
activated by immune complexes, IL-1β or LPS, or M2c used to describe those activated by 
IL-10, TGFβ or glucocorticoids (Lewis and Pollard, 2006; Martinez and Gordon, 2014; 
Mosser, 2003).  Whilst these categories provide information regarding the phenotype of 
macrophages, they cannot be used identify distinct subtypes as macrophage gene and 
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protein expression can vary so widely depending on environmental stimuli (Mantovani et 
al., 2004; Roszer, 2015). 
Plasticity between M1 and M2 macrophages has been observed and polarisation often 
depends on the chemokine environment macrophages found themselves in (Davis et al., 
2013; Lewis and Pollard, 2006; Mills et al., 2000).  However, M2 macrophages typically 
prevent polarisation of macrophages to an M1 phenotype (Hofkens et al., 2011) and  TAM 
are often described as displaying an M2 phenotype.  The most commonly used markers for 
macrophage polarisation and their physiological roles are described in Table 1.1.  The 
phenotypes of macrophages in oral diseases reflects that found in other diseases and is 
reviewed in detail here (Merry et al., 2012). 
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Table 1.1.  Cell surface antigens for the characterisation of monocytes and macrophages.   The table lists cell surface markers used to 
identify monocytes and macrophages, markers for monocyte to macrophage differentiation and markers to detect polarisation of 
macrophages.  The cells which express these proteins, the receptor binding partner and the role of each protein is also shown. 
Antigen Alternative names M1/M2 
macrophage 
Receptor binding partner Role Reference 
CD14 - M1 and M2 Microbial ligands Pattern recognition receptor to 
activate innate immunity 
(Poussin et al., 1998) 
CD36 SCARB3 M2 Thrombospondin, oxLDL, 
collagen 
Promotion of cell adhesion and 
scavenger receptor to protect 
from oxidative damage 
(Duque and Descoteaux, 2014) 
CD45 Leukocyte common 
antigen (LCA) 
M1 and M2 Galectin-1 Promotion of B and T 
lymphocyte development 
(Roach et al., 1997; St-Pierre 
and Ostergaard, 2013) 
CD80 B7-1, CD28LG M1 CD28, CTLA-4 Induction of T lymphocyte 
proliferation and cytokine 
production 
(Iwasaki and Medzhitov, 2004) 
CD86 B7-2, CD28LG M1 CD28, CTLA-4 Activation of T lymphocytes (Iwasaki and Medzhitov, 2004) 
CD163 Haemoglobin 
scavenger receptor 
M2 Haptoglobin-haemoglobin 
complexes 
Scavenger receptor to protect 
from oxidative damage 
(Duque and Descoteaux, 2014) 
CD206 Mannose receptor 
type 1 (MRC1) 
M2 Bacterial carbohydrates Mediates endocytosis, 
phagocytosis, macrophage 
activation and antigen 
presentation 
Chavez-Galan et al., 2015; 
Duque and Descoteaux, 2014) 
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CD14 binds microbial ligands such as LPS to initiate an inflammatory response (Poussin et 
al., 1998).  This is followed by expression of co-stimulatory molecules such as CD80 and 
CD86 that bind CD28 and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) to activate 
T lymphocytes (Iwasaki and Medzhitov, 2004).  CD36 and CD163 are scavenger receptors 
that bind thrombospondin and oxidised LDLs (CD36) and haptoglobin-haemoglobin 
complexes (CD163), protecting cells from oxidative damage (Duque and Descoteaux, 2014).  
The transcription of CD36 and CD163 is stimulated by IL-10 binding to its receptor which 
also stimulates upregulation of CD206 to bind bacterial carbohydrates for antigen 
presentation (Chavez-Galan et al., 2015; Duque and Descoteaux, 2014).  CD45 is expressed 
by all leukocytes for the activation of B and T lymphocytes.  It also plays a role in 
macrophage adhesion and migration (Roach et al., 1997; St-Pierre and Ostergaard, 2013). 
Prognostic value of tumour-associated macrophages in oral cancer 
A correlation between a high TAM number and poor prognosis in OSCC has been observed 
(Bagul et al., 2016; Balermpas et al., 2014; Boas et al., 2013; Li et al., 2002; Mori et al., 2011; 
Lu 2010).  However, alternative research has shown a large infiltration of TAM specifically 
into the tumour stroma correlates with poor overall disease-free survival suggesting that 
TAM micro-localisation, rather than number, may have a role to play in OSCC outcome (Ni 
et al., 2015).  In addition, TAM number, measured by CD68, was found to be higher in all 
pathological grades, but did not correlate with pathological grade (Bagul et al., 2016) which  
contradicted previously published research (Lo Muzio et al., 2010).  A limitation of these 
studies is the use of CD68 alone as a marker of TAM.   
Comparisons between the expression of CD68 and CD163 with regards to overall patient 
survival showed that whilst CD68 staining showed no correlation with overall survival, 
CD163 showed potential as a prognostic marker in oral cancer (Fujii et al., 2012; He et al., 
2014).  CD163 has also been shown to correlate with an unfavourable prognosis particularly 
after chemotherapy in HPV-negative patients (Balermpas et al., 2014).  Expression of CD163 
at the invasive front in combination with serum IL-8 and N status was even shown to 
successfully predict tumour relapse and correlate with histological grade (Fujita et al., 2014; 
Mori et al., 2011; Weber et al., 2014).  In oral cancer, high numbers of CD163+ macrophages 
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were shown to correlate with lymph node metastasis (Wehrhan et al., 2014) and the 
number of these was found to increase between pre-operative incision biopsy samples and 
tumour resection (Weber et al., 2014).  In addition to the use of CD163 as a marker of TAM, 
some success has been observed with the use of CD206 expression, particularly in the case 
of metastatic oral carcinoma, even at an early stage (Fujita et al., 2014; Weber et al., 2014; 
Weber et al., 2016). 
Expression of CD163 is emerging as a potential diagnostic and prognostic marker in oral 
cancer.  The important role that CD163 plays in cancer progression in general has led to its 
use as a diagnostic marker in a variety of human cancers, including carcinomas of the breast, 
endometrium, ovaries, non-small cell lung and colon, in addition to Hodgkin’s and 
angioimmunoblastic T cell lymphomas (Espinosa et al., 2010; Forssell et al., 2007; Harris et 
al., 2012; Hu et al., 2009; Medrek et al., 2012; Niino et al., 2010; Ohri et al., 2011).  A lack 
of understanding in the role that macrophages play in oral cancer compared to the role they 
play in other cancers, is limiting the potential use of these cells for clinical benefit.   
 Macrophages in cancer therapy 
Macrophages are an attractive target for cancer therapies as their genome is more stable 
than that of tumour cells, reducing the chance of drug resistance developing (Qian and 
Pollard, 2010).  However, similarly to their pro- and anti-tumour roles in cancer progression, 
macrophages have demonstrated both favourable and detrimental effects in response to 
cancer treatments and therapy (Mantovani and Allavena, 2015). 
Macrophages as therapeutic targets  
In murine models of breast, melanoma and colon carcinoma, anti-macrophage receptor 
with collagenous structure (MARCO) antibodies were used to selectively target TAM 
resulting in reduced metastatic spread, reduced tumour volume and weight, and a shift in 
macrophage polarisation from M2 to M1 (Georgoudaki et al., 2016).  Alternatively, anti-M-
CSF antibodies have been investigated to halt macrophage development.  This has been 
shown to reduce metastasis and increase the sensitivity of murine models to chemotherapy 
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(Cheng et al., 2010; Morandi et al., 2011).  Additionally, the use of a chemokine receptor 
type 2 (CCR2) inhibitor in murine models of breast and pancreatic cancer reduced the 
number of macrophages from both the primary and metastatic tumour, and resulted in a 
decrease in the tumour growth and a reduction in metastasis (Qian et al., 2011; Sanford et 
al., 2013).  However, data published more recently has shown that whilst CCL2 inhibition 
initially prevented development of macrophages from the bone marrow to prevent 
metastasis, removing inhibition resulted in a rapid increase in metastasis and more rapid 
death (Bonapace et al., 2014).   
Further uses of myeloid cells as therapeutic targets include the blockade of recruitment of 
these cells to tumours using an anti-CD11b/CD18 antibody, resulting in increased sensitivity 
of squamous cell carcinoma to radiotherapy in a murine model (Ahn et al., 2010).  
Additionally, activation of macrophages using a CD40 antibody agonist resulted in 
macrophages adopting a tumoricidal phenotype, characterised by high expression of CD86, 
to infiltrate a murine model of pancreatic cancer resulting in disaggregation of the tumour 
stroma (Beatty et al., 2011).  Aside from antibody therapies, bisphosphonates have been 
shown to promote re-polarisation of M2 macrophages to an M1 phenotype.  In addition, 
the use of zoledronic acid to stimulate apoptosis of TAM has reduced their survival and has 
been successful in prolonging the disease-free survival of patients (Coleman et al., 2011; 
Rogers and Holen, 2011).  Further strategies for re-polarising M2 macrophages to an M1 
phenotype remain one of the most promising therapeutic options (Mills et al., 2016) and 
additional uses of macrophages as therapeutic targets have previously been reviewed 
(Panni et al., 2013). 
Macrophages for drug delivery 
As well as providing promising therapeutic targets in the fight against cancer, macrophages 
can be modified for use as agents for drug delivery.  Liposomes are commonly used to target 
macrophages for drug delivery as these are readily taken up by macrophages through 
interactions with scavenger receptors and liposome properties can easily be tailored 
specifically to modify the drug and the efficiency of its delivery (Kelly et al., 2011).  In 
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particular, CD163 plays a key role in the uptake of drugs for targeted delivery (Graversen 
and Moestrup, 2015).  In order to further improve this method of drug delivery, Cao et al., 
have coated liposomes with an isolated macrophage membrane.  This has not only enabled 
the coated liposomes to specifically target breast cancer cells, but also enhanced uptake of 
the liposomes by metastatic cells through increased integrin expression.  This had the effect 
of reducing cancer cell viability and metastasis (Cao et al., 2016).  Similarly, macrophage 
membranes have been used to coat upconversion nanoparticles for effective targeting of 
cancer, and for the purpose of in vivo cancer imaging (Rao et al., 2016). 
The use of therapeutic nanoparticles also aims to provide more targeted tumour 
cytotoxicity in order to prevent the unfavourable systemic side effects that results in poor 
patient compliance to chemotherapy.  Although successful alone, a study showed that the 
uptake of drug-loaded nanoparticles by TAM resulted in a 37 % increase in accumulation of 
the chemotherapeutic agent within the tumour mass resulting in sustained and targeted 
drug delivery that was diminished when TAM numbers were depleted (Miller et al., 2015).  
The chemotaxis of macrophages towards cancer cells has also been used to attract 
macrophage-based ‘microbots’ containing drug-loaded magnetic nanoparticles to 
spheroids in murine models of colon and mammary gland carcinoma to induce targeted 
cytotoxicity of the tumour cells (Han et al., 2016).   
An alternative approach is the use of macrophages as vehicles for gene therapy (Burke et 
al., 2002).  Recent advances include the use of oncolytic viruses, under the regulation of a 
hypoxia inducible construct, contained within macrophages.  In regions of hypoxia, 
oncolytic viruses were able to replicate and specifically target prostate tumour cells in a 
xenograft model (Muthana et al., 2011).  When this approach was combined with 
chemotherapy and radiotherapy, which are typically followed by a marked increase in 
macrophage infiltration into tumours, metastasis and tumour regrowth were suppressed 
resulting in the increased survival of mice (Muthana et al., 2013).  Immunosuppressive Tie2-
expressing monocytes have been specifically targeted for tumour therapy (Coffelt et al., 
2011) and with the inclusion of Ifna1 gene resulted in a reduction in tumour growth and 
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metastasis in murine models of glioma and mammary carcinoma without the toxicity 
previously seen with systemic administration of IFNα (De Palma et al., 2008). 
 
1.3 Pre-clinical Models in Oral Health Research 
 Pre-clinical models 
Monolayer models  
Traditionally, cells are cultured as monolayers in tissue culture-treated flasks.  However, in 
2D culture, cells are flattened, lack cell-to-cell and cell-to-matrix interactions as the ECM 
component is missing (Mazzoleni et al., 2009).  In vivo, oral keratinoyctes form a multi-
layered epithelium at an air-liquid interface (ALI), however this cannot be achieved in 2D 
culture which prevents the formation of a stratified epithelium (Kriegebaum et al., 2012).  
In addition, the many oral cell types cultured in close proximity in vivo release signals to 
enable oral mucosa formation, but typically only a single cell type can be cultured in 2D.  
Therefore, in 2D, oral keratinocytes do not have a representative structure or function 
(Cukierman et al., 2001).   
Animal models  
There are many different in vivo animal models of oral cancer; oral cancer can be chemically 
induced, tumours can be transplanted or transgenic animals can be used (Mognetti et al., 
2006).  In vivo models are essential but, similarly to in vitro models, they have limitations.  
Evidence has shown that there are many inter-species differences between humans and 
animal models, and with limited conserved features, disease modelled in animals may not 
truly represent disease in humans (Kimlin et al., 2013).  Specifically, pathogenicity and liver 
toxicity have shown large differences between mice and humans (Mazzoleni et al., 2009).  
‘Humanised’ rodents have been developed for use when animal models are 
unrepresentative and human trials are not possible (Brusevold et al., 2010), however the 
results from these experiments are often variable (Gaballah et al., 2008).  In particular, 
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evidence confirming any similarities between macrophages in animals compared to those 
in humans is lacking (Qian and Pollard, 2010).  Macrophages in murine models, used in the 
majority of studies, differ markedly from those in the human immune system (Murray and 
Wynn, 2011; Roszer, 2015).  Whilst in mice iNOS is a prototypical M1 marker, CD64, 
indoleamine 2,3-dioxygenase (IDO), suppressor of cytokine signalling 1 (SOCS1) and CXCL10 
proteins are more typically used in human studies.  CD206 and TGM2 have both been used 
as an M2 marker in both human and mouse studies, however other markers used in human 
studies, such as CD23 and CCL22 are not used in murine studies (Martinez and Gordon, 
2014). A lack of humanised pre-clinical models makes the translation of therapies into 
clinical use difficult.   
3D spheroid models  
Spheroid models are formed by aggregation of cells in culture by using various methods; 
hanging drop, using spinner flasks, static liquid overlay technique (LOT) or by centrifugation 
(Fennema et al., 2013).  Spheroids provide a useful model for hypoxia in the tumour 
microenvironment, within the necrotic core (Sutherland et al., 1981), but as the simplest 
3D model, they typically do not represent a multi-layered tissue architecture which is 
essential for engineering oral mucosa (Kimlin et al., 2013).    
 Tissue-engineered models 
Structure of the oral mucosa 
The oral mucosa forms a protective barrier from mechanical or microbial damage to 
underlying tissues (Squier and Kremer, 2001).  It consists of the epithelium and connective 
tissue which are separated by the basement membrane (Figure 1.4).   
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Figure 1.4.  Structure of the oral mucosa.   Components of the epithelium, basement 
membrane and connective tissue are represented diagrammatically and labelled. 
The oral mucosa epithelium separates the oral cavity and deeper tissues, and consists of 
keratinocytes which form a stratified squamous epithelium.  Depending on location within 
the oral cavity, this epithelial layer can take on different characteristics, such as non-
keratinised (e.g. buccal mucosa and ventral surface of the tongue) or keratinised (e.g. on 
the hard palate and gingivae).   
Within a keratinised oral epithelium are four layers: the stratum basale which contains a 
single layer of cuboidal cells in contact with the basement membrane, which are rapidly 
proliferating; the stratum spinosum which is several cell layers thick; the stratum 
granulosum is formed of several layers of flat cells containing keratohyaline granules which 
Epithelium 
Lamina 
propria 
Stratum corneum 
Stratum granulosum 
Stratum spinosum 
Stratum basale 
Lamina lucida 
Lamina densa 
Lamina reticularis 
Submucosa 
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help form the impermeable keratin layer; and the stratum corneum characterised by a-
nuclear cells containing keratin filaments.  Cells of the stratum corneum are continuously 
replaced by proliferating cells in the stratum basale which differentiate upwards through 
the epithelial layers, with oral mucosa renewed every 41-57 days (Dongari-Bagtzoglou and 
Kashleva, 2006).  In a non-keratinised oral epithelium, the stratum corneum and stratum 
granulosum layers are absent and are replaced by the stratum intermedium (an epithelial 
structure closely associated with the inner dental epithelium) and stratum superficiale, 
where stratified squamous epithelial cells have reached maturity and as such are flat and 
non-proliferative cells (Koyama et al., 2001). 
The basement membrane is a specialised extracellular matrix containing many 
glycoproteins alongside collagen, integrins and proteoglycans, which forms a barrier 
between the epithelium and the connective tissue (Merker, 1994).  Components of the 
basement membrane have been shown to have an influence on the adjacent epithelium, 
such as collagen IV and laminin which have been shown to be important in the 
differentiation of oral keratinocytes in 3D culture (Kim et al., 2001). Three different layers 
of the basement membrane can be identified and these include; the lamina lucida on the 
epithelial side, lamina reticularis on the lamina propria side and lamina densa sandwiched 
in between. 
The connective tissue is also split into layers, with the lamina propria nearest the basement 
membrane, and the submucosa in limited areas of the mouth such as cheeks and lips.  The 
lamina propria contains blood and lymphatic vessels, nerves, fibroblasts and immune cells 
within the papillary and reticular layers all within a supportive inter-cellular matrix.  Fibrous 
proteins in the inter-cellular matrix include fibronectin, elastin and collagen, where collagen 
type 1 is the most abundant.  The submucosa provides attachment of the lamina propria to 
bone and muscle, and contains minor salivary glands. 
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Scaffolds for tissue engineering  
In vitro 3D culture has been shown to promote increased cell proliferation when compared 
to 2D culture (Li et al., 2013) and creates a more physiologically relevant structural 
architecture with the use of natural or artificial scaffolds (Lee et al., 2008).  This enables 
cells cultured in 3D in vitro to replicate more closely the gene and protein expression 
profiles of cells in vivo (Abbott, 2003).  3D culture provides a superior culture method to 2D 
culture as these changes in cell behaviour have produced more accurate and  predictive 
cell-based assays, improving clinical trial outcomes (Kimlin et al., 2013). 
3D models have not only become a useful tool with which to culture cells in a more 
physiologically relevant environment, but they also bridge the gap between in vivo animal 
models and human applications (Mazzoleni et al., 2009).  The European Chemicals 
Legislation have identified a need for development of representative in vitro models to 
reduce the use of in vivo models to produce more data related to humans (Lilienblum et al., 
2008).   
Hydrogels can be formed from natural, synthetic or a combination of natural and synthetic 
molecules.  They aim to simulate the ECM component of tissue, enabling 3D cell culture.  
These substrates of highly cross-linked polymers have a high water content allowing rapid 
diffusion of oxygen, nutrients and waste products between cells and the surrounding 
culture medium (Nguyen and West, 2002).  Collagen is the major structural component of 
the ECM where its main role is in mechanical integrity (Rajan et al., 2006).  It has therefore 
been used in the engineering of many different 3D models containing cells of different 
origin, including; intestinal (Viney et al., 2009), endothelial (Koh et al., 2008), dermal (Smola 
et al., 1998) and oral (Dongari-Bagtzoglou and Kashleva, 2006) either in mono-culture or as 
co-cultures.  Bovine, equine, rat-tail and plant-derived collagen is available, which can be 
combined with other components such as glycosaminoglycans (GAG)-chitosan to alter 
properties of the ECM (Griffon et al., 2006).  Apligraf is a commercially available collagen-
based skin substitute which combines collagen with dermal fibroblasts and human 
keratinocytes and is used clinically to promote wound healing.   
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Synthetic polymers have also been used to produce scaffolds on which cells can be cultured.  
These have an advantage over naturally-derived scaffolds as they are more reproducible.   
They can be derived from polymers such as poly-(L)-lactic acid (PLLA), polyglycolic acid 
(PGA) and polystyrene (Yang et al., 2001).  Commercially available oral mucosa models 
which incorporate a synthetic scaffold include MatTek and Skinethic, however these  both 
lack an essential connective tissue component including fibroblasts (Moharamzadeh et al., 
2008).   
Examples of scaffolds used for in vitro 3D oral mucosa models include de-epidermised 
dermis (DED), hydrogels, synthetic scaffolds and spheroids which can be used for modelling 
disease and drug testing, for example.  One of the limiting factors for 3D models however 
is the need for standardisation and the development of protocols to separate cells from the 
model for analysis (Mazzoleni et al., 2009).   
Tissue engineered models of the oral mucosa 
The use of ex vivo oral mucosa is popular for use as a scaffold in oral mucosa models as its 
architecture cannot always be recapitulated by engineered tissues.  Whilst porcine and 
bovine buccal mucosa can be used, human ex vivo tissue is the most relevant for modelling 
human disease.  Due to the limited size of human oral mucosa, human skin provides a useful 
alternative.  DED is produced by using skin grafts which are de-cellularised to remove the 
epidermis, leaving the basement membrane intact.  The collagen IV and laminin 
components of the basement membrane allow attachment of different cell types to the 
DED  to produce a tissue engineered oral mucosa (Hearnden et al., 2009).  Whilst DED 
models may provide the most physiologically relevant tissue architecture, there is vast 
patient variability between grafts and a lack of immune cell components (Colley et al., 
2011).  Alloderm is a commercially available matrix based on DED which is used clinically to 
support tissue regeneration, particularly in dental applications.   
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 Towards improved full-thickness oral mucosa models 
The tumour microenvironment is a complex interplay of multiple cell types residing within 
a specific ECM.  In 1863, Virchow first noted the link between leukocytes and cancer as he 
observed a large number of infiltrating cells into tumours (Virchow, 1863).  Since then, 
evidence has shown that the tumour stroma is more than just an observer to tumour 
progression, with fibroblasts, macrophages, other immune cells and secreted cytokines 
shown to play a role (Mueller and Fusenig, 2004).  Three-dimensional in vitro models are 
being developed which represent the tumour microenvironment more accurately than 
traditional monolayer cell culture, ex vivo and in vivo models.  Suggestions for 
improvements to currently available oral cancer models are described below. 
Oral mucosa models containing haematopoietic cells 
Haematopoietic stem cells (HSCs) that originate in the bone marrow, differentiate into all 
other mature blood cell types via either the common myeloid or lymphoid progenitors.  
Some studies have developed 3D models of the haematopoietic niche in order to further 
understand the mechanisms involved in haematopoiesis (Cook et al., 2012; Leisten et al., 
2012; Pietrzyk-Nivau et al., 2015).  Immune cells, that originate from HSCs, aid the oral 
mucosa in its role as a protective barrier.  The connective tissue component of oral mucosa 
contains dendritic cells, mast cells and macrophages in order to provide innate immunity 
(Feller et al., 2013).  These release cytokines, chemokines and antimicrobial peptides to 
protect the oral cavity against microbial invasion.  Mast cells and neutrophils are white 
blood cells which initiate inflammation in response to microbial products.  Dendritic cells 
have a primary role in antigen presentation accompanied by macrophages which also aid 
microbial clearance using phagocytosis (Feller et al., 2013). 
In order to further understand the role that immune cells play within tissues, in addition to 
how they develop and mature in the bone marrow, a need for an immune cell component 
within 3D tissue engineered in vitro models has been identified.  So far, immune cells have 
been incorporated into a limited number of models.  Monocyte-derived macrophages 
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(MDM) and dendritic cells within an intestinal mucosa collagen-transwell-based model have 
been used to improve drug delivery in inflammatory bowel disease (Leonard et al., 2010).  
This model was further developed to include THP-1 or MUTZ-3 cells in order to improve the 
reproducibility of the model (Julia Susewind, 2015, published dissertation).  Macrophages 
have also been co-cultured with tumour spheroids in a colon carcinoma model to assess 
tumour invasion, migration and the inflammatory response (Hauptmann et al., 1993).   
For the purpose of dermal research, Bechetoille et al., showed that macrophages within a 
bovine collagen, chitosan and chondroitine 4-6 sulfate solid scaffold secreted anti-
inflammatory cytokines in response to LPS (Bechetoille et al., 2011).  Dermal models have 
also been developed using commercially available dendritic cells (Uchino et al., 2009) and 
THP-1 monocyte cell line in a skin sensitisation model (Uchino et al., 2013).    TAM have 
been monitored within a 3D in vitro dermal model in which macrophages were incorporated 
within a collagen hydrogel (Linde et al., 2012).  In addition, a single co-culture system 
investigating the crosstalk between dermal keratinocytes and T cells has been identified, 
which uses a de-cellularised DED (van den Bogaard et al., 2014).  A comprehensive literature 
search failed to show any studies using 3D in vitro culture of neutrophils, likely due to their 
short life-span.  However, promyelocytic HL60 cells differentiated along the granulocytic 
pathway have been used as a replacement (Hirz and Dumontet, 2016).  Other areas of 
research which have successfully incorporated macrophages into 3D in vitro models include 
collagen hydrogels using lung adenocarcinoma cell lines (Liu et al., 2016) and a tetra-culture 
of fibroblasts, adipocytes, primary human monocytes or macrophages and breast 
carcinoma cell lines cultured under perfusion flow (DesRochers et al., 2015, published 
abstract).  These are summarised in Table 1.2.  
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Disease model Immune cell Scaffold Analyses Reference 
Inflammatory 
bowel disease 
MDM; monocyte-derived 
dendritic cells 
Collagen-coated transwell TEER; IHC-P; IF; CBA (Leonard et al., 2010) 
Healthy dermal 
equivalent 
MDM 
Bovine collagen, chitosan 
and chondroitine 4-6 
sulfate-coated insert 
ELISA; IHC; IF; fluorescent 
bead phagocytosis 
(Bechetoille et al., 2011) 
Monocyte-derived 
dendritic cell 
Collagen vitrigel 
membrane 
IHC; Ellman’s test (Uchino et al., 2009) 
THP-1 
Collagen vitrigel 
membrane 
ELISA; cytotoxicity assay (Uchino et al., 2013) 
Dermal squamous 
cell carcinoma 
MDM Collagen hydrogel IF; IHC; zymography (Linde et al., 2012) 
Dermal 
inflammation 
Primary T cells DED IHC; ELISA; qPCR 
(van den Bogaard et al., 
2014) 
Leukaemia HL60; Kasumi-1; MV411 
PGA/PLLA 90/10 co-
polymer discs 
IHC; flow cytometry; 
cytotoxicity assay; fluorescent 
dextran diffusion assay 
(Aljitawi et al., 2014) 
Lung 
adenocarcinoma 
Not specified Collagen hydrogel IF; ELISA; Western blot (Liu et al., 2016) 
Blood-brain-barrier Astrocytes Collagen hydrogel IF; dextran diffusion assay (Tourovskaia et al., 2014) 
Table 1.2.  In vitro 3D models containing an immune cell component.   Transepithelial electrical resistance (TEER), immunohistochemistry 
(IHC), cytokine bead array (CBA), immunofluorescence (IF), enzyme-linked immunosorbent assay (ELISA), quantitative polymerase chain 
reaction (qPCR).
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Whilst other fields have reported successes with 3D in vitro models containing immune 
cells, to the best of our knowledge, primary human immune cells have yet to be 
incorporated into a long-term collagen-based 3D in vitro oral mucosa model.  Examples of 
simple co-cultures include; an indirect co-culture combining peripheral blood monocytic 
cells (PBMC) and OSCC cell lines cultured in inserts (Essa et al., 2016), phorbol 12-myristate 
13-acetate (PMA)-treated THP-1 pro-monocytes seeded directly onto a mucoepidermoid 
carcinoma cell line monolayer (Chiu et al., 2014; Lee et al., 2014) or the use of PMA-treated 
THP-1 cells seeded onto chamber slides in combination with human oral squamous cell 
carcinoma cancer cell lines.  More complex tissue-like models have also used alternatives 
to primary human cells, including MUTZ-3 dendritic cell line which has been cultured in 
collagen hydrogel-based models of the human gingiva to investigate the maturation and 
migration of Langerhans cells (Kosten et al., 2015).  Mono Mac 6 (MM6) cell line has been 
perfused into an oral infection model of the periodontal pocket (Bao et al., 2015b).  In the 
only use of primary human immune cells within a 3D oral model that could be found, PBMC 
were seeded into a gingival model on gelatin-coated ThinCerts™ 24 hours before the end 
point to investigate the effect of radiation on modelled gingiva (Tschachojan et al., 2014).  
It has also been shown that macrophages could be detected in a myoma scaffold bearing 
human oropharyngeal squamous cell carcinoma cells (Nurmenniemi et al., 2009), and 
although the addition of exogenous immune cells to this scaffold has not been explored, 
the addition of conditioned media from PMA-treated THP-1 cells polarised to M2-type 
resulted in increased invasion and secretion of cytokines associated with OSCC (Pirila et al., 
2015).  Oral mucosa models containing commercially available immune cell lines are listed 
in Table 1.3.   
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Disease model Immune cell Culture method Reference 
Healthy gingival 
equivalent 
MUTZ-3 3D collagen hydrogel (Kosten et al., 2015) 
Periodontal 
pocket 
MM6 3D collagen sponge (Bao et al., 2015a) 
Immortalised 
gingival equivalent 
PBMC 
Gelatin-coated 
ThinCerts™ 
(Tschachojan et al., 
2014) 
Tongue SCC 
 
THP-1 Myoma punch biopsy (Pirila et al., 2015) 
Table 1.3.  In vitro 3D models of oral tissue containing an immune cell component. 
Previously published 3D models containing macrophages have shown dramatic differences 
in the proliferation, differentiation, morphology and cellular functions of macrophages 
cultured compared to those cultured as monolayer (Liu et al., 2016). 
Oral mucosa models containing stromal cells 
Fibroblasts and pericytes are the most common cell type in the stroma.  Fibroblasts are 
responsible for the turnover of the extracellular matrix, and pericytes are contractile cells 
which surround endothelial cells that make up the vasculature.  Fibroblasts are commonly 
used in tissue-engineered models as they secrete factors, such as keratinocyte growth 
factor (KGF), required for differentiation and stratification of an epithelium, and they 
contribute to the integrity of the scaffold used (Latkowski et al., 1995).  Models devoid of 
fibroblasts, but with exogenous application of KGF, produce a thick, but undifferentiated 
epithelium due to increased keratinocyte proliferation (Costea et al., 2003).  Stimulation of 
fibroblasts cultured in 2D can enable them to secrete enough of their own ECM to support 
culture of dermis in a tissue engineered model (Berning et al., 2015). 
Pericytes however are typically only used in models of angiogenesis.  There a number of 
methods for their isolation from primary tissue and commercially available pericyte cell 
lines, although their widespread use is limited by the lack of pericyte-specific markers.  
There is, however, an example of their successful incorporation into a collagen hydrogel 
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modelling the blood-brain-barrier in the only co-culture of pericytes with an immune 
component that could be found (Tourovskaia et al., 2014).  Other models containing 
pericytes in co-culture with endothelial cells are reviewed here (Gokcinar-Yagci et al., 2015).  
Of interest, a tissue-engineered model of angiogenesis containing both fibroblasts and 
pericytes showed that pericytes were recruited from fibroblasts, due to platelet-derived 
growth factor (PDGF, Berthod et al., 2012). 
Vascularisation of tissue-engineered models 
The rich vascular network present in the human body is essential for tissue growth and 
repair.  Evidence has also shown the importance that the vasculature has in tumour growth 
as it supplies nutrients, oxygen and removes waste.  In addition, it provides cancer cells with 
a route to enter circulation for metastasis and enables a constant supply of immune cells to 
extravasate from circulation to further support tumour development.  The vasculature is so 
essential to a malignancy that cancer cells employ many different mechanisms to promote 
angiogenesis (Nagy et al., 2009).  Many anti-cancer therapies aim to target angiogenesis, 
however in order to understand more about the mechanisms involved and test potential 
therapies, humanised tissue engineered models of cancer require a vasculature in order to 
best represent the in vivo situation.   
Vascularisation of tissue-engineered models typically involves the use of moulds, guides and 
sacrificial lattices to form channels where endothelial cells can be cultured into perfusable 
channels.  For example, to model angiogenesis and the blood-brain-barrier, a chip can be 
used into which endothelial cells are seeded to form vessels that are surrounded by an ECM 
containing stromal cells (Tourovskaia et al., 2014).  Alternatively, networks of 3D printed 
carbohydrate glass encapsulated within a polyethylene glycol (PEG) hydrogel containing the 
cells of interest, can be used to form a vessel template which later dissolves and can be 
lined with endothelial cells (Miller et al., 2012).  Mimetas offer a commercially available 
pump-free, perfusable 3D vasculature surrounded by a collagen gel.   
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Vascularisation of tissue-engineered models can also be achieved using the spontaneous 
sprouting observed by endothelial cells cultured within an appropriate scaffold (typically 
collagen).  A pre-vascularised tumour model has described co-cultures of breast or colon 
cancer cells with endothelial cells within tumour spheroids, embedded into a fibrin gel 
containing fibroblasts.  This model not only models angiogenesis, but also intravasation of 
tumour cells under the influence of hypoxia (Ehsan et al., 2014).  Tubule formation assays 
are becoming increasingly popular and have the potential for incorporation into 3D in vitro 
models.  Tubule formation assays involve the culture of endothelial cells within Cultrex 
Basement Membrane Extract, where they begin to form tubules under the influence of 
exogenous stimuli, such as VEGF, PDGF, epidermal growth factor (EGF) and FGF2 
(Arnaoutova and Kleinman, 2010; DeCicco-Skinner et al., 2014).  ThermoFisher offer an 
assay which supplies a gel and ‘positive inducer’ to promote tubule formation.   
Alternatively, a microvascular system has been developed which uses a micropump to 
induce flow around glass circuits which become covered with endothelial cells after 4 days 
(Schimek et al., 2013).  This technology can be incorporated into existing ‘human on a chip’ 
models to create more physiologically relevant model systems. 
1.4 Hypothesis and Aims  
Immunohistochemical studies have shown that macrophages, specifically those which are 
CD163+, correlate with a poor prognosis in OSCC.  However, due to a lack of reproducible 
models containing primary human immune cells, the role that macrophages play in oral 
cancer progression remains largely unknown.  In vitro 3D models are increasingly bridging 
the gap between basic and translational research due to their increased complexity 
compared to monolayer cultures, and increased clinical relevance and reduced cost 
compared to in vivo models.  The hypothesis of this study is that in vitro 3D models of the 
oral mucosa containing an immune component will improve understanding of the role TAM 
play in oral cancer progression.  Currently, to the best of our knowledge, there are no 
published models of the oral mucosa which incorporate primary human monocytes or 
macrophages.  In addition, to enable the analysis of macrophages cultured within 
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engineered tissues, molecular tools and rapid isolation methods are required to preserve 
the underlying phenotype of these highly plastic cells (Murray et al., 2014). 
Therefore, this thesis aims to address these problems, by: 
a) Generating a tissue-engineered 3D in vitro model of the oral mucosa containing 
primary human immune cells;  
b) Developing a multi-colour flow cytometry panel for the quantitative analysis of 
macrophage protein expression; 
c) Optimising the use of the multi-colour flow cytometry panel on macrophages 
isolated from tissue-engineered models of the oral mucosa. 
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 Chapter 2: Materials and Methods 
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2.1 Materials 
Manufacturers and product names for all reagents used in this work are described in the 
text. 
2.2 2D cell culture  
 Cell lines 
THP-1 (ATCC® TIB-202™) 
THP-1 cells, a promonocytic cell line originally isolated from a male infant with acute 
monocytic leukaemia (Tsuchiya et al., 1980), were maintained in suspension in Roswell Park 
Memorial Institute (RPMI) 1640 medium (Sigma Aldrich, Dorset, UK) supplemented with 
100 IU/mL penicillin (Sigma Aldrich, Dorset, UK), 100 µg/mL streptomycin (Sigma Aldrich, 
Dorset, UK) and 10 % batch-tested foetal bovine serum (FBS, v/v; Biosera, East Sussex, UK). 
Mono Mac 6 
Mono Mac 6 cells, established from a patient with acute monoblastic leukaemia (AML, 
Zieglerheitbrock et al., 1988),  were cultured in suspension in RPMI 1640 supplemented 
with 100 IU/mL penicillin, 100 µg/mL streptomycin, 10 % batch-tested FBS (v/v), 1-2x non-
essential amino acids (NEAA, v/v; Life Technologies, Paisley, UK) and 10 % OPI supplement 
(containing oxaloacetate, pyruvate and insulin, v/v; Sigma Aldrich, Dorset, UK).   
H357 
Human epithelial OSCC cell line, H357, isolated from the tongue of a 74 year old male (Prime 
et al., 1990) were cultured adherent to tissue culture plastic in Dulbecco’s modified Eagle’s 
medium (DMEM; Gibco, Paisley, UK) supplemented with 100 IU/mL penicillin, 100 µg/mL 
streptomycin and 10 % batch-tested FBS (v/v).   
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NIH/3T3 (ATCC® CRL-1658™) 
3T3 murine fibroblast cells were cultured adherent to tissue culture plastic in RPMI 1640 
supplemented with 100 IU/mL penicillin, 100 µg/mL streptomycin and 10 % iron-fortified 
calf bovine serum (Sigma Aldrich, Dorset, UK).   
For irradiation of 3T3, cells were exposed to 60 Grays using a cobalt-60 source irradiator to 
arrest cell growth and cryopreserved.  Irradiated 3T3s were resurrected immediately prior 
to use and referred to as ‘i3T3’ cells. 
FNB6 hTERT 
Human telomerase immortalised epithelial cell line, FNB6, isolated from a healthy volunteer 
were maintained in adherent culture on an i3T3 feeder layer in Green’s medium (Table 2.1).   
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Component Volume  Stock conc.  Final conc.  Storage 
DMEM 330 mL - 66 % 4°C 
Ham’s F12 108 mL - 21.6 % 4°C 
FCS 50 mL - 10 % -20°C 
Penicillin/streptomycin 5 mL - 1% -20°C 
Amphotericin B 1.25 mL  250 µg/mL 0.625 µg/mL -20°C 
Adenine 2 mL 6.25 µg/mL 0.025 µg/mL -20°C 
Insulin 2.5 mL  1 mg/mL 5 µg/mL 4°C 
3, 3, 5-Tri-
iodothyronine (T3)  
0.5 mL 136 µg/mL 136 ng/mL -20°C 
Apo-transferrin 0.5 mL 5 mg/mL 5 µg/mL -20°C 
Hydrocortisone 80 µL 2.5 mg/mL 4 µg/mL 4°C 
Epidermal Growth 
Factor (EGF) 
25 µL 100 µg/mL 5 ng/mL -20°C 
Cholera toxin 500 µL 8.47 µg/mL 8.47 ng/mL 4°C 
Table 2.1.  Green’s medium.   Table lists the volume, stock and final concentrations and 
storage conditions for the components required in Green’s medium used for FNB6 and NOK 
cells.  Adapted from Hearnden, V thesis, January 2011. 
 Primary cells 
Normal oral keratinocyte isolation 
Normal oral keratinocytes (NOK) were isolated from the oral mucosa during routine dental 
procedures with written informed consent (ethical approval number 09/H1308/66) as 
previously described (Hearnden et al., 2009).  Briefly, biopsies were incubated overnight at 
4 ᵒC in 0.05 % trypsin/0.02 % ethylenediaminetetraacetic acid (EDTA) supplemented with 
100 IU/mL penicillin, 100 µg/mL streptomycin and 0.625 µg/mL amphotericin B (Sigma 
Aldrich, Dorset, UK).  Following enzymatic digestion, the connective tissue was separated 
from the epithelium; keratinocytes were gently scraped from the surface of the biopsy and 
collected for subsequent culture.  Following centrifugation, NOK cells were cultured in 
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Green’s medium (Table 2.1) and maintained adherent to tissue culture plastic on an i3T3 
feeder layer until passage 3, where cells were discarded (Rheinwald and Green, 1975). 
Normal oral fibroblast isolation 
Primary human normal oral fibroblasts (NOF) were isolated from the oral mucosa during 
routine dental procedures with written informed consent (ethical approval number 
09/H1308/66) as previously described (Hearnden et al., 2009).  Briefly, biopsies were 
incubated overnight at 4 ᵒC in 0.05 % trypsin/0.02 % EDTA supplemented with 100 IU/mL 
penicillin, 100 µg/mL streptomycin and 0.625 µg/mL amphotericin B (Sigma Aldrich, Dorset, 
UK).  Following enzymatic digestion, the connective tissue was separated from the 
epithelium and finely minced, followed by digestion with 0.5 % collagenase A (w/v; Sigma 
Aldrich, Dorset, UK) overnight in a humidified environment at 37 ᵒC and 5 % CO2.  Following 
centrifugation, NOF cells were cultured adherent to tissue culture plastic in DMEM 
supplemented with 100 IU/mL penicillin, 100 µg/mL streptomycin (v/v) and 10 % batch-
tested FBS (v/v) until passage 9, where cells were discarded.  
Human peripheral blood monocyte isolation 
Human peripheral blood monocytes (PBM) were isolated from buffy coats (ethical approval 
number 012597) by Ficoll-hypaque (GE Healthcare, Buckinghamshire, UK) density gradient 
centrifugation.  Blood cells were mixed 1:1 with Hank’s balanced salt solution (HBSS, 
without Ca2+ and Mg2+; Fisher Scientific, Leicestershire, UK), carefully overlayed onto Ficoll-
hypaque and centrifuged at 400 x g for 40 minutes at room temperature with reduced 
deceleration.  The monocyte layer (between the upper serum and lower Ficoll layers) was 
removed by aspiraton using a Pasteur pipette and washed several times in HBSS.  In order 
to further enrich the monocyte population, a human pan monocyte isolation kit was used 
according to the manufacturer’s instructions (Miltenyi).  Briefly, CD14+CD16+ cells were 
negatively selected using a cocktail of antibodies bound to microbeads.  Magnetically 
labelled CD14-CD16- cells remained bound to an LS column, enabling CD14+CD16+ cells to 
be collected.  Monocyte purity was assessed by flow cytometry (CD14+).  Human monocytes 
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were cultured, initially in suspension until they became adherent to tissue culture, in 
Iscove’s modified Dulbecco’s medium (IMDM; Gibco, Paisley, UK) supplemented with 2 % 
human AB serum (v/v; Sigma Aldrich, Dorset, UK), 100 IU/mL penicillin and 100 µg/mL 
streptomycin.   
 Passaging, cryogenic preservation and recovery of cells 
Passaging of cells in suspension culture 
THP-1 cells were sub-cultured when cell concentration reached 0.8x106 cells/mL, by 
centrifugation for 5 minutes at 190 x g and cells were resuspended at 0.2-0.4x106 cells/mL 
in fresh, supplemented media.  MM6 cells were sub-cultured when cell concentration 
reached 1x106 cells/mL, by centrifuging for 5 minutes at 190 x g and re-suspending cells at 
0.6-0.8x106 cells/mL in fresh, supplemented media.  Cells were passaged every 2-3 days and 
cell concentration never exceeded 1x106 cells/mL.   
Passaging of cells in monolayer culture 
H357, FNB6 and NOF cells were passaged at 90% confluence by removing media and 
washing twice with calcium and magnesium-free phosphate buffered saline (PBS; Sigma 
Aldrich, Dorset, UK) before incubating with 0.05 % trypsin/0.02 % EDTA (Sigma Aldrich, 
Dorset, UK) at 37 ᵒC for 10 minutes, or until cells were detached.  Medium containing 10 % 
FBS was added at a 1:1 (v/v) ratio to prevent further enzymatic activity.  Cells were 
centrifuged at 190 x g for 5 minutes, re-suspended at the required concentration (Table 
2.2) of appropriate cell culture medium and seeded into 75 cm2 tissue culture flasks 
(Greiner-Bio-One, Germany).  At 80 % confluence, NIH/3T3 were passaged as above.  All 
cells were cultured in a humidified environment at 37 ᵒC in 5 % CO2 and routinely tested for 
mycoplasma contamination.  Media was refreshed every 2-3 days. 
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Cell type Seeding density 
H357 5x103/cm2 
FNB6 13x103/cm2 
NIH/3T3 3x103/cm2 
Table 2.2.  Seeding densities of cell lines.   The seeding density of cell lines H357, FNB6 and 
NIH/3T3 is described. 
Cells were counted using a Neubauer haemocytometer (Weber Scientific International, 
Middlesex, UK) using the equation below (Equation 2.1): 
𝐶𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 𝑜𝑓 𝑐𝑒𝑙𝑙𝑠 𝑝𝑒𝑟 𝑚𝐿 =  
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑐𝑒𝑙𝑙𝑠 𝑥 10,000
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑠𝑞𝑢𝑎𝑟𝑒𝑠 𝑥 𝑑𝑖𝑙𝑢𝑡𝑖𝑜𝑛 𝑓𝑎𝑐𝑡𝑜𝑟
 
Equation 2.1.  Equation to determine cell number.  The relationship between number of 
cells counted with a haemocytometer and the total concentration of cells is described. 
Freezing cells for cryogenic preservation 
For long term storage, cells were passaged (as above) and resuspended at 1x106 cells/mL in 
freezing medium (90 % FBS (v/v) with 10 % dimethyl sulfoxide (DMSO, v/v; Sigma Aldrich, 
Dorset, UK)).  One millilitre of this solution was added to each cryovial (Greiner bio-one, 
Gloucestershire, UK) for cryopreservation.  Cryovials were placed in a Mr. Frosty™ freezing 
container (Thermo Scientific, Leicestershire, UK) which achieves a cooling rate of 1 ᵒC per 
minute to -80 ᵒC prior to long-term storage in liquid nitrogen for optimal cell preservation.   
Recovery of frozen cells 
When required, cells were thawed and immediately re-suspended in appropriate 
supplemented cell culture media, centrifuged at 190 x g for 5 minutes to remove DMSO and 
the pellet re-suspended in media and seeded into 75 cm2 tissue culture flask. 
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 Differentiation of monocytes to macrophages 
Human monocyte-derived macrophages 
Human PBM in suspension were cultured in 75 cm2 tissue culture flasks, where they 
immediately became adherent.  Adherent monocytes were washed twice with PBS every 3 
days and cultured in fresh supplemented IMDM to remove non-adherent cells.   PBM were 
differentiated to MDM for between 7 and 14 days.   
THP-1 macrophages 
THP-1 monocytes were seeded at 5x105 cells/mL and treated with 200 nM PMA (Sigma 
Aldrich, Dorset, UK) as previously described (Daigneault et al., 2010).  Briefly, cells were 
incubated with PMA for 3 days followed by a resting phase for 5 days in a humidified 
environment of 5 % CO2 at 37 ᵒC.   
Mono Mac 6 macrophages 
To differentiate MM6 cells into a macrophage-like cell, adherence was induced as 
previously described (Zieglerheitbrock and Ulevitch, 1993).  Briefly, cell culture 24-well 
plates were pre-coated with 50 % (v/v) human serum diluted in PBS and incubated for 1 
hour at 37 °C.  With pre-coating serum removed, 1 mL of cell culture medium containing 
0.5x106 cells/mL was added to each well and cultured for 72 hours in the presence or 
absence of 10-50 ng/mL PMA. 
 Polarisation of macrophages 
To promote polarisation, MDM were treated with supplemented IMDM with the addition 
of human recombinant cytokines and E.coli LPS.  To polarise MDM to an M1 phenotype, 10 
ng/mL GM-CSF (Peprotech, London, UK) was added, or for M2 polarised MDM 25 ng/mL M-
CSF (Peprotech, London, UK) was added, for a total of 7 days with media and cytokines 
refreshed on days 3 and 6 (Zhang et al., 2013).  For the final 24 hours of the 7-day culture 
period, cell culture media was further supplemented with 100 ng/mL LPS (Sigma Aldrich, 
Dorset, UK) and 20 ng/mL IFNγ (Peprotech, London, UK) for M1 polarised MDM (Zhang et 
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al., 2013).  Alternatively, for M2a polarised MDM, 25 ng/mL IL-4 (Peprotech, London, UK) 
was added for the final 24 hours of culture (Zhang et al., 2013) or for M2c polarised MDM, 
20 ng/mL IL-10 (Peprotech, London, UK) was added (Mia et al., 2014).  This is summarised 
in Table 2.3. 
 M0 M1 M2a M2c 
6 days - 10 ng/mL 
GM-CSF 
25 ng/mL  
M-CSF 
25 ng/mL  
M-CSF 
24 hours  
- 
100 ng/mL 
LPS 
 
25 ng/mL  
IL-4 
 
20 ng/mL  
IL-10 20 ng/mL 
IFNγ 
Table 2.3.  Polarisation of monocyte-derived macrophages.   The supplements used for 
polarisation of MDM to M0, M1, M2a and M2c phenotypes are described. 
2.3 3D cell culture 
 Use of a collagen hydrogel 
Isolation of rat-tail type 1 collagen 
Rat-tail type 1 collagen was isolated from rat tails kindly donated by research groups led by 
Professor Boissonade, Professor Paul Hatton and Mrs Christine Freeman, The University of 
Sheffield, at the end of licensed studies and stored at -20 ᵒC.  When required, these were 
thawed and processed as previously described (Rajan et al., 2006).  Briefly, under sterile 
conditions, tails were folded and twisted to expose the underlying bone and tendons.  
Bones were removed, and exposed tendons were cut and washed in PBS.  Tendons were 
then dissolved for 7 days in 0.1 M sterile acetic acid (Sigma Aldrich, Dorset, UK) at 4 ᵒC.  The 
resultant collagen solution was freeze-dried (VirTis Benchtop K Manifold freeze drier, SP 
Scientific, Suffolk, UK) and re-dissolved in 0.1 M acetic acid to a stock concentration of 5 
mg/mL and stored at 4 ᵒC for use in collagen hydrogel preparation.   
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Preparation of collagen hydrogel 
Collagen hydrogels were prepared as previously described (Dongari-Bagtzoglou and 
Kashleva, 2006).  Briefly, keeping everything on ice, rat-tail type 1 collagen was mixed on 
ice with 10x DMEM, reconstitution buffer (a mixture of N-2-Hydroxyethylpiperazine-N-2-
ethane sulfonic acid (HEPES; Sigma Aldrich, Dorset, UK), sodium hydroxide (Sigma Aldrich, 
Dorset, UK) and sodium bicarbonate (Sigma Aldrich, Dorset, UK), FBS and L-glutamine 
(Sigma Aldrich, Dorset, UK; Table 2.4).  This solution was neutralised to pH 7.4 with 0.1 M 
sodium hydroxide (Sigma Aldrich, Dorset, UK) before addition of cells.  One millilitre of the 
thoroughly mixed collagen mixture was then distributed to each well of a 24-well plate 
(Greiner-Bio-One, Germany) and incubated at 37 ᵒC in a humidified environment for 20 
minutes, allowing the collagen hydrogel to set.   
Component Final Concentration 
10x RPMI 13.8 mg/mL 
Sodium bicarbonate 2.25 mg/mL 
HEPES 2 mM 
1M NaOH 6.3 mM 
FBS 8.5% v/v 
L-glutamine 2.1 mM 
Rat tail collagen, type 1 3.365 mg/mL 
Table 2.4. Preparation of collagen hydrogels.  The final concentration of components used 
in the preparation of collagen hydrogels.  4-(2-hydroxyethyl)-1-piperazinethanesulfonic acid 
(HEPES), sodium hydroxide (NaOH). 
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Mono-culture of monocytes and macrophages within collagen hydrogels 
One million monocytes (either PBM, THP-1 or MM6) or macrophages (MDM or PMA-
treated THP-1) were added per millilitre of collagen hydrogel mixture and cultured with 1 
mL per well of either supplemented IMDM (PBM and MDM) or RPMI 1640 (THP-1, MM6, 
and PMA-treated THP-1).   Cell-containing hydrogels were cultured for 14 days in a 
humidified atmosphere of 5 % CO2 at 37 ᵒC.  Media was refreshed every 2-3 days. 
Preparation of tissue-engineered oral mucosa 
Collagen hydrogels were prepared as described previously (Dongari-Bagtzoglou and 
Kashleva, 2006), with the addition of 0.05-0.2x106 NOF within the collagen hydrogel.  For 
models containing an immune component, either 0.5x106 THP-1 or 1-4x106 MDM were also 
added within the hydrogel mixture.  Once the hydrogel had set, 0.5x106 epithelial cells 
(FNB6, NOK or H357) in relevant cell culture media were seeded on top.  Engineered mucosa 
was incubated for 24 hours before lifting to an air-liquid interface (ALI) within a 6 well plate 
using perforated metal grids, with a fine mesh separating the grid and hydrogel (Figure 2.1).  
6mL of cell culture media, appropriate to the epithelial cell type, was used to fill each well 
to meet the underside of the engineered mucosa.  Media was refreshed every 2-3 days for 
14 days. 
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Figure 2.1.  Production of tissue-engineered oral mucosa.   Image shows a collagen 
hydrogel containing cells, cultured at air-to-liquid interface on top of a perforated metal 
grid, separated by a fine mesh (A).  Diagram (B) is a graphic representation of image A.  
Diagram (C) is a schematic example section of a collagen hydrogel populated with 
fibroblasts and macrophages with an overlying stratified epithelium. 
 Physical analyses of cell-containing collagen hydrogels 
Contraction assay 
After 14 days of culture, images of contracted hydrogels were taken using a background of 
graph paper.  The surface area was measured using ImageJ, and scale set using the graph 
paper (Schneider et al., 2012).  Results are reported as surface area measurements (mm2). 
A B 
C 
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Rheological examination 
A rheometer (Bohlin Gemini, Malvern instruments, UK) was used to collect data measuring 
the elastic modulus.  Samples were loaded, with epithelium facing upwards, between 20 
mm parallel plate and peltier plate heated to 37 °C.  Samples were surrounded by Green’s 
medium and 1.0 g of thrust was applied to maintain grip on the sample.  An oscillatory test 
(frequency sweep from 1.0-0.1 Hz, 0.02 strain) was undertaken, with elastic modulus and 
gap size measurements recorded.  In order to normalise the differences in sample size, 
surface area measurements from the contractility assay were related to the elastic modulus 
at 0.1 Hz by the following equation (Equation 2.2):   
𝑆𝑡𝑖𝑓𝑓𝑛𝑒𝑠𝑠 =  
𝑎𝑟𝑒𝑎 𝑜𝑓 𝑝𝑎𝑟𝑎𝑙𝑙𝑒𝑙 𝑝𝑙𝑎𝑡𝑒 (314.16𝑚𝑚2)
𝑠𝑢𝑟𝑓𝑎𝑐𝑒 𝑎𝑟𝑒𝑎 𝑜𝑓 𝑚𝑜𝑑𝑒𝑙 (𝑚𝑚2)
 𝑥 𝑚𝑒𝑎𝑠𝑢𝑟𝑒𝑑 𝑒𝑙𝑎𝑠𝑡𝑖𝑐 𝑚𝑜𝑑𝑢𝑙𝑢𝑠 (𝑃𝑎) 
Equation 2.2. Equation to determine stiffness.   The relationship between stiffness, sample 
surface area and elastic modulus is described. 
Results from oscillatory tests are reported as elastic modulus (Pa) and gap size (mm2). 
2.4 Histological analysis 
 Formalin-fixed paraffin-embedded  
Preparation of formalin-fixed paraffin-embedded blocks 
To visualise tissue morphology, collagen hydrogels were fixed in 10 % PBS-buffered formalin 
(v/v) for 24 hours, processed overnight using a Leica TP1020 benchtop tissue processor 
(Leica TP1020 benchtop tissue processor, Leica Microsystems, Germany; Table 2.5), 
bisected and embedded perpendicular to the bottom of the mould in paraffin wax (Leica 
EG1160 embedding centre, Leica Microsystems, Germany).  Formalin-fixed paraffin-
embedded (FFPE) blocks were stored at room temperature until use. 
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Solution Time in Solution 
10 % neutral buffered formalin 1 hour 
70 % alcohol 1 hour 
70 % alcohol 1 hour 
90 % alcohol 1 hour 
90 % alcohol 1 hour 
Absolute alcohol 1 hour 
Absolute alcohol 1 hour 
Absolute alcohol 1 hour 
Xylene 1 hour 30 mins 
Xylene 1 hour 30 mins 
Paraffin wax I 2 hours 
Paraffin wax II 2 hours 
Table 2.5.  Histological processing schedule.   Table shows the solutions and length of time 
FFPE samples spent in each solution for histological processing. 
Preparation of 4 µm sections 
FFPE blocks were cooled on ice blocks for 30 minutes prior to sectioning.  Initially, blocks 
were trimmed in 10 µm sections until the sample was exposed at the surface of the wax 
block.  Four micrometer sections were prepared in levels, 40 µm apart (Leica RM2235 
microtome, Leica Microsystems, Germany), floated on a paraffin section mounting bath 
(Barnstead Electrothermal, Staffordshire, UK), transferred to a Superfrost plus micro slide 
(VWR, West Sussex, UK) and incubated at 55 ᵒC for 20 minutes to ensure the section was 
fully adhered to the slide.   
  
 
57 | P a g e  
 
Haematoxylin and eosin staining  
Haematoxylin and eosin (H&E) staining was performed (Leica ST4040 Shandon Linear 
Stainer, Leica Microsystems, Germany; Table 2.6).   Haematoxylin is a basic dye which stains 
the acidic cell nucleus blue, whereas eosin counterstain is an acidic dye which stains the 
nucleus of cells pink.  Once stained, slides were mounted with Dibutyl phthalate, 
polystyrene, xylene (DPX) and samples were covered with an appropriately sized coverslip.  
Once DPX was set, slides were imaged using an Olympux BX51 microscope and colour view 
Illu camera with associated Cell^d SOFTWARE (Olympus soft imaging solutions, GmbH, 
Münster, Germany). 
Order Solution 
1 Xylene 
2 Xylene 
3 Xylene 
4 99 % IDA 
5 99 % IDA 
6 99 % IDA 
7 Distilled water 
8 Distilled water 
9 Harris’ haematoxylin (Shandon) 
10 Harris’ haematoxylin (Shandon) 
11 Harris’ haematoxylin (Shandon) 
12 Harris’ haematoxylin 
13 Running tap water 
14 0.1 % acid alcohol 
15 Running tap water 
16 Scott’s tap water substitute 
17 Running tap water 
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18 Eosin Y – aqueous (Shandon) 
19 Eosin Y – aqueous (Shandon) 
20 Eosin Y – aqueous (Shandon) 
21 Running tap water 
22 99 % IDA 
23 99 % IDA 
24 99 % IDA 
25 Xylene 
26 Xylene 
27 Xylene 
28 Xylene 
Table 2.6.  Histological staining schedule.   Table describes the order and solutions used for 
histological staining of organotypic co-culture sections.  Industrial denatured alcohol (IDA). 
Immunohistochemistry  
Immunohistochemistry (IHC) staining to determine the expression of CD68, E-cadherin, 
AE1/3, vimentin, Ki67, collagen IV and isotype-matched controls was performed by the core 
facility.  Staining was visualised using light microscopy and 3 fields of view for each section, 
cut in levels 40 µm apart, were analysed under the supervision of an oral pathologist. 
2.5 Molecular analyses 
 Protein expression analysis using flow cytometry 
Flow cytometry was used to analyse single cell expression of key macrophage markers of 
2D and 3D cultured cells.  Both single colour and polychromatic staining methods were 
used. 
Sample preparation 
Adherent cells were gently scraped using a cell scraper (Fisher Scientific, UK).  Non-adherent 
monocytes (THP-1, PBM and MM6) and detached macrophages (PMA treated THP-1 and 
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MDM) were centrifuged at 1800 x g for 5 minutes and re-suspended at 1x106 cells/mL in 
cold staining buffer (PBS supplemented with 1 % bovine serum albumin (BSA; Fisher 
Scientific, UK) and 0.1 % sodium azide (Sigma Aldrich, Dorset, UK)).  Alternatively, for 3D-
cultured cells, collagen hydrogels were enzymatically digested using 2 mg/mL collagenase 
IV (Sigma Aldrich, Dorset, UK) and incubated at 37 ᵒC with shaking at 100 rpm for 1.5 hours.  
Once digested, the resulting solution was passed through a 40 µm cell strainer (SLS, 
Nottinghamshire, UK) before washing twice with staining buffer.  All sample staining was 
performed on ice to reduce the metabolic activity of cells, prevent apoptosis and prevent 
receptor shedding or internalisation during staining. 
Single-colour sample staining 
One millilitre of cell suspension containing 1 million cells was transferred to individual 
microtubes and pelleted for staining.  For single-colour antibody staining of cell-surface 
markers, cell pellets were incubated for 20 minutes with either; primary followed by 
fluorescein-isothiocyanate (FITC)-conjugated secondary antibody (Life Technologies, 
Paisley, UK); or 20 minutes with directly conjugated antibody (Abcam, Cambridgeshire, UK); 
or mouse immunoglobulin G (IgG) isotype-matched control diluted in staining buffer (Table 
2.7).  Samples were incubated on ice, in the dark for 20 minutes.  Cells were washed with 
cold staining buffer and finally re-suspended in 350 µL staining buffer on ice.   
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Specificity Antibody Fluorochrome Vendor Dilution 
CD14 Primary (and 
secondary) 
PE Abcam 1:5 (1:10) 
CD45 Directly 
conjugated 
FITC eBioscience 1:20 
CD80 Directly 
conjugated 
FITC Abcam 1:5 
CD163 Directly 
conjugated 
APC eBiosceince 1:20 
CD206 Primary (and 
secondary) 
FITC Abcam 1:50 (1:25) 
CPM Primary (and 
secondary) 
FITC Abcam 1:50 (1:25) 
 
Table 2.7.  Antibodies used for single-colour staining.   The antibodies and fluorochromes 
used for single-colour flow cytometry analysis of key monocyte and macrophage cell surface 
markers are detailed.  Phycoerythrin (PE), fluorescein-isothiocyanate (FITC) and 
allophycocyanin (APC). 
Single-colour sample analysis  
For single-colour flow cytometry, samples were analysed using a FACSCalibur flow 
cytometer (BD Biosciences, Oxfordshire, UK) with 10 000 events collected.  Fifty µg/mL 
Propium Iodide (PI; Sigma Aldrich, Dorset, UK) was added immediately before sample 
analysis for dead cell exclusion; cells staining positively for PI (based on gates set using 
unstained cells cultured and treated under the same conditions as test samples) were 
excluded from the analysis.  Data was analysed using FlowJo software (TreeStar).  Cell 
populations were gated using forward scatter (FSC) and side scatter (SSC) voltages for size 
and granularity respectively.  A threshold for positively fluorescent cells was set using cells 
stained with an isotype-matched control.  Normalised median fluorescence index (nMFI) 
was determined as previously described (Chan et al., 2013) by the following equation 
(Equation 2.3): 
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nMFI = 
𝑀𝐹𝐼 𝑝𝑜𝑠𝑖𝑡𝑖𝑣𝑒 𝑠𝑡𝑎𝑖𝑛𝑖𝑛𝑔
𝑀𝐹𝐼 𝑛𝑒𝑔𝑎𝑡𝑖𝑣𝑒 𝑠𝑡𝑎𝑖𝑛𝑖𝑛𝑔
 
Equation 2.3. Equation to determine nMFI. The relationship between median fluorescence 
intensity (MFI) of positive and negative staining in relation to normalised MFI (nMFI) is 
described. 
Polychromatic sample staining 
The selected directly-conjugated macrophage markers were titrated in order to determine 
the optimal staining concentration.  Antibodies were used at the manufacturer 
recommended concentrations and with the following dilution factors: 1:5 (v/v) followed by 
serial dilutions of 1:2 (v/v).  Staining index was determined (Equation 2.4) and used to 
produce an antibody saturation curve to identify optimal antibody staining, shown on 
concatenated dot plots of the titrated antibody samples (red boxes, Figure 2.2).  
𝑆𝑡𝑎𝑖𝑛𝑖𝑛𝑔 𝑖𝑛𝑑𝑒𝑥 =  
𝑀𝐹𝐼 𝑝𝑜𝑠𝑖𝑡𝑖𝑣𝑒 − 𝑀𝐹𝐼 𝑛𝑒𝑔𝑎𝑡𝑖𝑣𝑒
2 𝑥 𝑠𝑡𝑎𝑛𝑑𝑎𝑟𝑑 𝑑𝑒𝑣𝑖𝑎𝑡𝑖𝑜𝑛
 
Equation 2.4. Equation to determine staining index.   The relationship between standard 
deviation and median fluorescence intensity (MFI) of positive and negative samples to 
determine staining index for a selected fluorchrome is described. 
Cells dispersed in a single cell suspension were washed in staining buffer and re-suspended 
at 0.5x106 cells/mL with 1 mL transferred to individual microtubes.  Samples were 
centrifuged at 1800 x g for 2 minutes, and supernatant discarded.  Cells were re-suspended 
in 40 µL staining buffer with 10 µL FcR blocking reagent and incubated for 15 minutes at 4 
°C.  A titrated amount  of each fluorochrome-conjugated antibody was added and the total 
volume made up to 100 µL with staining buffer (Table 2.8).  Samples were incubated for 20 
minutes on ice, and protected from light.  Cells were washed twice in 1 mL of staining buffer 
and amine-reactive blue live/dead stain was used according to the manufacturer’s 
instructions.  Cells were washed twice in 1 mL staining buffer and finally re-suspended in 
350 µL 1 % (w/v) paraformaldehyde diluted in PBS.  Samples were analysed within 48 hours 
of staining. 
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Figure 2.2.  Concatenate displays of antibody conjugates and non-antibody reagents.   Monocyte-derived macrophage gates were set based 
on FSC-SSC dot plots, followed by exclusion of doublets and non-viable cells.  Concatenate displays of titrations for CD80FITC (A), CD163PE (B), 
CD45PE eFluor 610 (C), CD86PE Cyanine7 (D), CD206eFluor 450 (E), CD36APC (F), CD14Alexa Fluor 700 (G), and amine-reactive blue (H), where each 
concatenated dot plot represents all concentrations of each antibody ranging from 1:10 to 1:1600 dilutions, are compared to the measured 
fluorescence for each fluorochrome. Titres used for optimal staining conditions are highlighted (red box). 
   U/S       1:20    1:100   1:200    1:400  1:800   1:1600 
    U/S     1:1K       1:5K    1:10K   1:20K   1:40K  1:80K 
   U/S       1:20    1:100   1:200    1:400  1:800   1:1600    U/S       1:20    1:100   1:200    1:400  1:800   1:1600    U/S       1:20    1:100   1:200    1:400  1:800   1:1600 
   U/S       1:20    1:100   1:200    1:400  1:800   1:1600    U/S       1:20    1:100   1:200    1:400  1:800   1:1600    U/S       1:10    1:50    1:100    1:200   1:400   1:800 
A B C D 
E F G H 
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Specificity Fluorochrome 
Antibody  
clone 
Vendor Catalogue no. 
Stock 
concentration 
Dilution 
CD14 Alexa Fluor® 700 61D3 eBioscience 56-0149 0.050 µg/µL 1:20 
CD36 APC AC106 MACS Miltenyi Biotec 130-100-307 0.055 µg/µL 1:10 
CD45 PE eFluor® 610 HI30 eBioscience 61-0459 0.050 µg/µL 1:20 
CD80 FITC 2D10.4 eBioscience 11-0809 0.200 µg/µL 1:20 
CD86 PE Cyanine7 IT2.2 eBioscience 25-0869 0.025 µg/µL 1:20 
CD163 PE eBioGHI/61 eBioscience 12-1639 0.050 µg/µL 1:20 
CD206 eFluor® 450 19.2 eBioscience 48-2069 0.050 µg/µL 1:20 
Viability 
Amine-reactive 
blue 
n/a Life Technologies L23105 n/a 1:1000 
Table 2.8. Flow cytometry reagent information.  Detailed information on the commercially available antibodies and non-antibody 
reagents used.  Not applicable (n/a). 
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Polychromatic sample analysis 
A customised LSRII flow cytometer (BD Biosciences, California, USA) with the configuration 
shown in Table 2.9 was used to collect all polychromatic flow cytometry data.   
Laser  
(type) 
Wavelength 
(nm) 
Laser 
power 
(mW) 
Spectral 
range for 
detector 
(nm) 
Long pass 
(nm) 
Band pass 
(nm) 
Fluorochrome 
 
Coherent® 
Sapphire™ 
(solid state) 
 
488  
(Blue) 
 
 
 
20 
515-545 505 530/30 FITC 
562-588 550 575/26 PE 
600-630 600 610/20 PE-eFluor 610 
750-810 755 780/60 PE-Cyanine7 
Coherent 
Radius™ 405 
(solid state) 
405  
(Violet) 
25 425-475 - 450/50 eFluor 450 
Lightwave 
Xcyte™  
(solid state) 
355  
(UV) 
20 425-475 - 450/50 Reactive blue 
JDS Uniphase™ 
1344P (helium-
neon (HeNe) 
gas) 
 
633  
(Red) 
 
17 
650-670 655 660/20 APC 
707.5-752.5 - 730/45 Alexa Fluor 700 
Table 2.9. LSRII Instrument configuration.  The polychromatic flow cytometry panel was 
set up using a customised BD LSR II with the listed lasers and filters.   
Data was analysed using FlowJo software and the following gating strategy applied to all 
stained samples (Figure 2.3).  FSC and SSC gating was used to remove debris, anti-CD14 and 
anti-CD45 antibodies were used to selected the cells of interest and single cells were 
selected to remove doublet events.  A time gate was used to check for stable flow of cells 
and viability gate was used to remove non-viable cells stained with amine-reactive blue 
viability stain.  Flow cytometry data in this work is presented with both percentage of cells 
positive and nMFI values reported.  Together these values provide an accurate summary of 
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the results; percentage positive gates (set based on <1 % positive cells in unstained samples) 
alone reduce the resolution of the data as they can be skewed to outliers and do not 
account for changes in fluorescence intensity.  This information is provided by nMFI values 
(Chan et al., 2013). 
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Figure 2.3.  Gating strategy used for polychromatic flow cytometry analysis.  Monocyte-derived macrophages were stained with 7 
fluorochrome-conjugated antibodies in addition to an amine-reactive viability stain.  Areas of stable flow were selected (A) and debris was 
excluded from the analysis (B).  Any CD14-CD45- events were excluded (C) before single (D) and viable (E) cells were selected.  The remaining 
cell population (F) is used for analysis. 
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Compensation and fluorescence-minus-one controls 
During cell staining, CompBeads and ArC Compensation Beads were stained according to 
the manufacturer’s instructions and re-suspended into 500 µL 1 % paraformaldehyde in 
PBS.  In addition, a sample of dead cells was prepared by incubating cells for 15 minutes in 
100 % (v/v) ethanol at room temperature.  These were mixed with the same number of 
viable cells and stained with amine-reactive blue viability stain according to the 
manufacturer’s instructions.  These samples were used to compensate for spillover of 
fluorochromes in polychromatic stained samples.  An example compensation matrix is 
provided (Table 2.10).  Fluorescence-minus-one (FMO) controls were used to set gating for 
all selected fluorochromes as shown (Figure 2.4). 
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Coherent® Sapphire™ 
Coherent 
Radius™ 405 
Lightwave 
Xcyte™ 
JDS Uniphase™ 1344P 
Blue 530/30 Blue 575/26 Blue 610/20 Blue 780/60 Violet 450/50 UV 450/40 Red 660/20 Red 730/45 
 
Coherent® 
Sapphire™ 
Blue 530/30 - 43.3357 18.2063 1.6358 0.000 0.2610 0.000 0.3025 
Blue 575/26 0.5077 - 42.7495 4.9803 0.0000 0.0246 0.0000 0.0508 
Blue 610/20 18.59 42.79 - 0.38 0.00 0.33 0.01 0.04 
Blue 780/60 0.00 5.00 11.01 - 0.00 0.20 0.21 1.09 
Coherent 
Radius™ 405 
Violet 450/50 0.10 0.00 0.03 0.00 - 19.37 0.00 0.00 
Lightwave 
Xcyte™ 
UV 450/40 0.30 0.02 0.00 0.45 2.72 - 0.02 0.00 
JDS 
Uniphase™ 
1344P 
Red 660/20 0.00 0.04 0.35 0.08 0.19 1.32 - 0.46 
Red 730/45 0.00 0.00 0.00 0.00 0.00 0.02 33.34 - 
Table 2.10.  Compensation matrix.   The Compensation matrix applied by BD LSRII using BD™ CompBead and ArC™ Amine Reactive 
Compensation Beads. 
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Figure 2.4.  Fluorescence-minus-one controls. Fluorescence-minus-one (FMO) controls excluding CD45PE eFluor 610 (B) and CD14Alexa Fluor 700 (C) 
were used to accurately gate CD14- and CD45-positive cells (D).  The use of unstained cells alone to draw gates (red dotted line, A) would 
have resulted in selection of CD14-negative cells as false-positive.  FMO controls excluding FITC (E), PE (F), PE Cyanine7 (G), eFluor 450 (H) 
and APC (I) were also used for the correct positioning of gates. 
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2.6 Analysis of model culture media 
Cell culture media was collected from MDM in adherent culture (2D) following 7 days of 
differentiation from monocytes, or from collagen hydrogels containing MDM alone or oral 
mucosa models containing FNB6 and NOF in addition to MDM (3D) following 14 days of 
culture.  Cell culture media was centrifuged for 5 minutes at 1800 x g, aliquoted and stored 
at -80 ᵒC until analysis.  These samples were analysed using enzyme-linked immunosorbent 
assay (ELISA) and a lactate dehydrogenase release (LDH) assay, as described below. 
Enzyme-linked immunosorbent assay 
Conditioned media was collected and analysed for the presence of IL-6 protein by ELISA 
using an BD OptEIA™ IL-6 ELISA set (BD Biosciences, California, USA) following the 
manufacturer’s instructions.  Presence and concentration of IL-6 protein was determined 
using a spectrophometer (Tecan, Männedorf, Switzerland) at 450nm (with wavelength 
correction at 570nm) and analysed according to the manufacturer’s instructions using 
Microsoft Excel.  The concentration of protein was determined by comparison to a standard 
curve using a range of IL-6 of known concentrations. 
Lactate dehydrogenase assay 
The CytoTox 96® non-radioactive cytotoxicity assay (Promega, UK) was used to detect 
lactate dehydrogenase (LDH) release as a measure of cell death as lactate dehydrogenase 
is released upon cell lysis.  In this assay, LDH released from lysed cells results in the 
conversion of iodonitrotetrazolium chloride (INT salt) into a red formazan product.  Cell 
culture conditioned media was used to detect LDH release following the manufacturer’s 
instructions. The amount of red colour formed was proportional to the number of lysed 
cells and can be measured at an absorbance wavelength of 490 nm by spectrophotometer 
(Tecan, Männedorf, Switzerland). 
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 Gene expression analysis 
RNA isolation 
Total RNA was isolated from cell pellets of PBM immediately following magnetic cell sorting, 
or from cell pellets of MDM cultured for 7 days adherent to tissue culture plastic, in the 
absence or presence of M-CSF or GM-CSF using Isolate II RNA mini kit (Bioline) according to 
the manufacturer’s instructions.  RNA quantity and quality was measured using a NanoDrop 
spectrophotometer (Fisher Scientific) to assess the ratio of absorbance at 260 nm and 280 
nm (only samples with a ratio of approximately 2.0 were used).  RNA was stored at -80 ᵒC 
until use. 
Preparation of cDNA 
Complementary DNA (cDNA) was prepared from isolated RNA using a high capacity cDNA 
reverse transcription kit (Applied Biosystems) according to the manufacturer’s instructions.  
Using a 2720 thermal cycler (Applied Biosystems), gene-specific and oligo dT priming was 
enabled at 25 ᵒC for 10 mins, followed by 120 mins at 37 ᵒC for optimal reverse transcription 
of RNA and 5 mins at 85 ᵒC for termination of the reaction.  cDNA was stored at -20 ᵒC until 
use. 
Quantitative real-time PCR 
cDNA was subsequently analysed using quantitative real-time polymerase chain reaction 
(qRT-PCR) by the addition of cDNA to qRT-PCR master mix containing 1x SYBR Green mixture 
(Applied Biosystems) with 0.5 µM gene specific forward and reverse primers (Sigma).  Small 
nucleolar RNA U6 (TaqMan probe) was used as an endogenous control for all qRT-PCR 
assays.  Assays were performed in triplicate using 7900 HT Fast real time PCR equipment 
(Applied Biosystems) and measured using SDS version 2.4.  Forty cycles comprising of 95 ᵒC 
for 15 s to enable cDNA strand denaturation, 60 ᵒC for 60 s to enable primer annealing and 
strand elongation, and 95 ᵒC for 15 s for strand termination were used.  Cycle threshold (CT) 
values were recorded using RQ manager version 1.2.1 and the difference in CT values 
between the target gene and endogenous control was recorded as ΔCT.  ΔΔCT values were 
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calculated by normalising ΔCT values to untreated samples.  Primer sequences are indicated 
in Table 2.11. 
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Primer Name Forward sequence Reverse sequence 
CPM 5’-AAGGTGGAATGCAAGATTAC 3’-GGATATTTACAGCATGACAGC 
Table 2.11.  Oligonucleotide sequences. 
The melt curve of designed SYBR Green primer is provided in the appendix. 
2.7 Statistical analyses 
Error bars are not typically recommended for experiments where n=3 or less, therefore 
individual data points have been plotted where possible.  To draw comparisons between 
control and experimental data, standard error mean bars have been shown for 
independently repeated experiments (n=3 or more) and the number of repeated measures 
have been indicated (Cumming et al., 2007).  The length of these inferential error bars can 
give a graphic depiction of uncertainty in the data, as opposed to descriptive error bars, 
such as range and standard deviation, which show the spread of the data.  Where 
representative experiments are shown (i.e. n=1) statistics have not been presented.   
As repeats in this work are typically limited to n=3, the distribution of the data cannot be 
determined.  Therefore, parametric tests have been used as it is recommended that non-
parametric tests are only used when n ≥ 10 in the absence of normally distributed data due 
to the Central Limit Theorum.  In addition, non-parametric tests, whilst making fewer 
assumptions than parametric tests, often provide higher p values, resulting it difficulties 
identifying true differences, especially in the case of small sample sizes.  For small sample 
sizes, statistical tests are not robust, and can only give an indication of whether the null 
hypothesis may be rejected or accepted. 
GraphPad Prism 7 was used for all statistical analysis. 
One-sample T-test 
A one-sample T-test compares the mean of data to a hypothetical value.  A small p value 
suggests that differences between the mean and hypothetical value are unlikely to be due 
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to coincidence and so may be statistically significant.  Conversely, a large p value suggests 
there is no evidence for difference between the mean of the data and a hypothetical value. 
Unpaired T-test 
An unpaired T-test has been used to compare the means between two different groups.  A 
small p value suggests that the differences observed between the two means are not a 
coincidence.  A large p value here suggests that there is not enough evidence to show that 
the means of the data differ. 
One-way ANOVA with Tukey’s post-test 
A one-way analysis of variance (ANOVA) compares three or more un-matched groups and 
determines whether or not random sampling would result in equal means.  With the 
addition of Tukey’s post-test for multiple comparisons, a one-way ANOVA provides more 
robust statistical analysis that accumulating results from multiple T-tests.  A small p value 
suggests any differences observed between means are unlikely to be due to random 
sampling. 
Linear regression 
Linear regression was calculated to determine the best-fit line and hence determine 
collagen concentration from matrix stiffness Figure 5.9. 
 
 
 
 
  
  
 
75 | P a g e  
 
 Chapter 3: Development of 2D Culture 
Methods for Primary and Cell Line Monocytes 
and Macrophages 
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3.1 Introduction  
Monocyte cell lines are often used in place of primary cells due to the challenges of 
acquiring ethical approval, collecting patient samples and isolating cells from samples.  
Although there is an abundance of published research using both primary and cell line 
monocytes and macrophages, a huge variety of methods are cited.  Therefore, the two-
dimensional (2D) culture methods of both primary and cell line monocytes and 
macrophages required optimisation. 
3.2 Isolation and purification of peripheral blood monocytes 
 Isolation of peripheral blood monocytes from whole blood 
Whole blood is mostly made up of plasma (55 %) containing electrolytes, nutrients, organic 
waste and proteins dissolved in water.  This aids the transport of erythrocytes (45 %) and 
peripheral blood mononuclear cells (<1 %).  Monocytes are found in the buffy coat layer, 
along with small numbers of other leukocytes (neutrophils, eosinophils and basophils) and 
platelets. 
Whole blood from healthy volunteers was stained with PE-conjugated anti-CD14 antibody, 
erythrocytes lysed and samples analysed by flow cytometry to determine the percentage of 
monocytes present (Figure 3.1).  A CD14+ gate was drawn based on an unstained sample.   
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Figure 3.1.  Leukocyte composition of whole blood.  CD14+ events in whole blood (A) are 
labelled as monocytes and shown separated from lymphocytes and neutrophils by FSC and 
SSC (B) with percentage numbers of cells in whole blood displayed.  Gates were set based 
on unstained cells.  Dot plots are representative of two independent experiments, 
measured in duplicate (n=2) and summarised in scatter plot (C) where error bars show 
standard error mean. 
A distinct population of cells stained positive for CD14 and could easily be separated from 
the rest of the cells in the whole blood preparation.  The nMFI of monocytes was 16.4 
compared to 1.03 for lymphocytes and 2.34 for neutrophils.  Separation of monocytes, 
based on CD14 expression, from lymphocytes and neutrophils (subsequently gated based 
on FSC and SSC) shows that samples of whole blood were composed of 55.7 % lymphocytes, 
29.0 % neutrophils and 5.9 % monocytes.      
A B 
C 
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 Isolation and purification of peripheral blood monocytes from buffy coats 
Buffy coat layers are separated from plasma and erythrocytes through the centrifugation of 
whole blood and the use of these for isolation of PBM may result in a higher yield of CD14+ 
cells.  Additionally, a pan monocyte isolation kit using negative selection by depletion of 
magnetically labelled, non-monocyte cells, can further enrich the number of CD14+ cells 
(Figure 3.2).   
 
Figure 3.2.  Purification of peripheral blood monocytes isolated from buffy coats.   The 
percentage of CD14+ cells in buffy coat layers before use of a magnetic purification column 
(A), after magnetic separation (B) and residual cells remaining bound to the magnetic 
column (C).  Dot plots are representative of two independent experiments, measured in 
duplicate (n=2) and summarised in scatter plot (C).  Error bars show standard error mean.  
Isolation of monocytes from buffy coats using Ficoll-hypaque centrifugation resulted in an 
increase of CD14+ cells from 5.9 % in whole blood to 33.7 % in the peripheral blood 
A 
D 
B C 
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mononuclear cell preparation.  The additional use of a magnetic purification column 
resulted in a marked increase in the percentage of CD14+ cells to 94.2 % with only 4.5 % 
CD14+ cells residually bound to the column after its use.   
3.3 Monocyte to macrophage differentiation 
Monocytes are small, spherical cells with a reniform nucleus and very few granules (Auffray 
et al., 2009; Geissmann, 2010; Ginhoux and Jung, 2014; Terry and Miller, 2014).  In response 
to MCP-1, monocytes are recruited to sites of injury where they extravasate into the tissue, 
from the blood stream, and differentiate into macrophages.  This change can be 
characterised by a morphological change where cells increase in size and granularity (Chang 
et al., 2012).  In vitro, human monocyte to macrophage differentiation can be stimulated 
through plastic adherence or the use of exogenous cytokine stimulation, such as M-CSF or 
GM-CSF.   
 Differentiation of peripheral blood monocytes to monocyte-derived 
macrophages in vitro in 2D 
PBMC isolated from buffy coats through Ficoll-hypaque density centrifugation were seeded 
at 1x106 cells/mL (v/v) to 5x106 cells/mL (v/v) to determine an optimal seeding density, with 
3x106 cells/mL frequently reported in the literature and found here to provide a good yield 
of MDM per 75cm2 tissue culture flask.  As monocytes adhere rapidly to tissue culture 
plastic, PBMC were washed after 3 hours, 24 hours, and every 3 days thereafter for up to 
14 days to remove contaminating lymphocytes.   
Detachment of monocyte-derived macrophages from cell culture plastic 
In order to determine purity and viability of MDM, cells required detachment from tissue 
culture plastic.  Previous literature mostly omitted information relating to cell detachment, 
therefore a variety of methods were tested, including the use of cell scrapers into flow 
cytometry staining buffer or cell culture media, low adherence plates, macrophage 
detachment solution, EDTA alone or in combination with trypsin and cell dissociation 
solution.  Detachment methods were compared in terms of MDM recovered as a 
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percentage of the total events, and the percentage of these that were viable, determined 
by staining with PI (Figure 3.3). 
  
 Key 
1 Trypsin EDTA 
2 EDTA 
3 Macrophage detachment 
solution 
4 Cell dissociation solution 
5 Scraping into staining buffer 
6 Scraping into IMDM 
 
Figure 3.3.  Recovery of viable 2D in vitro cultured monocyte-derived macrophages using 
a variety of detachment methods.  Following monocyte to macrophage differentiation over 
14 days of adherent culture, monocyte-derived macrophages (MDM) were recovered using 
a variety of methods (shown in key).  Recovered MDM were stained with propium iodide 
for dead cell exclusion and percentages of total events (A) and percentages of viable cells 
(B) reported.  Gates were set based on unstained cells treated under the same detachment 
conditions.  Data shown are for three independent experiments (n=3) and error bars show 
standard error mean.  
Low adherence plates prevented monocytes from adhering in the first instance resulting in 
unsuccessful culture of MDM.  The use of EDTA alone (9.1 %) or in combination with trypsin 
(15.5 %), or cell dissociation solution (7.9 %) led to recovery of a very low percentage of 
intact MDM.  The use of macrophage detachment solution (62.7 %) and scraping into PBS 
(87.8 %) or IMDM (61.0 %) enabled improved recovery of intact MDM.  Of the three 
detachment methods that yielded the highest percentages of intact MDM, scraping into 
IMDM resulted in the highest percentage of viable cells (67.9 %) compared to macrophage 
detachment solution (57.5 %) and scraping into flow cytometry staining buffer (28.6 %). 
Statistical analysis using a one-way ANOVA with Tukey’s multiple comparisons showed a 
significantly higher percentage of viable MDM after scraping into IMDM compared to 
scraping into staining buffer (p=0.0301).  However, there was no statistically significant 
difference in the percentage of viable MDM through scraping into macrophage detachment 
solution compared to either scraping into staining buffer (p=0.0983) or scraping into IMDM 
A B 
ns 
ns 
* 
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(0.6261).  For all further experiments, MDM were recovered using scraping into IMDM due 
to improved recovery of intact MDM and percentage of viable MDM recovered following 
adherent culture in 2D, compared to other detachment methods tested. 
Percentage of monocyte-derived macrophages expressing CD14+ over 14 days 
CD14 binds microbial ligands such as LPS to initiate an inflammatory response (Poussin et 
al., 1998).  It is often used as a marker for monocytes and macrophages.  Literature 
frequently cites culture of MDM from 7 to 14 days in order to acquire a population of MDM 
>95 % CD14+.  In order to determine the optimum cell culture time for >95 % CD14+ cells, 
PBMC were differentiated to macrophages for up to 14 days.  Purity was assessed using 
anti-CD14 antibody staining and analysis by flow cytometry, after 3 hours, 24 hours, 7 days 
and 14 days of culture.  The percentage of CD14+ events was compared to those found in 
whole blood and immediately after Ficoll-hypaque density centrifugation.  Gates used were 
based on unstained samples from the same time point (Figure 3.4). 
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Figure 3.4.  Percentage of monocyte-derived macrophages expressing CD14 following 
isolation and culture.  The percentage CD14+ events in whole blood (A) or immediately 
after Ficoll-hypaque density centrifugation (0hrs, B), and subsequent culture for 3 hours (C), 
24 hours (D), 7 days (E) and 14 days (F) of plastic adherent culture.  Following culture of 
various times, cells were stained using anti-CD14PE antibodies and analysed using flow 
cytometry, following dead cell exclusion using propium iodide.  Gates were set using 
unstained cells cultured under the same conditions.  Data are summarised in scatter plot 
(G) and dot plots are representative of three independent experiments (n=3), error bars 
show standard error mean and significance was determined using results from a one-way 
ANOVA with Tukey’s multiple comparisons (* = p<0.05). 
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The percentage of CD14+ events analysed by flow cytometry increased from whole blood 
(4.8 %), again following density centrifugation (25.7 %) and again following culture for 3 
hours (52.4 %), 24 hours (76.0 %), 7 days (92.6 %) and 14 days (93.1 %).  The size of individual 
cells and spread of the whole population also increased over 14 days.  There was no 
significant difference in the percentage of CD14+ events identified between whole blood 
and 0 hours (p=0.0675), 3 hours and 24 hours of culture (p=0.0346), 24 hours and 7 days of 
culture (p=0.1938) or 7 days and 14 days of culture (p=>0.9999), however there was a 
marked increase in CD14+ events from 76.0 % after 24 hours to 92.6 % after 7 days.  There 
was also a significant increase in the percentage of CD14+ detected between 0 hours and 3 
hours of culture (p=0.0157) and 3 hours and 24 hours of culture (p=0.0346).  Consequently, 
MDM were cultured for 7 days in ensuing experiments. 
Carboxypeptidase M gene expression by monocyte-derived macrophages in 2D 
The cell surface expression of carboxypeptidase M (CPM) by macrophages has been shown 
to be increased compared to expression by monocytes.  CPM has therefore become a widely 
used marker of monocyte to macrophage differentiation (Rehli et al., 1995).  The expression 
of CPM by PBM isolated from buffy coats and purified using magnetic separation was 
compared to the expression of CPM by MDM cultured in the presence of either GM-CSF, M-
CSF or un-stimulated for 7 days.  The expression of CPM was measured using qRT-PCR 
(Figure 3.5). 
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Figure 3.5.  Monocyte-derived macrophages appear to express higher levels of 
carboxypeptidase M than peripheral blood monocyte.   Expression of CPM by peripheral 
blood monocytes (PBM), or monocyte-derived macrophages (MDM) cultured for 7 days in 
the absence or presence of cytokines (M-CSF or GM-CSF) was compared using fold change 
determined by qPCR.  Data are representative of two independent experiments (n=2).   
Compared to monocytes, which expressed very low levels of CPM, MDM expressed 29-fold 
more CPM.  In addition, stimulation with GM-CSF and M-CSF resulted in even higher levels 
of CPM expression, with a 31-fold and 41-fold increase in expression respectively compared 
to monocytes.  In proceeding experiments, GM-CSF and M-CSF were used in M1 and M2-
stimulated cultures of MDM, respectively, and compared to MDM cultured in the absence 
of additional cytokine stimulation used to promote differentiation (Table 2.3). 
 Differentiation of Mono Mac 6 
Previous literature has shown that MM6 monocytes could be differentiated to display 
characteristics of macrophages, such as reduced proliferation and increase phagocytosis 
through the use of prostaglandin E2, LPS or PMA (Zieglerheitbrock et al., 1994).  However, 
this study was unable to successfully differentiate MM6 cells and replicate published 
results. 
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3.4 Preliminary comparison between THP-1, Mono Mac 6 and peripheral blood 
monocytes 
THP-1 and MM6 commercially available monocytes are often used in research to represent 
PBM, however there is limited evidence comparing the expression of key markers in these 
cells.  THP-1 and MM6 monocytes cultured in suspension were compared to PBM in relation 
to size, granularity and cell surface expression of key monocyte and macrophage markers 
using flow cytometry. 
 Differences in morphology of THP-1, Mono Mac 6 and peripheral blood 
monocytes  
PBM, THP-1 and MM6 monocytes in cell culture medium were visualised using light 
microscopy and analysed by flow cytometry.  Monocytes were gated based on FSC and SSC 
to exclude contaminating lymphocytes in the mononuclear cell preparation and cell debris 
from all samples.  The size and granularity of the different monocyte cell types was 
compared (Figure 3.6).  
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Figure 3.6.  Differences in morphology of peripheral blood monocytes, THP-1 and Mono Mac 6.   Peripheral blood monocytes (PBM) 
immediately following isolation and magnetic cell sorting, or THP-1 and Mono Mac 6 (MM6) cells cultured in suspension were imaged and 
analysed using flow cytometry.  Light microscopy images show the differences in size of PBM (A), MM6 and THP-1 (B) cells.  Dot plots show 
differences in size (FSC) and granularity (SSC) of PBM (C), MM6 (D) and THP-1 (E) cells, with gates used for analysis displayed, following dead 
cell exclusion using propium iodide.  Arrows indicate PBM (A) and THP-1 (B) in suspension, and figures display data from a single experiment 
(n=1). 
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C D E 
87 | P a g e  
 
Light microscopy showed visible differences in size between blood monocytes (6 µm) and 
THP-1 cells (16 µm, Chitra et al., 2014).  Forward scatter data collected using flow cytometry 
was measured as 553, 512 and 456 for PBM, THP-1 and MM6 respectively, and side scatter 
was measured as 254, 269 and 342, respectively.  
 Differential protein expression in THP-1, Mono Mac 6 and peripheral 
blood monocytes 
To determine whether THP-1 or MM6 monocytes could accurately represent PBM in the 
expression of key monocyte and macrophage markers, flow cytometry using antibodies 
targeting CD14, CD45, CD80, CD163, CD206 and CPM was used.  PBM, THP-1 and MM6 
monocytes were stained with primary and fluorochrome-conjugated secondary antibodies 
or fluorochrome-conjugated primary antibodies and analysed by flow cytometry to detect 
cell surface expression of selected markers (Figure 3.7). 
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Figure 3.7.  Differential expression of key monocyte and macrophage markers in THP-1, Mono Mac 6 and peripheral blood monocytes.   
Peripheral blood monocytes (PBM) directly following isolation and THP-1 or Mono Mac 6 (MM6) monocytes cultured in suspension were 
labelled with antibodies to detect expression of CD14, CD45, CD80, CD163, CD206 and carboxypeptidase M (CPM) through flow cytometry 
analysis.  Black, unfilled histograms show expression of markers for PBM (A), THP-1 (B) and MM6 (C) cells, compared to an isotype-matched 
control (grey, filled histogram) in the absence of FcR blocking reagent.  Gates used for analysis are as shown in Figure 3.6, where cells are 
gated on size and granularity in the absence of dead cell exclusion.  Green box highlights M1 marker, CD80, and red box highlights M2 
markers, CD163 and CD206.  Data are shown for a single experiment (n=1). 
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As expressed by nMFI values, PBM expressed high levels of CD14 (327.8), CD45 (92.7), 
CD163 (14.3) and CD206 (6.8) with lower levels of CPM (21.0) and CD80 (2.5).  
Comparatively, THP-1 monocytes expressed lower levels of CD14 (25.8), CD45 (41.8), CD163 
(1.8) and CD206 (1.6) but higher levels of CPM (23.5) and CD80 (5.0).  MM6 monocytes 
expressed the lowest levels of CD14 (18.3), CD45 (9.7), CD206 (1.3), CPM (6.9) and CD80 
(1.4) but expressed higher levels of CD163 (4.4) compared to THP-1 cells, although this was 
still considerably lower than for PBM cells. 
3.5 Preliminary comparison between THP-1 PMA and monocyte-derived macrophages 
Although THP-1 PMA cells are often used to represent MDM, it has previously been 
reported that they do not show the same increases in size, granularity or cytoplasmic-to-
nuclear ratio as those seen in MDM (Daigneault et al., 2010).  2D-cultured THP-1 PMA were 
compared to MDM in relation to size, granularity and cell surface expression of key 
monocyte and macrophage markers.   
 Differences in morphology of THP-1 PMA and monocyte-derived 
macrophages 
Once differentiated, THP-1 PMA and MDM were compared using light microscopy and 
analysed by flow cytometry.  A gate excluded smaller events likely to be cell debris and the 
two cell types were compared using FSC and SSC as measures of size and granularity 
respectively (Figure 3.8).  
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Figure 3.8.  PMA-treated THP-1 monocytes appear to display a difference in morphology 
to monocyte-derived macrophages.   Monocyte-derived macrophages (MDM) cultured for 
7 days in adherent culture or THP-1 monocytes treated with PMA for 8 days in adherent 
culture were imaged and analysed using flow cytometry.  Light microscopy images show the 
differences in size of monocyte-derived macrophages (MDM, A) and PMA-treated THP-1 
(THP-1 PMA, B) cells.  Dot plots show differences in size (FSC) and granularity (SSC) of MDM 
(C) and THP-1 PMA (D) cells, with gates used for analysis displayed following dead cell 
exclusion with propium iodide.  Block arrows indicate macrophages, dashed arrows indicate 
nuclei and non-adherent cells are highlighted in circle.  Figures display data from a single 
experiment (n=1).   
The visible differences between THP-1 monocytes and PBM were again apparent between 
THP-1 PMA and MDM.  Through light microscopy, MDM were visualised as a homogeneous 
population will large, flat cells displaying a large nucleus and cytoplasmic-to-nuclear ratio.  
In contrast, THP-1 PMA formed a heterogeneous population with some cells displaying 
features of differentiated macrophages, whilst others appeared un-affected by PMA 
treatment.  In addition, the large differences in size between MDM (31µm) and THP-1 PMA 
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(23µm) could be observed (Chitra et al., 2014).  Flow cytometry measured FSC for MDM as 
462 and 615 for THP-1 PMA.  SSC was measured as 214 for MDM and 287 for THP-1 PMA, 
indicating that MDM were larger and more granular than THP-1 PMA. 
 Differential protein expression of THP-1 PMA and monocyte-derived 
macrophages 
To determine whether THP-1 macrophages could accurately represent MDM in the 
expression of CD14, CD45, CD80, CD163, CD206 and CPM, flow cytometry was performed.  
THP-1 PMA and MDM were stained with primary and fluorochrome-conjugated secondary 
antibodies or fluorochrome-conjugated antibodies for cell surface expression of selected 
markers to enable comparisons to be drawn between the two cell types (Figure 3.9). 
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Figure 3.9.  Differential expression of key monocyte and macrophage markers in PMA-treated THP-1 and monocyte-derived macrophages.   
THP-1 monocytes treated with PMA (THP-1 PMA) for 8 days or monocyte-derived macrophages (MDM) cultured for 7 days in adherent 
culture were detached using scraping into IMDM and labelled with antibodies to detect the expression of CD14, CD45, CD80, CD163, CD206 
and carboxypeptidase M (CPM).  Black, un-filled histograms show the expression of markers by MDM (A) and THP-1 PMA (B), compared to 
an isotype-matched control (grey, filled histograms) in the absence of FcR blocking reagent.  Gates used for analysis are as shown in Figure 
3.8, where cells were selected using size and granularity, in the absence of dead cell exclusion.  Green box highlights M1 marker, CD80, and 
red box highlights M2 markers, CD163 and CD206.  Data are shown for a single experiment (n=1). 
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Measured by nMFI, MDM showed high expression of CD14 (9.7), CD80 (1.8), CD206 (14.9) 
and CPM (14.9) with lower expression of CD45 (4.1) and CD163 (4.6) compared to THP-1 
PMA which expressed lower levels of CD14 (4.2), CD80 (1.1), CD206 (1.0) and CPM (5.2) but 
higher expression of CD45 (23.9) and CD163 (6.3).  
 Preliminary comparison of monocyte to macrophage differentiation of 
THP-1 to THP-1 PMA and peripheral blood monocytes to monocyte-
derived macrophages   
The nMFI values of the panel of markers used to characterise PBM, THP-1, MM6, MDM and 
THP-1 PMA cells were used to draw comparisons in the expression of selected markers 
between PBM and MDM, and THP-1 and THP-1 PMA (Figure 3.10).  
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Figure 3.10.  Changes in expression levels of key monocyte and macrophage markers through differentiation of peripheral blood 
monocytes to monocyte-derived macrophages, and THP-1 to THP-1 PMA.   Peripheral blood monocytes (PBM) immediately following 
isolation and magnetic purification, THP-1 monocytes cultured in suspension, THP-1 monocytes treated with PMA (THP-1 PMA) for 8 days 
or monocyte-derived macrophages (MDM) cultured for 7 days in adherent culture were detached using scraping into IMDM (THP-1 and 
MDM only) and labelled with antibodies to detect the expression of CD14, CD45, CD80, CD163, CD206 and carboxypeptidase M (CPM).  
Normalised median fluorescence intensity (nMFI) values for CD14, CD45, CD80, CD163, CD206 and CPM are displayed as bar charts to 
compare PBM with MDM (A) and THP-1 with THP-1 PMA (B).  Data shown are for a single experiment (n=1). 
A B 
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As measured by nMFI values, a decrease in the expression of CD14 (327.8 to 9.7), CD45 
(92.7 to 4.1), CD80 (2.5 to 1.8), CD163 (14.3 to 4.6) and CD206 (6.8 to 1.0) was observed in 
PBM and MDM respectively.  An increase in the expression of CPM was observed from 14.9 
in PBM to 21.0 in MDM.  A comparison between THP-1 and THP-1 PMA showed a decrease 
in the expression of CD14 (25.8 to 4.2), CD45 (41.8 to 23.9), CD80 (5.8 to 1.1), CD206 (1.6 
to 1.0) and CPM (23.5 to 5.2), and an increase in CD163 expression (1.8 to 6.3), respectively. 
3.6 Discussion 
There are many barriers in research preventing scientists from using primary cells in all 
experiments; ethical approval, primary tissue availability, patient-patient variation, longer 
protocols and added costs, to name just a few.  Therefore, cell lines are often used as 
alternatives due to ease of culture and increased reproducibility.  However, cells lines are 
in most cases derived from malignancies and are therefore not representative of primary, 
normal cells in many aspects.  The results in this chapter have shown the optimisation of 
methods for the isolation and culture of primary monocytes and macrophages, and a 
preliminary comparison to their cell line equivalents has been drawn.  These results will 
now be discussed in light of the published literature. 
 Isolation of peripheral blood monocytes 
Monocytes are the precursors to macrophages; monocytes can be found circulating in 
peripheral blood, whereas macrophages can be found terminally differentiated and residing 
in tissues.  Typically, monocytes are isolated from peripheral blood and differentiated to 
macrophages in vitro.  This is mostly due to difficulties in acquiring macrophage-containing 
primary tissue and a lack of tools available to specifically isolate macrophages from primary 
tissue. 
CD14 is commonly used as a specific monocyte and macrophage marker and is often used 
to assess the purity of primary monocyte preparations using flow cytometry.  In whole 
blood, CD14+ cells represented just 5.9 % of the population, slightly less than is typically 
reported.  CD14 is not expressed by lymphocytes, and is expressed at only very low levels 
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by neutrophils.  However, it is expressed on dendritic cells which may therefore can result 
in contamination of the monocyte population.   
Firstly, to improve the yield of monocytes retrieved, the percentage of CD14+ cells isolated 
from buffy coats was compared to that from whole blood.  Ficoll-hypaque density 
fractionation of whole blood resulted in the separation of a buffy coat layer containing 
peripheral blood mononuclear cells such as lymphocytes, monocytes and dendritic cells, 
from other components of whole blood, such as erythrocytes and polymorphonuclear cells 
such as eosinophils and neutrophils.  Flow cytometry analysis of the PBMC preparation 
resulted in an increase in the percentage of CD14+ cells from 5.9 % in whole blood to 33.7 
% in the buffy coat layer.  In addition, fractionation of whole blood to separate the buffy 
coat layer removes much of the dendritic cell contamination which can be found 
representing <1 % of the buffy coat layer (Freudenthal and Steinman, 1990).  Neutrophils 
and lymphocytes are very short-lived, and are typically dead after 48 hours (AntalSzalmas 
et al., 1997).   
In order to further purify monocytes from the PBMC preparation, the use of magnetic 
purification was explored.  A negative monocyte isolation kit was used to prevent activation 
of monocytes by binding of the CD14 receptor.  This uses an antibody cocktail to specifically 
label all non-monocyte cells.  These biotin-conjugated antibodies bind to anti-biotin 
magnetic beads, that with the use of a magnet, results in the binding of non-monocyte cells 
to a purification column, whilst monocytes elute through the column for collection.  The 
additional use of magnetic purification resulted in an increase in CD14+ cells to >90 %, with 
<5 % of CD14+ remaining bound to the column after purification.  However, the yield of 
PBM following this purification step was consistently ≤1x106 cells which is too low for many 
applications.  This highlighted a real need for methods to isolate and purify primary cells, in 
large quantities. 
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 Differences between THP-1 and Mono Mac 6 cell lines and peripheral 
blood monocytes  
The THP-1 pro-monocytic cell line is often used as an alternative to PBM in various 
experimental procedures, often because of ease of culture and difficulty in isolating primary 
cells from blood (Qin, 2012).  However, there is limited published evidence to show that 
their phenotype is similar to that of PBM.  Therefore, the morphological characteristics and 
expression levels of key cell surface monocyte and macrophage markers were examined to 
determine if THP-1 and MM6 share similar phenotypes with PBM.  Flow cytometry and light 
microscopy were used to compare the size and granularity of THP-1, MM6 and PBM and 
flow cytometry was used to assess the expression profiles of CD14, CD45, CD80, CD162, 
CD206 and CPM in the three monocyte types. 
Light microscopy showed that PBM from healthy volunteers were visibly smaller than both 
THP-1 and MM6 cell lines.  However, this could not be confirmed using flow cytometry due 
to changes in voltages during data collection.  During haematopoiesis, monocytes become 
smaller, compared to monoblasts and promonocytes, and as an immature monocyte, it 
follows that THP-1 monocytes will be larger than PBM.  Therefore, the data presented here 
confirms previously published data (Chitra et al., 2014). 
In addition to differences in size and granularity, PBM from healthy volunteers expressed 
high levels of the pan-leukocyte marker CD45 and the monocyte markers CD14 and CD163, 
as has been previously described (Curat et al., 2004; Griffin et al., 1981; Zhang et al., 2013).  
In contrast, expression of these important cell surface markers on THP-1 and MM6 cells was 
markedly lower.  THP-1 and MM6 monocyte cell lines are derived from patients suffering 
from acute myeloid leukaemia (AML) and monoblastic leukaemia respectively, where 
leukocytes from these cancer patients are typically characterised by low levels of CD45 
compared to healthy subjects (Deszo et al., 2001; Lacombe et al., 1997).  Both THP-1 and 
MM6 cells are immature pro-monocytes as a result of premature release from the bone 
marrow into the circulation. 
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The expression of CD14 has been shown to increase as pro-monocytes develop into mature 
blood monocytes (Fraser et al., 2006) providing an explanation for the higher expression of 
cell surface CD14 on PBM from volunteers than on both pro-monocytic cell lines.  In 
addition, the expression of low levels of CD163 on THP-1 cells compared to PBM has been 
previously described (Neu et al., 2013).  The marked differences in the expression of the 
classical leukocyte/monocyte markers, CD14, CD45 and CD163 between PBM and the pro-
monocytic cell lines may cause marked differences in the cell biology exhibited by these 
cells.  For example, CD14 is a receptor for bacterial-derived LPS and so differences in the 
expression of this receptor may alter the immune response of THP-1/MM6 cells compared 
to PBM.  CD45 is crucial for T cell receptor activation and so there may also be significant 
differences in immune signalling and T cell activation.  Similarly, CD163 is a scavenger 
receptor with essential roles in homeostasis and adhesion, binding both endothelial cell 
adhesion molecules and haemoglobin (Kowal et al., 2011).  Low expression of this molecule 
in the pro-monocyte cell lines may perturb cell function.   
Expression of CPM and CD80 was similar in PBM and THP-1 cells but lower for MM6, 
suggesting that similarities in marker expression exist between PBM and THP-1 cells.  In all 
cases, expression of key cell surface markers was very low on MM6 suggesting that these 
are most different phenotypically from PBM.   
The differences in the expression of important cell surface molecules suggests that the pro-
monocytic cell lines have a different phenotype to PBM and may therefore not be 
appropriate cells to model PBM in these experiments.  Whilst this comparison provided only 
preliminary data to show the differences in expression of key markers between PBM, THP-
1 and MM6, it also highlighted the need for a robust flow cytometry panel for in depth 
characterisation of monocytes.  In addition, due to abundant expression of FcγR on the 
surface of monocytes, essential in facilitating their roles in immune surveillance, data 
highlighted the need for an FcγR blocking step in sample preparation for flow cytometry; 
non-specific binding of the isotype-matched control can be observed in Figure 3.7 
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particularly in the staining of MM6 cells and Figure 3.9 in samples stained with CD163APC 
and isotype-matched controls. 
 In vitro monocyte to macrophage differentiation  
During monocyte to macrophage differentiation, monocytes become larger with 
increasingly large cytoplasms, increase in granularity and nuclei change in shape from 
reniform to spherical.  Previous literature cites differentiation time periods ranging from 7 
to 14 days resulting in a pure (> 95 % CD14+) population of CD14+ cells (Chitra et al., 2014; 
Eligini et al., 2013; Kreutz and Andreesen 1990; Martinez et al., 2006; Rehli et al., 2000; Vogt 
and Nathan, 2011).  This can be stimulated in vitro using plastic adherence or exogenous 
cytokines (Kelley et al., 1987).  The addition of GM-CSF or M-CSF has previously been 
reported to promote monocyte to macrophage differentiation, but has also been reported 
to promote macrophage polarization to M1 or M2 phenotype.   
Published literature describing research involving MDM largely omits information relating 
to macrophage detachment from cell culture plastic.  For flow cytometry analysis of cell 
surface receptors, the use of non-enzymatic detachment of cells is recommended as 
enzymes, such as trypsin, may cleave the protein of interest from the cell surface (Zhang et 
al., 2012).  MDM are highly adherent and consequently many different products are 
marketed for the easy detachment of viable macrophages following in vitro culture.  Many 
of these are non-enzymatic, including the macrophage detachment solution tested in this 
work (PromoCell, Heidlberg, Germany).  In addition, cell culture plastic with special coatings 
are marketed for non-adherent or low-adherent cultures.  Attempts to culture MDM using 
non-adherent or low-adherent culture plates were unsuccessful, and of the detachment 
methods tested, scraping into IMDM resulted in the highest percentage of viable MDM.   
Whilst cell scraping has previously been shown to increase the expression of annexin V 
associated with apoptosis (Bundscherer et al., 2013), it has also been shown by SEM that 
membrane domain structures are minimally altered, even if the integrity of the membrane 
as a whole may become mechanically damaged (Batista et al., 2010).  This is re-iterated in 
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the data presented in this thesis, as while cell viability is decreased with cell scraping 
(although it retains the highest viability of MDM of the methods tested), the events 
collected by flow cytometry are consistently found in the MDM gate, rather than in the 
region where cell debris and extracellular vesicles are found.  For some applications it may 
be that enzymatic detachment such as the use of trypsin is optimal, however this must be 
determined by the investigator for different purposes (Mutin et al., 1996). 
The culture of MDM in vitro is often cited as taking between 7 and 14 days and whilst the 
purity of the resulting cell populations is reported as a percentage CD14+, to the best of our 
knowledge, the changes in percentage expression of CD14 by MDM over 14 days has never 
been measured.  It is important for the resulting MDM population to have a high percentage 
of CD14+ cells, however the use of MDM in subsequent long-term cultures planned in this 
work requires shorter differentiation protocols. 
This work has shown that the percentage of CD14+ cells increases over time, throughout 14 
days from 25.7 % after density centrifugation to 93.1 % after 14 days.  At first, there are 
significant increases in the percentage of CD14+ cells between 0 and 3 hours, and 3 hours 
and 24 hours.  Between 24 hours and 7 days, no statistically significant difference in the 
percentage of CD14+ was observed, however 92.6 % CD14+ cells were identified after 7 
days.  Whilst not of statistical significance, this increase is scientifically important.  Very little 
increase in the percentage of CD14+ cells was subsequently found between 7 days and 14 
days.  Consequently, MDM were cultured for 7 days for the remainder of this work. 
During the in vitro differentiation of monocytes to macrophages, regular washing of the 
cells to remove non-adherent cells is recommended by most published protocols.  Non-
adherent cells are typically lymphocytes as the other major leukocyte cell types, such as 
neutrophils, have a short lifespan and are often non-viable in buffy coat preparations. 
Unlike PBM, THP-1 monocytes do not become spontaneously adherent or differentiate to 
macrophages.  Instead, they require stimulation from exogenous stimuli, such as Phorbol 
myristate acetate (PMA) or 1,25-dihydroxyvitamin D3 which promote adherence, 
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phagocytosis, and expression of CD14, whilst preventing proliferation in order to imitate a 
differentiated macrophage-like state through the activation of protein kinase C (Schwende 
et al., 1996).  PMA is a protein kinase C (PKC) agonist, which activates the Raf/MEK/ERK 
pathway in THP-1 monoblastic cells for transcription of genes involved in differentiation 
(Traore et al., 2005).   
There are many different protocols available for the in vitro generation of macrophage-like 
cells from THP-1 using PMA treatment; over 24 hours (Smith et al., 2015), 48 hours (Chanput 
et al., 2013; Park et al., 2007), 3 days of treatment followed by 1 day of rest (Mittar et al., 
2011), and 3 days of treatment followed by 5 days of rest (Daigneault et al., 2010).  The 
method developed by Daigneault et al., was used in this work as their data showed these 
THP-1 macrophages more closely resembled MDM than THP-1 differentiated using 
alternative protocols.  In particular, their comparisons focussed on the increase in 
cytoplasmic-to-nuclear ratio and downregulation of CD14 expression, associated with MDM 
differentiation from monocytes. 
In the work presented here, differentiated MDM appeared as a mildly heterogeneous 
population, with cells ranging from circular to spindle-shaped.  However, they all displayed 
a spherical nucleus and large cytoplasmic-to-nuclear ratio.  In comparison, THP-1 PMA 
appeared as a highly heterogeneous population, with some very small cells, that were 
lightly adherent, and some that resembled MDM with a large cytoplasmic-to-nuclear ratio, 
spherical nucleus and flattened morphology.  This is in accordance with previously 
published data (Daigneault et al., 2010). 
THP-1 monocytes treated with PMA and plastic-adherent PBM displayed changes in cell 
morphology, becoming larger and more granular indicating differentiation to macrophages, 
confirming previously published data (Bosque et al., 1997).  However, the different methods 
used to achieve this is reflected in the differential expression of the differentiation marker, 
CPM.  CPM is a specific marker of monocyte to macrophage differentiation and previous 
studies have shown that cell surface expression of CPM increases as monocytes 
differentiate into macrophages (Rehli et al., 1995).  This is confirmed by gene expression 
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data which showed a 29-fold increase in CPM expression in MDM compared to PBM.  In the 
presence of GM-CSF and M-CSF, this was further increased. 
Importantly, the protein expression of CPM by PMA-treated THP-1 macrophages was much 
lower than that by MDM.  Accordingly, cell surface expression of CPM increased as PBM 
were differentiated to MDM.  However, although CPM expression was detected on THP-1 
cells, its expression decreased with PMA treatment.  Since CPM expression correlates with 
macrophage maturation, it is likely that the low levels of CPM observed on the surface of 
THP-1 macrophages are due to their immature phenotype (Rehli et al., 2000).  The failure 
to increase expression of this key differentiation marker suggests that PMA-differentiated 
THP-1 cells do not adequately model the monocyte to macrophage differentiation of 
primary cells in vitro.  Regarding the differentiation of MM6 cells, attempts to confirm 
previously published data by Zieglerheitbrock et al., were unsuccessful (Zieglerheitbrock et 
al., 1994).  
 Differences between THP-1 PMA and monocyte-derived macrophages 
The expression of CD14 and CD45 has previously been shown to decrease during monocyte 
to macrophage differentiation (Zieglerheitbrock and Ulevitch, 1993).  As previously 
described, both PBM and THP-1 monocytes displayed decreased expression of CD14 upon 
differentiation to macrophages (Ambarus et al., 2012).  However, whilst PBM also displayed 
decreased expression of CD45 upon differentiation, PMA-treated THP-1 cells showed an 
increase in CD45 expression.  Taken together, these data suggest that PMA-treated THP-1 
cells show dramatically altered expression of differentiation markers compared to 
peripheral blood MDM.  This may be due to the actions of the potent protein kinase C 
stimulator (PMA) used to initiate the differentiation process.   
3.7 Conclusion 
Due to the 2D culture methods optimised in this chapter, large numbers of CD14+ PBM and 
MDM can be isolated and viably cultured in vitro and detached for use in downstream 
applications.  In addition, a preliminary comparison has been drawn between primary and 
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cell line monocytes and macrophages.  However, a more robust, multi-colour flow 
cytometry panel may enable a more thorough characterisation of the protein expression 
profiles of these different cell types to confirm any differences in expression.  Additionally, 
the expression of a range of markers using qRT-PCR could provide further understanding in 
differences at the gene expression level.  Whilst THP-1 and MM6 have been preliminarily 
compared in this work, further work could also compare other human monocyte cell lines 
such as AML-193, established from a young female with AML with lymphoblast morphology 
and GM-CSF dependency (Lange et al., 1987); HL-60, a promyeloblast cell line which has the 
capacity for differentiation to a macrophage-like cell, established from the peripheral blood 
leukocytes of a female with AML (Collins, 1987); Kasumi-3 derived from the blast cells of an 
adult male with myeloperoxidase-negative acute leukaemia, which is capable of maturation 
of a monocytic lineage (Asou et al., 1996); and U-937 derived from an adult male with 
histiocytic leukaemia and can be terminally differentiated (Sundstrom and Nilsson, 1976). 
In conclusion, due to the important differences in morphology and protein expression 
observed in THP-1 and MM6 cell lines compared to primary cells (particularly of key markers 
CD45, CD14 and CD163) PBM and MDM will be used in the ensuing experiments.  However, 
as very few optimized protocols are available for the 3D culture of primary monocytes and 
macrophages, cell lines will be used for method development, and these methods will then 
be applied to the 3D culture of primary cells.   
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 Chapter 4: 3D Culture of Functional and Viable 
Macrophages 
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4.1 Introduction 
Tissue-engineering is increasingly used in regenerative medicine for improved wound 
healing and several companies offer tissue-engineered oral mucosa for use in the clinic 
(Moharamzadeh et al., 2012).  In addition, tissue-engineering is becoming a more 
widespread technique in research as it provides several benefits compared to 2D and mono-
culture experiments which are very simple, quick, and cost-effective, but lack the 
complexity of in vivo tissues.  As such, 2D monolayer experiments have been shown 
repeatedly to fail to represent the in vivo environment (Cukierman et al., 2001; Kriegebaum 
et al., 2012; Mazzoleni et al., 2009).  Animal models are often used to test drugs for clinical 
application, however, due to the differences between humans and animals, results from 
these experiments are not always transferable (Gaballah et al., 2008; Kimlin et al., 2013; 
Mazzoleni et al., 2009; Qian and Pollard, 2010).  Therefore, there is an increased demand 
for accurate models of human tissues, which can represent an in vivo environment and 
therefore inform future clinical trial decisions and further understanding of disease 
progression. In vitro 3D co-culture models offer the benefits of including multiple cell types 
to more accurately represent human tissues, whilst providing a cost-effective, clinically 
relevant alternative to in vivo models and at the same time retaining the ease of use and 
reproducibility of 2D culture. 
However, there are very few examples of 3D cultured immune cells, and of these, even 
fewer use primary human immune cells.  As macrophages are shown to have an increasingly 
important role in the development and progression of oral cancer, this project aims to 
develop methods for the 3D culture of viable and functional macrophages in order to 
further develop existing in vitro 3D models of oral cancer. 
4.2 Viable 3D culture of THP-1 monocytes 
THP-1 cells are an established cell line which are often used to represent primary monocytes 
as they do not require lengthy isolation procedures, proliferate in culture and can be 
differentiated using PMA to produce a macrophage-like cell.  This commercially available 
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cell line was initially used in this research to optimise methods for the 3D culture of 
monocytes and macrophages within a collagen hydrogel.   
 Changes in proliferation of THP-1 cells cultured in a collagen hydrogel 
In order to show viable 3D culture of THP-1 cells over an experimental time course, an 
appropriate viability assay was required which did not involve cell lysis.  AlamarBlue® is a 
non-toxic cell viability assay which measures cell proliferation through the reduction of non-
fluorescent, membrane-permeable resazurin into resorufin during cell metabolism.  Cell 
culture media surrounding collagen hydrogels in the presence or absence of THP-1 cells was 
sampled over 14 days (on days 1, 4, 7, 10 and 14) and the red fluorescence of resorufin was 
measured at 570 nm by a spectrophotometer (Tecan, Männedorf, Switzerland). 
A collagen hydrogel was prepared as previously described (Dongari-Bagtzoglou and 
Kashleva, 2006) into which 1x106 THP-1 cells were incorporated.  Once set, hydrogels were 
cultured with 1 mL supplemented RPMI 1640 for 14 days.  Cell culture media with the 
addition of alamarBlue® was sampled and analysed for changes in resorufin absorbance on 
days 1, 4, 7, 10 and 14.  Media from THP-1-containing hydrogels was compared to media 
from cell-free hydrogels maintained under the same conditions (Figure 4.1). 
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Figure 4.1.  Absorbance of alamarBlue® over 14 days.  THP-1-containing or cell-free 
collagen hydrogels were cultured for 14 days and absorbance of alamarBlue® was 
measured at 570nm on days 1, 4, 7, 10 and 14.  Samples from six independent 
experiments were measured in triplicate (n=6), error bars show standard error mean, and 
significance was determined using an unpaired two-tailed T-test (*** = p<0.005). 
Over 14 days, cell-free models showed no conversion of resazurin into resorufin, however, 
there was a small increase in resorufin in media surrounding THP-1-containing models 
suggesting an increase in the number of proliferating cells (Figure 4.1).  After 14 days, an 
unpaired two-tailed T-test was carried out and concluded that collagen hydrogels 
containing THP-1 cells showed a significant increase in absorbance at 570 nm (p=0.0001) 
compared to a cell-free hydrogel.   
 Preparation of 3D cultured THP-1 cells for flow cytometry 
Flow cytometry is a technique which uses lasers to interrogate individual cells in a fluid 
sample stream in order to detect scattered light relating to the physical characteristics (such 
as size, complexity and expression of proteins labelled with fluorochrome-conjugated 
antibodies) of the cells in a sample.  Previous data suggested that THP-1 monocytes 
spontaneously differentiated to macrophages when cultured within a collagen hydrogel 
(Jennings, L., unpublished data).  Therefore, flow cytometry was selected to detect changes 
in cell size and granularity which are associated with monocyte to macrophage 
*** 
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differentiation.  However, a single-cell suspension was required for flow cytometry analysis.  
In addition, viability stains could be incorporated into flow cytometry sample staining 
methods for precise quantification of cell viability. 
The concentration of collagen for hydrogel preparation was tested between 3-7 mg/mL in 
order to optimise formation of a hydrogel suitable for manipulation, viable cell culture and 
to enable rapid digestion of the hydrogel.  In addition, incubation times of varying lengths 
were tested for rapid digestion of models, with and without the use of shaking or additional 
co-factor molecules such as calcium chloride ions, which stabilise the enzyme and promote 
its activity by facilitating its binding to collagen.  Incubation of 2 mg/mL collagenase IV 
diluted in cold DMEM for 1.5 hours at 37 °C with shaking at 100 rpm enabled visible 
disaggregation of the collagen hydrogel.  After 14-days of culture, THP-1-containing 
collagen hydrogels were digested using collagenase IV to release individual cells.  However, 
un-digested collagen fibres prevented a THP-1 cell pellet forming upon centrifugation.  
Therefore, the use of a cell strainer to remove un-digested fibres was explored.   THP-1 
monocytes, cultured in 3D for 14 days, before and after use of a cell strainer were compared 
to a suspension of THP-1 monocytes cultured in 2D and a collagen hydrogel preparation 
devoid of cells that had not been subjected to processing with a cell strainer (Figure 4.2).  
These samples were analysed using flow cytometry. 
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Figure 4.2.  Preparation of a single-cell suspension suitable for flow cytometry.  THP-1 
monocytes cultured in 3D for 14 days were prepared into a single cell suspension suitable 
for flow cytometry using a cell strainer to eliminate contaminating un-digested collagen 
fibres.  Dot plots show forward scatter (FSC) and side scatter (SSC) data measured using 
flow cytometry.  The removal of undigested collagen molecules, such as those present in 
hydrogels devoid of cells (A) from disaggregated collagen hydrogels produced a 
homogeneous single-cell suspension suitable for flow cytometry (B), comparable to THP-1 
cells cultured in suspension (C), without the collagen contamination which was previously 
observed (D).  Dot plots show representative data from three independent experiments, 
measured in duplicate (n=3). 
A collagen hydrogel devoid of cells, digested with collagenase IV and prepared for analysis 
by flow cytometry, without prior processing with a cell strainer, retained particles of 
undigested collagen that were falsely detected as cells during flow cytometry analysis.  Once 
this sample had passed through a cell strainer, no events were detected by the flow 
cytometer (data not shown).  The use of a cell strainer removed this undigested collagen 
contamination from THP-1 monocytes cultured in 3D resulting in detection of a 
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homogeneous THP-1 cell population using flow cytometry, which was comparable to that 
of THP-1 cells cultured in 2D.  All subsequent samples of 3D-cultured cells for flow cytometry 
analysis were processed using a cell strainer before staining with antibodies. 
 Viability of THP-1 cells cultured in 3D 
In order to quantitatively determine the viability of THP-1 cells cultured in 3D over 14 days, 
single-cell suspensions of THP-1 monocytes released from a digested collagen hydrogel 
were stained with propium idodide (PI).  However, repeated, high levels of cell death were 
observed.  Different aspects of hydrogel preparation were investigated to determine if gel 
dehydration during gelation, gel disaggregation using collagenase IV, cell culture media 
used, or gel pH were responsible for cell death.  For the preparation of the hydrogel, the 
published protocol described neutralisation according to ‘if the solution looks acidic (judged 
visually by the color of the phenol red…)’ (Dongari-Bagtzoglou and Kashleva, 2006).  
However, this resulted in a mixture of pH 9.1, as determined by pH probe analysis.  The 
preparation of a hydrogel of pH 7.4 required a reduced quantity of NaOH, displaying a subtle 
change in colour of phenol red (Figure 4.3). 
 
Figure 4.3. Preparation of collagen hydrogels of different pH.  Images show the colour 
difference of solutions of pH 9.1 (A) and pH 7.4 (B) used for collagen hydrogel preparation.   
Collagen hydrogels prepared under the guidance of a colour change of phenol red resulted 
in a hydrogel pH of 9.1.  To determine whether this highly alkaline pH affected cell viability 
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during 3D cell culture, THP-1 monocytes were cultured in gels prepared at pH 9.1 and pH 
7.4, and viability analysed by flow cytometry using PI (Figure 4.4). 
  
  
 
112 | P a g e  
 
 
 
Figure 4.4.  Viability of THP-1 monocytes cultured within a collagen hydrogel.  THP-1 monocytes cultured in suspension (A), with the 
additional treatment of collagenase IV as a control (Ctrl, B) and in 3D, in a collagen hydrogel of either pH 7.4 (C) or pH 9.1 (D) for 14 days 
were analysed using flow cytometry.  Viability assessed by dead cell exclusion using propium iodide is summarised in scatter plot (E).  Gates 
were set based on unstained samples treated under the same condition.  Samples from three independent experiments were measured in 
duplicate (n=3) where dot plots show representative data.  Error bars show the standard error mean and significance was determined using 
a one-way ANOVA with Tukey’s multiple comparisons (**** = p<0.0001).   
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THP-1 monocytes cultured in 2D showed 97.0 % viability as measured with PI and analysed 
by flow cytometry.  Preparation of collagen hydrogels of pH 7.4 enabled recovery of a 
significant increase in the percentage of viable THP-1 cells recovered after 14 days 
compared to hydrogels of pH 9.1, up to 91.8 % from 19.7 % respectively (p=<0.0001).  THP-
1 cells cultured in 3D within collagen hydrogels of pH 7.4 showed no significant decrease in 
viability compared to THP-1 cells cultured in a 2D suspension (p=0.4045).  THP-1 cells 
cultured in a 2D suspension treated with collagenase IV, used as a control (Ctrl), showed 
86.4 % viability and also showed no significant decrease in viability compared to THP-1 cells 
cultured in 2D without treatment with collagenase IV (p=0.0543).  Subsequently, all ensuing 
collagen hydrogel mixtures were pH-probed before addition of cells to ensure a pH of 7.4.  
 Visualisation of THP-1 cells cultured in 3D 
In order to visualise THP-1 monocytes cultured within the collagen hydrogel, formalin-fixed 
hydrogels containing THP-1 cells after 14 days of culture were processed, bisected and 
paraffin-embedded.  Haematoxylin and eosin (H&E) stains were used to identify cell nuclei 
and cytoplasms respectively, and cell distribution overall (Figure 4.5).   
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Figure 4.5.  H&E stained THP-1 cells cultured within a collagen hydrogel.   Collagen hydrogels containing THP-1 monocytes cultured for 14 
days were formalin fixed, sectioned and stained using H&E.  Images taken at 10x (A), 20x (B) and 40x (C) magnification are representative of 
three independent experiments (n=3).  Monocytes with typical morphology are exemplified (arrows).  Scale bars indicate 200 µm (A), 100 
µm (B) and 50µm (C).
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Following 14 days of culture within a collagen hydrogel, evenly dispersed clusters of THP-1 
cells stained with H&E can be observed.  Here, THP-1 cells can be observed as small, 
spherical cells with a reniform nucleus and very few granules.   
 Changes in proliferation of viable THP-1 cells cultured in a collagen 
hydrogel 
Previous data in this chapter showed that THP-1 monocytes cultured in 3D, stained with PI 
and analysed by flow cytometry were viable.  Additionally, the use of alamarBlue® over the 
time course of 14 days to measure cell proliferation, combined with the use of PI at the end 
of the cell culture period to measure cell viability was explored.  Culture media of collagen 
hydrogels containing THP-1 cells with or without the addition of alamarBlue® were sampled 
(Figure 4.6) and compared to samples from THP-1 cells cultured in suspension.   
 
Figure 4.6.  Viability of THP-1 cells cultured within a collagen hydrogel treated with 
alamarBlue®.  THP-1 cells cultured in suspension (A), or in a collagen hydrogel for 14 days 
in the absence (B) or presence of alamarBlue® (C) were analysed by flow cytometry using 
propium iodide dead cell exclusion.  Gates were set based on unstained samples treated 
under the same conditions.  Dot plots are representative of two independent experiments 
measured in duplicate (n=2). 
THP-1 monocytes cultured in 2D or in 3D without the addition of alamarBlue® showed >90 
% viability, however those treated with alamarBlue® showed <1 % viability measured with 
PI.   
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 THP-1 monocytes cultured in 2D and 3D show no differences in size and 
granularity 
Previous evidence suggested that monocytes cultured in 3D spontaneously differentiate to 
macrophages in a manner representative of circulating monocyte differentiation to 
macrophages within tissues in vivo (Jennings, L., unpublished).  Monocyte to macrophage 
differentiation is characterised by a morphological change as cells increase in size, 
cytoplasmic-to-nuclear ratio and number of cytoplasmic granules to increase production of 
hydrolytic enzymes (Chang et al., 2012).  Previous data determined monocyte to 
macrophages differentiation visually by light microscopy and H&E staining of 4 µm FFPE 
sections.  However, with methods now developed for analysis of 3D-cultured THP-1 
monocytes by flow cytometry, changes in size (FSC) and granularity (SSC) of THP-1 cells, 
indicative of monocyte to macrophage differentiation, could be compared between those 
cultured in 2D and 3D.  THP-1 cells cultured within a collagen hydrogel for 14 days were 
retrieved using collagenase IV digestion and a single-cell suspension was prepared using a 
40 µm cell strainer (Figure 4.7). 
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Figure 4.7.  Comparison of size and granularity of THP-1 cells cultured in 2D and 3D.  
Forward scatter (FSC) and side scatter (SSC) data of THP-1 cells cultured in a 2D suspension 
(A) or in a 3D collagen hydrogel for 14 days (B) was measured using flow cytometry following 
dead cell exclusion using propium iodide, and compared using summarised data in scatter 
plots (C and D) for FSC and SSC respectively.  Gates were set based on unstained samples.  
Samples from three independent experiments were measured in duplicate (n=3), error bars 
show standard error mean and significance was determined using an unpaired T-test. 
FSC values of THP-1 monocytes cultured in 2D were measured as 522.7 ± 15.28 compared 
to those cultured in 3D which were measured as 489.2 ± 25.59.  SSC values were measured 
as 355.3 ± 30.42 in 2D-cultured THP-1 monocytes, and 368.5 ± 23.92 in those cultured in 
3D.  An unpaired T-test showed that THP-1 cells cultured in 2D and 3D showed no significant 
difference in size or granularity (p=0.3238 and p=0.7508 respectively).   
4.3 3D culture of peripheral blood monocytes  
Following the successful culture of THP-1 monocytes in 3D within a collagen hydrogel for 14 
days, the 3D culture of PBM was explored.  Monocytes were isolated from buffy coats using 
density centrifugation and purified using magnetic separation.  One million of the resulting 
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cells were incorporated into a collagen hydrogel for 3D culture and cultured with 
supplemented IMDM for 14 days. 
Due to poor yields of purified populations of monocytes using magnetic separation, it was 
not possible to acquire enough primary monocytes for analysis of 3D cultures by flow 
cytometry.  Of the pooled samples that were tested, viability was very low after 24 hours, 
and no viable cells could be detected following 14 days of culture (data not shown). 
4.4 3D culture of Mono Mac 6 
Whilst THP-1 cells are regularly used to represent PBM, a need for a more mature monocyte 
cell line was addressed by Ziegler-Heitbrock et al.,  who established a new human monocyte 
cell line, Mono Mac 6, which expressed phenotypic and functional features more similar to 
mature monocytes than THP-1 or U937 monocyte cell lines (Zieglerheitbrock et al., 1988).  
However, MM6 cells are also derived from a patient with monoblastic leukaemia, so while 
they may be preferential in some aspects of monocyte biology compared to THP-1 cells, 
they may not be representative in other aspects. 
Due to the limitations in the viable 3D culture of PBM, the use of MM6 monocytes was 
explored as an improvement to THP-1 monocytes.  In a similar way to THP-1 cells, MM6 are 
cultured in suspension and rapidly proliferate once established in culture.  Therefore, it is 
possible to culture large numbers of these cells to prepare 3D cultures. 
A collagen hydrogel was prepared into which 1x106 MM6 cells were incorporated.  After 14 
days, MM6 cells were retrieved from the collagen hydrogel using collagenase IV digestion, 
prepared into a single cell suspension using a cell strainer, and stained with PI for flow 
cytometry analysis.  Alternatively, models were fixed in formalin, embedded in paraffin and 
stained with H&E (Figure 4.8). 
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Figure 4.8.  Viability of 3D-cultured Mono Mac 6.   Mono Mac 6 (MM6) were cultured in 
3D within a collagen hydrogel for 14 days and compared to those cultured in suspension 
(2D).  For flow cytometry analysis, cells were selected based on dead cell exclusion and 
gates set based on unstained samples cultured under the same conditions.  For histological 
analysis, models were formalin fixed, sectioned and stained with H&E.  Viability of MM6 cell 
line cultured in 2D (A) or within a 3D collagen hydrogel (B) is summarised in scatter plot (C).  
H&E stained MM6 cultured in 3D (D) and dot plots are representative of two independent 
experiments (n=2).  Error bars shows standard error mean and arrows indicate MM6 cells 
sparsely populating the hydrogel. 
Viability of MM6 cells cultured in a 2D suspension, measured using PI and analysed by flow 
cytometry, dropped from 86.2 % to 50.4 % when cultured in 3D.  However, 2D-cultured 
MM6 monocytes treated with collagenase IV only resulted in 10 % loss in viability (data not 
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shown).  MM6 cells cultured in 3D and stained with H&E can be observed sparsely 
distributed throughout the hydrogel.   
 Differentiation of peripheral blood monocytes to monocyte-derived 
macrophages in situ within collagen hydrogel 
CPM cleaves terminal arginine and lysine residues on peptides to control binding of growth 
factors and hormones on the cell surface and degradation of cell-surface peptides.  
Importantly here, it is a marker of monocyte to macrophage differentiation as its expression 
levels are higher in macrophages than in monocytes.  In the literature, GM-CSF and M-CSF 
are often used to promote monocyte to macrophage differentiation and therefore to 
stimulate an increase in the expression of CPM.  An increase in expression of CPM was used 
to indicate monocyte to macrophage differentiation on monocytes and macrophages 
cultured in 2D and 3D and in the presence or absence of GM-CSF or M-CSF. 
Carboxypeptidase M gene expression in 3D 
One million PBM isolated from buffy coats and purified using magnetic separation were 
incorporated into a collagen hydrogel and cultured with supplemented IMDM for 14 days, 
in the presence or absence of GM-CSF or M-CSF.  After 14 days, cells were retrieved using 
collagenase IV digestion of the hydrogel and processed using a cell strainer to remove 
undigested collagen fibres.  RNA was extracted from cell pellets and yield determined. 
Due to poor yields of purified populations of monocytes using magnetic separation, and loss 
of cells during the processing of 3D cultures, negligible amounts of RNA were acquired and 
it was therefore not possible to analyse gene expression of CPM by PBM cultured in 3D.   
Carboxypeptidase M protein expression in 3D 
One million PBM isolated from buffy coats and purified using magnetic separation, or MDM 
were incorporated into a collagen hydrogel and cultured with supplemented IMDM for 14 
days.  After the culture period, hydrogels were fixed, paraffin-embedded and stained with 
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H&E and immunohistochemically stained with anti-CPM antibody and counter-stained with 
haematoxylin (Figure 4.9).   
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Figure 4.9. Carboxypeptidase M expression of peripheral blood monocytes and monocyte-derived macrophages on day 1 and day 14 of 
3D culture.   Immediately following isolation and purification of peripheral blood monocytes (PBM, A-C) or following 7 days of adherent 
culture of monocyte-derived macrophages (MDM, D-F), cells were cultured within a collagen hydrogel.  Models were cultured in the absence 
(A and D) or presence of GM-CSF (B and E) or M-CSF (C and F) for 14 days.  Light microscopy images display collagen hydrogels containing 
PBM on days 1 (A and D) and 14 (B, C, E and F) of culture stained using anti-CPM antibodies and counter-stained with haematoxylin.  Images 
are representative of two independent experiments (n=2).  Arrows indicate areas of staining positive for CPM and scale bars indicate 100 
µm.  
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PBM appeared visibly smaller than MDM on day 1, however they were of comparable size 
by day 14.  Additionally, increased amounts of CPM staining could be visualised in MDM 
samples compared to PBM samples.  Whilst no CPM staining could be observed in models 
containing PBM on day 1, small amounts could be detected on day 14 in the presence of 
GM-CSF, which was further increased in the presence of M-CSF. 
4.5 3D culture of THP-1 PMA 
To determine whether THP-1 PMA could be viably cultured in 3D, THP-1 monocytes were 
stimulated with PMA in 2D for 8 days (Daigneault et al., 2010).  After differentiation, 1x106 
THP-1 PMA were incorporated into a collagen hydrogel and cultured for 14 days with 
supplemented RPMI.  After 14 days, cultures were formalin-fixed, processed, stained with 
H&E and visualized using light microscopy.  Additionally, hydrogels were disaggregated 
using collagenase IV, processed using a cell strainer, and stained with PI for assessment of 
cell viability using flow cytometry (Figure 4.10). 
 
Figure 4.10.  Viability of 3D-cultured THP-1 PMA.   THP-1 monocytes treated with PMA 
(THP-1 PMA) for 8 days were recovered using cell scraping and cultured within a collagen 
hydrogel for 14 days.  H&E stained sections of THP-1 PMA cultured in 3D are representative 
of three independent experiments (n=3).  Arrows indicate THP-1 PMA and scale bar 
indicates 100 µm. 
Two cells can be visualized in the uppermost layer of the hydrogel.  H&E staining shows a 
large nucleus and minimal cytoplasm.  Due to the low numbers of THP-1 PMA recovered 
following 14 days of 3D culture, it was not possible to perform viability analysis using flow 
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cytometry.  Of the pooled samples that were tested after 24 hours, <30 % of cells were 
viable (data not shown). 
4.6 3D culture of monocyte-derived macrophages 
Small numbers of macrophages have previously been cultured within a collagen hydrogel 
model of the dermis (Linde et al., 2012).  However, this has not been successfully combined 
with a tissue-engineered model of the oral mucosa.  With so many differences identified 
between MDM and THP-1 PMA, it was essential to determine methods for the viable 3D 
culture of MDM.  In order to determine whether MDM could be cultured in 3D, a variety of 
methods to incorporate MDM within a collagen hydrogel were tested; monocytes were 
seeded into wells or on top of models and allowed to differentiate for 7 days as it was 
hypothesized that differentiated MDM may extravasate into the collagen hydrogel.  
However, MDM remained on the surface of the hydrogel and could not be visualized within 
the hydrogel (data not shown).   
 Viability of monocyte-derived macrophages cultured in 3D  
Monocytes differentiated to MDM in 2D over 7 days were detached using gentle scraping 
into IMDM.  One million MDM were incorporated into the collagen hydrogel mixture, and 
once set, cultured for 14 days with supplemented IMDM.  After 14 days, cells were retrieved 
from the hydrogel using collagenase IV, processed using a cell strainer and viability 
measured using PI and analysed using flow cytometry.  Alternatively, hydrogels were 
formalin-fixed, processed, paraffin-embedded, stained with H&E and visualized using light 
microscopy (Figure 4.11). 
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Figure 4.11.  Viability of 3D-cultured monocyte-derived macrophages.   Monocyte-derived 
macrophages (MDM) cultured for 7 days in adherent culture were recovered using cell 
scraping and analysed using flow cytometry.  Viability of MDM cultured in 2D (A) or within 
a 3D collagen hydrogel (B) is summarised in scatter plot (C).  H&E stained MDM cultured in 
3D (D) and dot plots are representative of three independent experiments (n=3).  Error bars 
shows standard error mean.  Arrows indicate MDM and scale bar indicates 100 µm. 
Following 14 days of 3D culture, >95 % of MDM were measured as viable using flow 
cytometry.  An unpaired two-tailed T-test concluded that there was no significant difference 
in viability observed between MDM cultured in 2D and 3D (p=0.7978).  Compared to 
unstained samples, viability gates were set at different positions for 2D and 3D samples, 
suggesting that the auto-fluorescence, FSC and SSC were altered in MDM cultured in 3D 
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compared to 2D.  Staining of hydrogels with H&E showed an even distribution of MDM 
throughout the hydrogel.  These cells appeared as large, irregular-shaped cells with a darkly 
stained spherical nucleus. 
 MDM cultured in 3D release inflammatory cytokines in response to LPS  
Macrophages play a key role in host defences, providing the first line of defence against 
invading pathogens.  LPS is the major component of the outer membrane of gram-negative 
bacteria which binds to CD14 on the surface of macrophages, resulting in the production of 
an inflammatory response.  This is characterised by the release of pro-inflammatory 
cytokines, such as IL-6.   
To demonstrate that MDM are not only viable in 3D culture, but can also respond to 
exogenous stimuli in a manner representative of their role in vivo, LPS was added to fresh 
media on 2D and 3D cultured MDM on days 7 and 14 of culture respectively.  After 24 hours, 
cell culture media was collected and assayed for any cytotoxic effects of LPS through LDH 
release, and evidence of a pro-inflammatory response was detected using ELISA to measure 
IL-6 release (Figure 4.12). 
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Figure 4.12.  Monocyte-derived macrophages cultured in 2D and 3D release IL-6 in 
response to lipopolysaccharide.   Monocyte-derived macrophages (MDM) were cultured 
for 7 days in adherent culture, and recovered using cell scraping (2D).  For 3D cultures, MDM 
were additionally cultured for 14 days within a collagen hydrogel.  Lactate dehydrogenase 
(LDH) release (A and B) and IL-6 release (C and D) of MDM cultured in 2D (A and C) or 3D (B 
and D) were measured using LDH assay and ELISA respectively.  Data are representative of 
three independent experiments measured in triplicate (n=3) and error bars show standard 
error mean.  Significance was determined using an unpaired T-test (****=p<0.0001). 
The addition of LPS did not result in an increase in release of LDH from MDM in both 2D and 
3D cultures (p=0.3782 and p=0.5678, respectively) as determined by an unpaired two-tailed 
T-test.  However, the amount of LDH released from MDM cultured in 3D was higher than 
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that of MDM cultured in 2D.  In both 2D and 3D cultures, there was a significant increase in 
IL-6 released in response to stimulation of MDM with LPS (p<0.0001).  However, the amount 
of IL-6 released from 2D cultures was almost 10-fold higher than that released by 3D 
cultures.   
4.7 Discussion 
Collagen is the main component of the ECM and as such can be used to form a hydrogel for 
the 3D culture of cells to mimic the ECM.  Whilst it lacks the complexity of other scaffolds, 
such as DED, cells can easily be incorporated into the mixture whilst it is still viscous.  This 
makes it ideal for the 3D culture of cells which typically reside within the ECM, such as 
macrophages.  In order to best represent tissue resident macrophages in vivo, this research 
sought to model monocyte to macrophage differentiation in situ within the gel.  Previous 
data suggested that monocytes cultured within a 3D hydrogel may spontaneously 
differentiate to macrophages in response to culture within a 3D environment (Jennings, L., 
unpublished). 
Published studies that have incorporated monocytes into tissue-engineered models 
typically use THP-1 or MM6 cell lines (Table 1.2); no studies could be found incorporating 
primary human monocytes into a collagen hydrogel.  In this chapter, the viable 3D culture 
of primary human monocytes within a collagen hydrogel is explored.  Due to the challenges 
presented by isolating primary cells, 3D culture methods were developed using THP-1 cell 
line which is often used to represent primary monocytes.  However, results from Chapter 3 
demonstrated important differences between PBM, THP-1 and MM6.  Consequently, 
optimised methods were then applied to the 3D culture of primary cells. 
 Viable 3D culture of THP-1  
No published articles could be found describing the culture of THP-1 monocytes within a 
collagen hydrogel.  Previous H&E data showed that THP-1 monocytes cultured in 3D 
appeared larger with a macrophage-like appearance suggesting differentiation of THP-1 
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monocytes to macrophages (Jennings, L., unpublished).  This work also identified challenges 
in maintaining the viability of THP-1 cells in 3D culture. 
To measure cell viability within the collagen hydrogel over the 14-day culture period, an 
assay for measuring cell viability was required.  Commonly used cell viability reagents 
include (3-4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) tetrazolium (MTT), 
PrestoBlue®, Resazurin and alamarBlue®.  An MTT assay involves cell lysis, making it an end-
point assay so it cannot be used to measure cell viability over time.  Resazurin, PrestoBlue® 
and alamarBlue® are all resazurin-based reagents and so can be used interchangeably 
depending on reaction times required.  AlamarBlue® was selected to measure THP-1 
viability on days 1, 4, 7, 10 and 14.  Published models of the oral mucosa, using DED, are 
cultured for 14 days, hence, the viable culture of THP-1 in 3D was sought for 14 days (Colley 
et al., 2011; Hearnden et al., 2014). 
AlamarBlue® detects cell viability as a measure of metabolic activity.  The modest increase 
in absorbance of alamarBlue® over 14 days indicates a modest increase in metabolic activity 
of the cells within the hydrogel.  Macrophages are less metabolically active than monocytes, 
so through differentiation, little increase in metabolic activity would be detected using 
alamarBlue®.  This supported previous data suggesting that in response to a 3D 
environment, THP-1 monocytes were differentiating to macrophages. 
Flow cytometry can not only detect changes in size and granularity of cells, or morphological 
changes associated with monocyte to macrophage differentiation, but could also be used 
to quantitatively measure cell viability and expression levels of proteins associated with 
monocyte to macrophage differentiation, such as CPM.  In order for flow cytometry analysis 
to be possible, a single-cell suspension was required.  This involved the disaggregation of 
the collagen hydrogel using collagenase IV to retrieve cells contained within it.  Whilst 
conditions were optimised for the visible disaggregation of the collagen hydrogel, un-
digested collagen fibres prevented a pellet of THP-1 monocytes from forming upon 
centrifugation and also resulted in collagen fragments falsely detected as cells during flow 
cytometry analysis.  Cell strainers are often used in flow cytometry, particularly for cells 
  
 
130 | P a g e  
 
which typically form adherent junctions, such as keratinocytes, to prevent clogging of the 
flow chamber.  In this case, a cell strainer was effective in removing contaminating un-
digested collagen fibres to produce a single-cell suspension of THP-1 monocytes suitable for 
flow cytometry analysis.  
Previous data has shown an increase in the size and granularity of PMA-treated THP-1 cells 
compared to THP-1 monocytes (Daigneault et al., 2010) and therefore changes in FSC and 
SSC respectively could indicate monocyte to macrophage differentiation.  Flow cytometry 
analysis comparing the size and granularity of THP-1 cells cultured in 2D and 3D showed no 
significant difference.  Histological analysis of 3D cultured THP-1 using H&E staining 
revealed evenly distributed clusters of cells indicative of cell proliferation.  Further analysis 
using proliferation markers, such as Ki67, may indicate whether THP-1 cells are 
proliferating.  However, it is widely considered that macrophages are terminally 
differentiated and therefore do not proliferate within tissues, although unless treated with 
PMA, or other differentiation-inducing stimuli, THP-1 monocytes are not considered 
terminally differentiated. 
Analysis of THP-1 monocytes cultured in 3D using flow cytometry also enabled quantitative 
measurement of viability over 14 days.  PI is a membrane impermeant intercalating dye 
which penetrates cells with damaged or permeable membrane to bind to the DNA, thus 
enabling dye exclusion of non-viable cells excited at 488 nm and detected at emission 
wavelength of 617 nm.  It is often used to assess viability using flow cytometry.  This showed 
that cells cultured in 3D for 14 days were non-viable.  The decrease in metabolic activity 
identified by alamarBlue® thought to indicate monocyte to macrophage differentiation was 
in fact due to cell death.  However, probing of the collagen hydrogel mixture identified a pH 
of 9.1, that is not supportive to maintaining viable cells.  Altering the pH to 7.4 resulted in 
successful, viable culture of THP-1 monocytes for 14 days within a collagen hydrogel.   
Resazurin, in the alamarBlue® reagent, fluoresces at the same wavelength as PI, with 71 % 
overlap in emission spectra, resulting in cells treated with alamarBlue® measured falsely as 
non-viable by flow cytometry.  Whilst there are alternative viability dyes available for flow 
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cytometry, a major component of this project is the development of a polychromatic flow 
cytometry panel for detailed characterisation of macrophages.  The use of alamarBlue® 
limits the number of fluorochromes available for use in the multi-colour panel, as its 
fluorescence emission spectra demonstrates spectral overlap with many commonly used 
reagents (such as 24 % overlap with FITC, 87 % overlap with PE and 63% overlap with Texas 
Red).  By using separate hydrogels for each time point and/or analysis, the benefits of using 
a live cell assay would be lost.  In addition, the manufacturer reports that alamarBlue® is 
metabolized by leukocytes making it difficult to interpret results (ThermoFisher).  
Therefore, in ensuing experiments, flow cytometry will be used to quantitatively measure 
cell viability during extended culture. 
 3D culture of peripheral blood monocytes 
In order to develop an in vitro culture system truly representative of the in vivo 
environment, the use of primary cells is preferred.  No published articles could be found 
describing the 3D culture of PBM within a collagen hydrogel.  As methods had previously 
been developed for the 3D culture of commercially available monocytes, attempts were 
made using PBM isolated from healthy volunteers.  PBM were purified using magnetic 
separation and cultured for 14 days within a collagen hydrogel.  However, due to the limited 
number of PBM resulting from magnetic purification, few PBM were available for seeding 
into the collagen hydrogel.  H&E staining identified cells sparsely populating the hydrogel, 
and after 14 days, no events were detected using flow cytometry.  After just 24 hours in 3D 
culture, cell viability was <20 % suggesting that large-scale cell death was occurring over 14 
days.  A previously published study incorporated PBMC into a ThinCert™ coated with gelatin 
for 24 hours, but did not assess viability of cells (Tschachojan et al., 2014). 
Within human tissues, monocytes extravasate from the blood stream into tissues where 
they differentiate to macrophages.  With the use of exogenous stimuli, the differentiation 
of PBM to macrophages in situ within the hydrogel was explored.  It was hypothesized that 
differentiation of PBM to MDM may improve the poor viability of PBM cultured in 3D 
observed previously, by more accurately replicating the in vivo transition from circulating 
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monocyte to resident tissue macrophage.  CPM is used as a marker of monocyte to 
macrophage differentiation (Rehli et al., 2000) and whilst immunohistochemical staining of 
CPM provided some evidence that monocytes could be stimulated to differentiate to 
macrophages within the models, the numbers of monocytes available after magnetic 
purification were too low and hydrogels were sparsely populated with cells.  Using currently 
available methods of monocyte isolation and purification, it was not possible to seed the 
required number of PBM into the hydrogel in order for sufficient cells to be recovered for 
measurement of viability by flow cytometry.   
 Viable 3D culture of Mono Mac 6  
To test methods of 3D monocyte culture optimized for THP-1 cells, and as a more mature 
monocyte alternative in the absence of success with 3D culture of PBM, the 3D culture of 
MM6 was assessed.  MM6 cells are also an alternative to primary monocytes, but as shown 
previously in Chapter 3, display many differences to PBM.  H&E stained sections of 3D 
cultured THP-1 monocytes showed large clusters of cells, indicative of cell proliferation, that 
were absent in the 3D cultures of MM6.  Instead, cells were found sparsely populating the 
hydrogel, with low percentages of viability measured using flow cytometry.  As previous 
work had identified that MM6 may not be representative of PBM in size, granularity, and 
protein expression profile, and with the additional challenges in their culture compared to 
THP-1 monocytes, they were discarded. 
 3D culture of THP-1 PMA 
As insufficient numbers of PBM could be isolated to prepare 3D cultures at physiologically 
relevant concentrations of cells, the use of macrophages in 3D cultures was explored.  
Again, due to the challenges accompanying the isolation and purification of primary tissue-
resident macrophages, this work sought to use 2D in vitro generated MDM.  However, there 
are also challenges posed during the isolation and culture of MDM, which during method 
development were overcome by using PMA-treated THP-1 to represent macrophages.  
PMA-treated THP-1 have previously been shown to be representative of MDM in 
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characteristics such as resistance to apoptosis, phagocytosis and increased cytoplasmic-to-
nuclear ratio (Daigneault et al., 2010).  However, data presented in Chapter 3, showed that 
the expression of key markers was markedly different between THP-1 and primary 
macrophages.  Crucially, for method development in this work, THP-1 PMA are adherent 
and similar methods for cell detachment and subsequent incorporation into the collagen 
hydrogel are required as for MDM. 
The protocol selected for the generation of macrophage-like cells from THP-1 using PMA 
resulted in low yields of differentiated cells compared to the high numbers of cells seeded 
at the beginning of the 8-day differentiation protocol.  In addition, even fewer cells were 
recovered using collagenase after 14 days of culture within a hydrogel.  As a result, too few 
cells could be detected using flow cytometry to accurately determine viability.  However, 
the cells could be visualised, sparsely populating a 3D hydrogel.  Interestingly, single cells 
were visualised within the gel, compared to the clusters of cells visualised in models 
containing un-stimulated THP-1 cells.  This could indicate terminal differentiation of THP-1 
following treatment with PMA, or that cells are non-viable.  TUNEL or 
immunohistochemistry to detect caspase expression could be used to determine cell 
viability or cells undergoing apoptosis.  No other examples of THP-1 PMA cultured within a 
collagen hydrogel could be found. 
 Viable 3D culture of functional monocyte-derived macrophages 
Compared to 3D culture of THP-1 PMA, MDM responded very positively to culture within a 
collagen hydrogel.  Not only was there a high percentage of viable cells measured after 14 
days, but MDM could be found evenly dispersed throughout the gel.  The 3D culture of THP-
1 monocytes showed evenly dispersed clusters of cells indicating proliferation.  However, 
these were not observed in the 3D cultures of MDM.  In large amounts of the literature, 
MDM are considered to be terminally differentiated, and therefore do not proliferate, 
although this is still a subject for debate (Jenkins et al., 2011; Klappacher et al., 2002).  Of 
those models which had previously incorporated MDM, authors either did not measure 
viability directly (Leonard et al., 2010; Linde et al., 2012) or cells were largely non-viable (Liu 
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et al., 2016).  The only study that detected viable MDM in 3D culture used calcein AM, 
analysed using immunofluorescence (Bechetoille et al., 2011).  By using flow cytometry to 
measure cell viability however, it is possible to quantify precisely the viable cells and exclude 
non-viable cells from further analysis. 
Macrophages are integral to the innate immune response to invading pathogens and thus 
play a key role in the initiation and maintenance of inflammation.  In response to PAMPs 
binding PRRs, macrophages release pro-inflammatory cytokines such as IL-6, IL-8 and TNF 
(Rosso et al., 2011).  In order to assess the functionality of MDM in 3D culture, E.coli LPS 
was applied to cell culture media for 24 hours, following 14 days of culture.  LPS is often 
used to activate macrophages and the release of IL-6, among other pro-inflammatory 
cytokines, can be measured using ELISA.  
Previous literature has shown that in response to 100 ng/mL LPS, in comparison to lower 
concentrations of LPS, macrophages secreted significantly increased amounts of TNF which 
further stimulated release of IL-6 (Thorley et al., 2007).  In addition, incubation of 
macrophages with LPS released more pro-inflammatory cytokines after 24 hours than time 
points at 6, 12 and 18 hours.  Data presented here shows a similar pattern, with a 
significantly increased amount of IL-6 released by macrophages cultured in 2D and 3D 
following stimulation with LPS compared to those which were un-stimulated.  Interestingly, 
higher amounts of IL-6 were measured in cell culture media from 2D cultures compared to 
3D cultures.  Due to the differences in culture techniques between 2D and 3D culture, 
macrophages were cultured at a higher concentration in 3D cultures.  Therefore, the lower 
amounts of measured IL-6 in cell culture media may be due to capture of the cytokine within 
the collagen scaffold.  Previously published literature has found that cytokines diffuse 
through the ECM faster than through cell culture media unless they bind to the ECM (Mittal, 
2012).  It has previously been observed that IL-6 does not bind to ECM proteins, but TNF 
can bind tightly to ECM proteins such as laminin and fibronectin, and to a lesser amount to 
collagen (Alon et al., 1994).  The use of a collagen hydrogel to measure cytokine diffusion 
rates is generally popular as it accurately models those rates found in vivo (Ramanujan et 
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al., 2002).  Therefore, in future experiments the collagen hydrogel was degraded using 
collagenase and the solution stored for future analysis. 
4.8 Conclusion 
The 3D culture of THP-1, THP-1 PMA, MM6, PBM and MDM was explored in this chapter.  
Ultimately, MDM were selected for addition into ensuing 3D cultures as they demonstrated 
superior viability compared to the other cell types, as well as increased physiological 
relevance.  Following 14 days of culture in 3D, not only did flow cytometry detect that these 
macrophages were viable, but ELISA also demonstrated a significant release of IL-6 in 
response to LPS challenge suggesting that MDM are functional within the hydrogel.  
Following the successful mono-culture of MDM within a collagen hydrogel, the 
incorporation of MDM into a tissue-engineered model of the oral mucosa can now be 
attempted. 
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 Chapter 5: Development of a 3D In Vitro Oral 
Mucosa Model Containing Macrophages 
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5.1 Introduction 
The 3D culture of cells is becoming increasingly popular due to the limitations of 2D cell 
culture and in vivo models.  3D in vitro models provide a more physiologically relevant 
culture environment compared to 2D culture which enable cells cultured in 3D to more 
accurately represent cells in vivo (Abbott, 2003; Kimlin et al., 2013; Lee et al., 2008; Li et al., 
2013; Mazzoleni et al., 2009).  In addition, European legislation has identified a need for 
more and improved in vitro models to produce more clinically relevant data and reduce the 
numbers of animals used in research (Lilienblum et al., 2008).  An increasing number of 
culture systems modelling the oral mucosa have become available, however, very few of 
these contain an immune component and none contain primary human immune cells 
cultured for more than 24 hours (Bao et al., 2015b; Kosten et al., 2015; Pirila et al., 2015; 
Tschachojan et al., 2014).  In addition, the analyses possible on the individual cells within 
these models is often limited to IHC or IF microscopy.   
Chapter 4 described methods for the 3D culture of monocytes and macrophages.  However, 
in order to determine the role that TAM play in oral cancer progression, the next aim of the 
project was to further develop this mono-culture collagen hydrogel culture system into a 
co-culture model of oral cancer which contains immune cells.  In addition, methods for 
detailed analyses of the individual cells, and their interactions with other cells of the tumour 
microenvironment, and engineered tissue as a whole would need to be optimised. 
The following data will present the development of tissue-engineered oral mucosa models 
using an oral keratinocyte cell line established from a malignant biopsy (H357) and an 
immortalised ‘normal’ oral keratinocyte cell line (FNB6). 
5.2 Incorporation of THP-1 cells into an oral mucosa model containing H357 oral 
squamous cell carcinoma cell line 
Initially, an oral mucosa model containing H357 oral squamous cell carcinoma cell line and 
THP-1 monocyte cell line was used for method development; the H357 cell line was 
established from the tongue of a patient suffering from oral squamous cell carcinoma, and 
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the THP-1 monocyte cell line was established from a patient with acute myeloid leukaemia.  
Based on previously published literature, 0.2x106 NOF were incorporated into a collagen 
hydrogel in the absence or presence of 0.2x106 THP-1 cells (Dongari-Bagtzoglou and 
Kashleva, 2006; Linde et al., 2012).  Five hundred thousand H357 cells were seeded on top, 
and the model system was cultured for 14 days at an air-to-liquid interface.  After 14 days, 
models were fixed in formalin, processed, paraffin-embedded, sectioned and stained either 
with haematoxylin and eosin (H&E), or immunohistochemically stained using anti-CD68, 
anti-Ki67 and pan-cytokeratin (AE1/3) antibodies and counter-stained with haematoxylin.  
These were compared to isotype-matched controls.  Mounted and stained sections 40 µm 
apart were analysed using light microscopy and staining assessed visually under the 
supervision of an oral pathologist (Figure 5.1).  
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Figure 5.1.  Addition of THP-1 monocytes to oral mucosa models containing OSCC cell line, H357, appeared to increase epithelial invasion.  
Tissue-engineered oral mucosa models containing oral squamous cell carcinoma cell line, H357, and normal oral fibroblasts (NOF) were 
cultured at air-liquid interface in the absence (A-D) or presence (E-H) of THP-1 monocytes.  Following 14 days of culture, models were fixed 
and sections were stained with H&E (A and E), and immunohistochemically stained to show the expression of CD68 (B, F and I), Ki67 (C, G 
and J) and AE1/3 (D and H), and counter-stained with haematoxylin.  Images I and J show examples of CD68+ and Ki67+ cells in high 
resolution, with the latter demonstrating a mitotically dividing cell.  Arrows indicate areas positive for protein expression.  Data are shown 
for a single experiment (n=1) and scale bars indicate 200 µm (A-H) and 50 µm (I and J). 
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H&E staining showed an even distribution of NOF within the hydrogel, with many cells 
visible in each section.  H357 cell line formed a thick, multi-layered epithelium in both the 
presence and absence of THP-1 cells, however this did not appear as a stratified epithelium; 
cells were not organised into rows, nuclei were present throughout the epithelium and 
proliferating cells, indicated by staining with antibodies targeting Ki67, could be found 
throughout the epithelium.  In particular, models containing THP-1 monocytes showed an 
even more disorganised epithelium and in addition displayed an increase in the invasion of 
the epithelium into the connective tissue component of the model where cells expressing 
proliferation and cytokeratin markers (Ki67 and AE1/3) could be found penetrating much 
deeper within the connective tissue.  Arrows in figure indicate tumour invasion visualised 
as tumour islands (Figure 5.1, D and H).  Models devoid of THP-1 monocytes did not stain 
positively for CD68. 
Epithelial invasion in the presence of THP-1 monocytes did not appear to be a result of the 
high numbers of cells present as even the inclusion of only 7.5x104 THP-1 monocytes, 
resulted in the invasion of both H357 and FNB6 cell lines (Figure 5.2).   
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Figure 5.2.  Addition of THP-1 monocytes to oral mucosa models containing FNB6 and 
H357 keratinocytes, even in reduced numbers, appeared to increase epithelial invasion. 
Tissue-engineered oral mucosa models containing immortalised FNB6 keratinocyte cell line 
(A and C) or oral squamous cell carcinoma cell line, H357, (B and D) were cultured in the 
absence (A-B) or presence (C-D) of THP-1 monocytes.  Following 14 days of culture at air-
liquid interface, models were fixed and stained with H&E.  Data are shown for a single 
experiment (n=1) and scale bars indicate 200 µm.  Arrows indicate areas of epithelial 
invasion visualised as tumour islands. 
H&E staining showed a sparsely populated hydrogel, with stromal cells rarely visualised in 
sections.  Both FNB6 and H357 cell lines formed a thick, multi-layered epithelium in both 
the presence and absence of THP-1 monocytes, however this did not appear as a stratified 
epithelium.  As seen previously in Figure 5.1, the addition of THP-1 monocyte, albeit in 
reduced numbers, resulted in an increase in epithelial invasion into the collagen hydrogel 
which could be visualised as tumour islands in the connective tissue component of the 
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model.  In addition, preliminary experiments used the culture media from THP-1 cells alone, 
or after simple 2D co-culture of THP-1 and NOF, on oral mucosa models containing 
keratinocytes and NOF alone.  In these, no epithelial invasion was visualised in the absence 
of intact cells (data not shown).  Further repeats of this work were performed using THP-1 
cells cultured at low passage and results could not be confirmed. 
5.3 Incorporation of monocyte-derived macrophages into an oral mucosa model 
containing FNB6 cell line 
H357 keratinocytes originate from an oral cancer biopsy, and THP-1 monocytes originate 
from a leukaemia patient.  Therefore, as these cell lines are derived from malignancies, the 
use of FBN6 cell line (an immortalised ‘normal’ keratinocyte cell line) and MDM was 
explored in order to produce an oral mucosa model which more closely represents 
malignancy-free oral mucosa.  Monocytes were differentiated to MDM in vitro using plastic 
adherence over 7 days and recovered into supplemented cell culture medium using cell 
scraping.  A collagen hydrogel mixture containing NOF was prepared and models were 
prepared either additionally containing or devoid of MDM.  Once set, FNB6 cells were 
seeded upon the hydrogels and cultured at ALI for 14 days.  Models were fixed, processed 
and stained using H&E or analysed using immunohistochemistry and counter-stained with 
haematoxylin to measure the expression of CD68 and E-cadherin (Figure 5.3); pan-
cytokeratins (AE1/3), vimentin and  Ki67 (Figure 5.4); or collagen IV and compared to 
isotype-matched controls (Figure 5.5).  Mounted sections were analysed using light 
microscopy. 
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Figure 5.3.  H&E, CD68 and E-cadherin expression of tissue-engineered oral mucosa 
models containing immortalised keratinocyte cell line, FNB6, normal oral fibroblasts and 
monocyte-derived macrophages.  Tissue-engineered oral mucosa models containing 
immortalised keratinocyte cell line, FNB6, and normal oral fibroblasts (NOF), were cultured 
at air-liquid interface in the absence (A-C) or presence (D-F) of monocyte-derived 
macrophages (MDM).  Following 14 days of culture, models were fixed and sections were 
stained with H&E (A and I) or immunohistochemically stained to show the expression of 
CD68 (B and E) and E-cadherin (C and F) and counter-stained with haematoxylin.  Images 
are representative of three independent experiments (n=3) and scale bars indicate 200 µm.  
Arrows indicate CD68+ staining and boxes highlight areas of E-cadherin expression. 
A 
C 
D 
E B 
F 
  
 
144 | P a g e  
 
 
H&E staining showed an even distribution of NOF in the connective tissue component of 
the model and a stratified epithelium resembling that of normal tissue; cells were organised 
into layers, with cuboidal cells forming a stratum basale and cells devoid of nuclei forming 
a stratum corneum.  The extracellular matrix was stained pink, suggesting ECM deposition 
has occurred.  Stratification is a good maker of epithelial maturation (Schroeder, 1981). 
CD68 is a classical macrophage marker.  Models containing MDM stain positively for CD68, 
however those devoid of MDM are absent of CD68 staining.  CD68+ cells can be observed 
throughout the connective tissue component, but not within the epithelial compartment of 
the model, and can be viewed abundantly in every section.   
E-cadherin, as a marker of cell adhesion, can be viewed in the epithelium, but not in the 
connective tissue of the model.  Expression of E-cadherin is highest in the basal cells of the 
epithelium and it is present at the periphery of individual cells, where these form adherent 
junctions with other keratinocytes in the epithelium.  There does not appear to be a 
difference in staining for E-cadherin in models containing or devoid of MDM.   
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Figure 5.4.  Cytokeratin, vimentin and Ki67 expression of tissue-engineered oral mucosa 
models containing immortalised keratinocyte cell line, FNB6, normal oral fibroblasts and 
monocyte-derived macrophages.  Tissue-engineered oral mucosa models containing 
immortalised keratinocyte cell line, FNB6, and normal oral fibroblasts (NOF), were cultured 
at air-liquid interface in the absence (A-C) or presence (D-F) of monocyte-derived 
macrophages (MDM).  Following 14 days of culture, models were fixed and sections were 
immunohistochemically stained to show the expression of cytokeratins (AE1/3, A and D), 
vimentin (B and E) and Ki67 (C and F) and counter-stained with haematoxylin.  Images are 
representative of three independent experiments (n=3) and scale bars indicate 200 µm.  
Arrows indicate areas of positive staining. 
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Pan-cytokeratin staining using AE1/3 shows that the epithelium is entirely composed of cells 
expressing cytokeratins.  No specific staining of AE1/3 can be seen in the connective tissue 
of the model indicating that there is no invasion of keratinocytes into the connective tissue 
in either the absence or presence of MDM. 
Vimentin is an intermediate filament typically expressed by mesenchymal cells, of which 
only fibroblasts are present in this model.  Both models containing and devoid of MDM 
show abundant expression of vimentin in the connective tissue, but additionally it is 
expressed in the stratum basale of the epithelium. 
Ki67 is used to specifically distinguish cells in the active phases of the cell cycle from those 
in resting phase (G0).  Its presence therefore indicates cells which are actively proliferating.  
Few cells positive for Ki67 can be observed in the epithelium of both models containing and 
devoid of MDM.  These are primarily in the bottom-most layers of the epithelium. 
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Figure 5.5.  Collagen IV expression of tissue-engineered oral mucosa models containing 
immortalised keratinocyte cell line, FNB6, normal oral fibroblasts and monocyte-derived 
macrophages compared to an isotype-matched control.  Tissue-engineered oral mucosa 
models containing immortalised keratinocyte cell line, FNB6, and normal oral fibroblasts 
(NOF), were cultured at air-liquid interface in the absence (A-B) or presence (C-D) of 
monocyte-derived macrophages (MDM).  Following 14 days of culture, models were fixed 
and sections were immunohistochemically stained to show the expression of collagen IV (A 
and C) compared to isotype-matched controls (B and D) and counter-stained with 
haematoxylin.  Images are representative of three independent experiments (n=3) and scale 
bars indicate 200 µm.   
Type IV collagen is a major constituent of the basement membrane, however no positive 
staining for collagen IV can be observed in models either in the absence or presence of 
MDM. 
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 Monocyte-derived macrophages cultured within a tissue-engineered oral 
mucosa model release inflammatory cytokine, IL-6, in response to 
lipopolysaccharide 
Macrophages rapidly respond to the binding of PAMPs, such as LPS present on the 
membrane of gram-negative bacteria, to their PRRs by releasing pro-inflammatory 
cytokines.  To determine whether MDM cultured within an oral mucosa model retained the 
ability to respond to pathogen challenge, LPS was added to the cell culture media of models 
containing an FNB6 epithelium for an additional 24 hours following 14 days of culture at 
ALI.  Response was determined by measuring the release of pro-inflammatory cytokine IL-
6 using ELISA and compared to models devoid of MDM.  Additionally, models were fixed, 
processed and stained with H&E, and the cytotoxic effect of LPS on models was analysed 
using an LDH assay. 
Lipopolysaccharide does not have a significant cytotoxic effect on oral mucosa models 
containing monocyte-derived macrophages 
After treatment of models with LPS for 24 hours, cell culture media was aspirated and 
analysed using an LDH assay (Figure 5.6).  
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Figure 5.6.  Lactate dehydrogenase release by tissue-engineered oral mucosa models 
containing FNB6 cells, normal oral fibroblasts and monocyte-derived macrophages 
stimulated with lipopolysaccharide.   Tissue-engineered models of the oral mucosa 
containing immortalised keratinocyte cell line, FNB6, and normal oral fibroblasts (NOF) in 
the absence or presence of monocyte-derived macrophages (MDM) were cultured at air-
liquid interface.  Following 14 days of culture, cell culture medium was sampled and lactate 
dehydrogenase release in response to lipopolysaccharide (LPS) measured in the absence (A) 
or presence (B) of MDM.  Data are representative of three independent experiments 
measured in triplicate (n=3) error bars show standard error mean and statistical significance 
was determined using an unpaired T-test. 
There was no significant difference in the amounts of LDH released in the presence or 
absence of LPS treatment in both models devoid of or containing MDM (p=0.3755 and 
p=0.4464, respectively).   
Models containing monocyte-derived macrophages release interleukin-6 
After treatment of models with LPS for 24 hours, cell culture media was aspirated and 
analysed using ELISA to detect release of IL-6 (Figure 5.7).  
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Figure 5.7.  Tissue-engineered oral mucosa models containing immortalised keratinocyte 
cell line, FNB6, in the absence or presence of monocyte-derived macrophages release IL-
6 in response to lipopolysaccharide.  Tissue-engineered oral mucosa models containing 
immortalised keratinocyte cell line, FNB6, and normal oral fibroblasts (NOF), in the absence 
(FN) or presence (FNM) of monocyte-derived macrophages (MDM) were cultured at air-
liquid interface.  Following 14 days of culture, models were stimulated with 
lipopolysaccharide for 24 hours, after which cell culture media was collected and IL-6 
release was measured by ELISA.  Data are representative of three independent experiments 
measured in triplicate (n=3), error bars show standard error mean and statistical 
significance was determined using an unpaired T-test. 
Models devoid of MDM released low levels of IL-6, which was unaltered in the presence of 
LPS stimulation.  However, in the presence of MDM, IL-6 release increased even in un-
stimulated models.  The addition of both MDM and LPS to oral mucosa models resulted in 
the release of the highest concentration of IL-6.  However, an unpaired two-tailed T-test did 
not identify a significant difference in the levels of IL-6 released in response to LPS in models 
devoid of MDM (p=0.7056) or containing MDM (p=0.4783).  Interestingly, models 
containing MDM, but in the absence of LPS stimulation also released an increased amount 
of IL-6 compared to compared to models devoid of MDM. 
5.4 Optimising cell numbers within oral mucosa model 
In order to develop an oral mucosa model truly representative of in vivo oral mucosa, the 
numbers of cells used required optimisation. 
ns ns 
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 Optimising the number of normal oral fibroblasts 
Within the connective tissue, NOF are responsible for matrix deposition.  Whilst collagen 
type I is the main constituent of the extracellular matrix, and thus the source of the hydrogel 
used in this culture system, the ECM in vivo contains many other proteins, including elastin, 
fibronectin and laminin.  Within the collagen hydrogel in 3D, fibroblasts release many of 
these proteins, thus improving the physiological relevance of the ECM compared to the use 
of a collagen hydrogel devoid of fibroblasts (Costea et al., 2003; Latkowski et al., 1995).  In 
addition, biological tissues are well populated with cells, so the optimisation of NOF number 
was explored.    
A collagen hydrogel was prepared with either 0.05x106, 0.1x106 or 0.2x106 NOF and seeded 
with 0.5x106 FNB6.  Models were cultured for 14 days at ALI and subsequently formalin-
fixed, paraffin-embedded, sectioned, H&E stained and analysed using light microscopy 
(Figure 5.8). 
 
Figure 5.8.  Optimisation of normal oral fibroblast number in oral mucosa models.  Normal 
oral fibroblasts (NOF) were cultured in 3D with 0.05x106 (A), 0.1x106 (B) or 0.2x106 (C) cells 
per model with an FNB6 epithelium.  H&E stained sections are representative of three 
independent experiments (n=3) and scale bars indicate 200 µm.  
Models containing 0.05x106 NOF were visibly acellular and NOF were identified in very few 
sections and fields of view.  In contrast, NOF could be found more frequently and evenly 
distributed in models containing 0.1x106 NOF.  The highest frequency of NOF could be 
visualised in sections of models containing 0.2x106 NOF.  Additionally, the ECM of these 
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models was stained the darkest pink compared to models containing 0.1x106 and 0.05x106 
NOF. 
 Optimising the number of monocyte-derived macrophages 
The number of macrophages present in a biological sample varies greatly depending on the 
tissue, and state of health or disease.  Therefore, it was not possible to determine an 
absolute number of MDM to represent primary tissue.  Due to limitations of cell culture, it 
was not possible to include more than 4x106 MDM per model, however in stained sections 
of these models, many MDM could be visualised per field of view, and from these it was 
possible to isolate sufficient numbers of cells for gene and protein analyses. 
5.5 Measuring the stiffness of tissue-engineered oral mucosa 
Tissue stiffness can vary greatly in health and disease, between different sites of the oral 
cavity and between patients (Chen et al., 2015; Handorf et al., 2015; Paszek et al., 2005).  In 
particular, changes in the microenvironment during tumour development alter the stiffness 
of a tissue, largely due to changes in matrix deposition and activation of myofibroblasts 
(Bagul et al., 2015; Mason et al., 2011).  To measure stiffness, the use of a rheometer was 
explored to perform a frequency sweep.   
To determine the sensitivity of the rheometer for measuring the stiffness of tissue-
engineered oral mucosa, collagen was prepared at a range of concentrations (2.5-15.0 
mg/mL) and the elastic modulus was measured in order to draw a standard curve (Figure 
5.9).   
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Figure 5.9.  Rheometry was used to measure the stiffness of collagen hydrogels composed 
of collagen at varying concentrations.   Collagen hydrogels composed of collagen ranging 
from 2.5-15.0 mg/mL were prepared and stiffness measured as elastic modulus at 0.1 Hz 
(G’) using rheometry.   
As the concentration of collagen increases, so does the value of the elastic modulus 
measured at 0.1 Hz (R2 = 0.9675, p=0.0004).  Tissue-engineered models of the oral mucosa 
containing NOF and FNB6 were prepared and analysed individually.  The elastic modulus 
was measured at 716 ± 59.67 and gap size measured at 1.14 ± 0.07.  A one-sample T-test 
showed no significant variance in stiffness or gap size (p=0.25 and p=0.5, respectively) 
between different biological samples prepared under the same conditions.  Therefore, no 
technical repeats, only biological repeats, were performed on proceeding samples. 
To determine if oscillation of the tool on the rheometer may cause damage to the 
epithelium of the tissue-engineered mucosa, post-rheometry samples of tissue-engineered 
oral mucosa models containing NOF and FNB6 cells were formalin-fixed, processed, 
sectioned and stained with H&E.  These were compared to samples prepared under the 
same conditions that had not been subjected to oscillatory tests (Figure 5.10). 
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Figure 5.10.  Rheometry does not cause visible damage to the epithelium of tissue-
engineered oral mucosa.  Tissue-engineered oral mucosa models containing FNB6 
immortalised keratinocytes and normal oral fibroblasts (NOF) were compared without (A) 
and after analysis by rheometry (B).  H&E stained sections are representative of three 
independent experiments (n=3) and scale bars indicate 200 µm.   
Stained sections of tissue-engineered oral mucosa showed no visible differences in 
epithelial integrity or signs of shearing of the stratum granulosum in samples analysed using 
rheometry, compared to those which had not.  Following the optimisation of methods 
presented here, comparisons between models containing or devoid of MDM and those 
containing NOK, FNB6 or H357 epithelia are discussed in Chapter 7. 
5.6 Discussion 
Due to the important role that macrophages play in cancer progression, they are used as 
diagnostic and prognostic markers in breast and colon carcinomas, for example (Hu et al., 
2009; Medrek et al., 2012).  An increasing number of studies have identified a correlation 
between TAM and poor patient prognosis, suggesting they may play an important role in 
oral cancer progression (Bagul et al., 2016; Balermpas et al., 2014; Boas et al., 2013; Li et 
al., 2002; Mori et al., 2011).  Although oral cancer research has readily adopted the use of 
3D models as an improvement to 2D models, very few models have incorporated immune 
cells and of those, none have incorporated primary human macrophages (Bao et al., 2015b; 
Kosten et al., 2015; Pirila et al., 2015; Tschachojan et al., 2014).  With macrophages forming 
more than 65 % of the tumour mass, the inclusion of macrophages in tissue-engineered 
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models of the oral mucosa is essential (Liu et al., 2008).  In addition, macrophages are a 
highly secretory cell, and the cytokines they release play an important role in altering the 
tissue environment to promote tumour progression.  Therefore, new and improved tools 
are required to further understand the interactions that macrophages have with other cells 
of the tumour microenvironment.  The results presented in this chapter aim to demonstrate 
the development of one such tool; a tissue-engineered model of the oral mucosa containing 
macrophages. 
 THP-1 monocytes may promote epithelial invasion 
Previously, 2D co-cultures of THP-1 monocytes and oral cancer cell lines (YD38 and OE) has 
shown that co-culture with monocytes promotes cancer cell invasion and migration relative 
to malignancy (Lee et al., 2014).  In this study, THP-1 monocytes were co-cultured with NOF 
and the oral cancer cell line, H357, at an air-liquid interface for 14 days.  Results show that 
incorporation of THP-1 monocytes promoted an increase in invasion of oral cancer into the 
connective tissue component of 3D in vitro oral cancer models.  In addition, observations 
demonstrated that their inclusion promoted contraction of collagen within the extracellular 
matrix compared to a control excluding THP-1 monocytes.  This was also observed in models 
containing FNB6 immortalised keratinocytes.  However, when repeated with low passage 
THP-1 monocytes, the amount of invasion was markedly lower.  It is possible that THP-1 
monocytes in the initial experiment had undergone phenotypic drift through repeated 
passaging, promoting their pro-tumour phenotype.  In addition, preliminary data 
incorporating THP-1 macrophages or conditioned media from THP-1 monocytes cultured in 
2D alone or in combination with NOF showed no invasion of the epithelium into the 
connective tissue.  Therefore, it is likely that epithelial invasion is a result of secreted 
proteins involved in the cross-talk between fibroblasts, monocytes or macrophages and 
keratinocytes, either all together or in various combinations (Comito et al., 2014).  In any 
case, this line of thought requires further investigation. 
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 Tissue-engineered normal oral mucosa containing monocyte-derived 
macrophages 
Previous data in chapter 3 showed that THP-1 and MM6 cell lines were not necessarily 
representative of primary monocytes and macrophages in morphology and the expression 
of key markers.  Therefore, following the 3D culture of MDM, which were shown to be viable 
and responsive to LPS, MDM were included within an oral mucosa model containing normal 
immortalized keratinocytes. 
Unlike models containing THP-1 monocytes, the presence of MDM did not result in invasion 
of the epithelium into the connective tissue.  However, the use of FNB6 cells to replace 
H357 cells resulted in the formation of a stratified epithelium, although some nuclei could 
be visualized in the outermost layers of the epithelium, indicative of moderate dysplasia 
(Geetha et al., 2015).  Immunohistochemical staining of these models showed that E-
cadherin, AE1/3 and Ki67 were restricted to the epithelial component of the models, and 
CD68 staining was restricted to the connective tissue component of models containing 
MDM which confirmed previously published data of normal oral mucosa (Colley et al., 2011; 
Helal and Wahba, 2016; Sridevi et al., 2015).  However, Ki67 staining was not restricted to 
the stratum basale, indicating proliferation of cells beyond the basal cells, indicative of 
dysplasia (Colley et al., 2011).   
Vimentin, a marker of stromal cells, was expressed in the stratum basale of the epithelium 
and not restricted to the connective tissue component.  This did not match previous data 
which showed no expression of vimentin in the epithelium of normal oral mucosa compared 
to low expression of vimentin in OSCC (Balasundaram et al., 2014).  Vimentin is often used 
as a marker of EMT and published data using a breast carcinoma cell line suggests that these 
intermediate filaments play a key in role in reorganization of the cytoskeleton, adhesion, 
stiffness and motility of epithelial cells undergoing EMT which is associated with their 
decreased expression of E-cadherin (Liu et al., 2015; Mendez et al., 2010).  However, 
positive staining for E-cadherin was observed in the model presented here in a similar 
pattern to that found in normal oral mucosa, and was not found to be downregulated as in 
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the case of EMT (Balasundaram et al., 2014).  Previously published data has shown that 
aberrant vimentin expression correlated with histopathological grade of dysplasia (Sawant 
et al., 2014). 
Collagen IV and laminin are deposited by fibroblasts residing in the connective tissue and 
represent the major components of the basement membrane (Sanderson et al., 1986).  The 
basement membrane separates the epithelial and connective tissue components of the oral 
mucosa (Squier and Kremer, 2001).  However, during cancer progression, epithelial cells 
breach the basement membrane, and at this point the cancer is considered invasive 
(Bradley et al., 2010; Scully and Bagan, 2009a).  Collagen IV was used to identify the 
basement membrane in the model, however, no positive staining was observed in these, in 
contrast to positively stained positive control samples.  This is in contrast to previously 
published data that showed the deposition of laminin, integrin α6 and collagen IV in 
organotypic models containing macrophages, fibroblasts and dermal keratinocytes.  In 
those models, a continuous basement membrane did not form as had been observed in 
murine models, particularly in the presence of MDM (Linde et al., 2012).  In addition, models 
containing many more fibroblasts resulted in the deposition of both laminin and collagen 
IV which formed a basement membrane, especially following further addition of KGF 
(Costea et al., 2003).  A previous model of the oral mucosa devoid of macrophages and using 
DED showed strong positive staining for collagen IV at the interface of the epithelium and 
connective tissue (Colley et al., 2011).  Commercially available basement membrane 
substitutes, such as Matrigel, as well as other materials, can be used to mimick the protein 
expression of the basement membrane (Bye et al., 2014).  The importance of the basement 
membrane was shown in a previous study which used a collagen type I scaffold coated with 
laminin and collagen IV to produce a tissue-engineered oral mucosa.  These additions 
promoted the differentiation of keratinocytes into a stratified epithelium (Kim et al., 2001). 
The oral mucosa model presented in this thesis demonstrated similarities in protein 
expression and tissue architecture compared to previously published data analysing patient 
oral mucosa biopsies (Colley et al., 2011).  In addition, the aim of this research was to 
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include viable and functional macrophages within this tissue-engineered oral mucosa.  The 
primary role of macrophages is in defence against invading pathogens, providing innate 
immunity (Sheel and Engwerda, 2012; Shi and Pamer, 2011; Wrigley et al., 2011; Yang et 
al., 2014a).  Macrophages respond to PAMPs, such as LPS on the surface of gram-negative 
bacteria, by releasing pro-inflammatory cytokines, such as IL-6, IL-8 and TNF (Rosso et al., 
2011).  The release of these co-ordinates additional immune cells to respond to the 
pathogen challenge. 
Therefore, to determine whether macrophages may retain some functionality when 
cultured in 3D, models were treated with LPS for 24 hours, following 14 days of culture at 
ALI.  Following LPS stimulation, culture media was collected and an LDH assay was used to 
detect LDH release in response to LPS, to detect cell death.  ELISA was also used to measure 
release of pro-inflammatory cytokine, IL-6, in response to LPS stimulation.  Similarly, to Haw 
et al., who analysed the activation of BV2 microglia in a 3D collagen hydrogel, results show 
that low LDH release was observed following stimulation of models with LPS (Haw et al., 
2014).  Additionally, this published study used a cytokine bead array and qPCR to analyse 
the expression of IL-6 at both the gene and protein level 6 hours and 48 hours post 
stimulation.  A significant increase in IL-6 was detected following LPS stimulation.  An 
alternative model measured the activation of RAW 264.7 murine macrophages when co-
cultured within a 3D tissue-engineered skin model.  Here, LPS stimulation induced increased 
expression of IL-6 measured by ELISA in both the absence and presence of co-culture with 
engineered skin (Chung et al., 2014).  Whilst not statistically significant, in this work ELISA 
measured a marked increase in IL-6 release following LPS stimulation, confirming that 
macrophages are functional within this model, in line with previously published results. 
 Collagen hydrogel contraction 
During wound healing, fibroblasts become activated and contractile.  Gel contraction assays 
are often used to measure the activation of fibroblasts.  Whilst informative, within a tissue-
engineered oral mucosa model based on a collagen gel scaffold, fibroblast contraction 
posed challenges to tissue disaggregation.  The addition of fibroblasts is key for the 
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proliferation and stratification of the epithelium (Latkowski et al., 1995).  However, 
observations suggested that models containing an increased number of NOF experienced 
increased amounts of contraction.  The number of NOF added required balancing between 
the amount of matrix deposition (for improved physiological relevance and to prevent the 
connective tissue from being too acellular) and contraction.  Too much contraction resulted 
in poor disaggregation of the models using collagenase IV and prevented analysis using flow 
cytometry.  The amount of matrix deposition could be detected using haematoxylin staining 
and appeared as pink staining in the connective tissue component of the model (Fischer et 
al., 2008).  An alternative approach for reducing the amount of contraction, rather than 
reducing the number of fibroblasts, may be found in addition of Src kinase inhibitor PP2 
(Fletcher et al., 2011).  Results show that the addition of 0.2x106 NOF generated a well 
populated connective tissue.  A decreased amount of contraction was found to enable 
disaggregation of the tissue for analysis by flow cytometry.  Importantly, the inclusion of 
MDM, in contrast to THP-1, within the model resulted in a reduced amount of contraction. 
 The stiffness of tissue-engineered oral mucosa 
During normal development and during disease progression, the stiffness of tissues around 
the body can vary enormously.  In particular, malignant tissues increase in stiffness 
compared to normal tissue and can be used in screening for potential malignancies; for 
example, an increase in stiffness of mammary tissue associated with breast carcinoma can 
be detected as a hard lump (Boyd et al., 2014; Paszek et al., 2005).  This increase in stiffness 
of malignant tissues is likely due to abnormal matrix deposition and the contraction of 
myofibroblasts (Bagul et al., 2015).  In turn, changes in tissue stiffness can alter the 
proliferative, migratory and invasive phenotypes of cells, resulting in a positive feedback 
loop (Mason et al., 2011).  Preliminary observations of oral cancer models containing THP-
1 monocytes and H357 oral squamous cell carcinoma cells suggested that these were more 
contracted following 14 days of culture, compared to models devoid of THP-1 monocytes.  
In addition, these models appeared stiffer than those which had not contracted.  Therefore, 
the use of rheometry and contraction assays was explored to quantitate these changes.  The 
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stiffness of a material can be analysed using a variety of methods (Canovic et al., 2016).  For 
the analysis of biological samples however, indentation and rheometry are most commonly 
used.  In this chapter, the suitability of rheometry to detect changes in collagen hydrogel 
stiffness was explored.  Results showed that oscillatory tests performed by the rheometer 
caused minimal damage to the epithelium of models, and changes in stiffness of collagen 
hydrogels containing increasing concentrations of collagen could be detected.  Therefore, 
rheometry may be useful in detecting changes in the stiffness of models containing a variety 
of components from the tumour microenvironment. 
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 Chapter 6: Development of an 8-colour Flow 
Cytometry Panel for the Analysis of 
Macrophage Polarisation Status 
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6.1 Introduction 
Flow cytometry uses lasers to interrogate individual cells for specific markers which can be 
identified by bound fluorochrome-conjugated antibodies.  It can not only quantitatively 
identify changes in protein expression of individual cells, but also changes in expression of 
the entire cell population as a whole.  This provides a quantitative analysis of both 
intracellular and extracellular proteins, and any changes in expression in response to various 
stimuli.  Recent advances in technology have enabled researchers to analyse multiple 
protein markers at the same time using polychromatic flow cytometry.  Whilst an increasing 
number of fluorochrome conjugates have become available recently, the number of 
antibodies targeting macrophage-specific cell surface proteins remains limited.   
The development of polychromatic flow cytometry panels requires thorough optimisation 
of every step of the experiment; from reagent selection, to equipment configuration, to 
data analysis.  In view of this, flow cytometry journal, Cytometry, Part A, preferentially 
publishes such panels under a unique category of ‘Optimized Multicolor 
Immunofluorescence Panel’.  Since the first of these was published in 2010, 34 have been 
published in total.  These typically feature cells of the immune system, such as T cells, 
natural killer cells and B cells, however none to date have been directed towards 
macrophages. 
In addition to a limited choice of reagents targeting macrophage-specific proteins, with a 
limited range of fluorochrome conjugates, flow cytometry analysis of macrophages is 
challenging due to the high levels of auto-fluorescence that they display which limits the 
choice of suitable fluorochromes even further.  The aim of this work was to develop a novel 
polychromatic flow cytometry panel that could be used to quantitatively analyse the 
expression of key macrophage markers on macrophages cultured within a 3D model of the 
oral mucosa.  As with previous chapters, cell lines were used for the initial optimisation of 
methods.  These optimised methods were later applied to primary cells. 
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 Separating macrophages from fibroblasts and keratinocytes 
The model of the oral mucosa presented in this thesis contains fibroblasts and keratinocytes 
in addition to macrophages.  Human macrophages are typically a large cell between 20-30 
microns in diameter compared to fibroblasts at 10-15 microns and keratinocytes around 10 
microns.  The differences in size and granularity of different cell types can often be used to 
distinguish between the cells using flow cytometry.  For example, monocytes can easily be 
identified from lymphocytes and neutrophils in flow cytometry samples prepared from 
whole blood (Figure 3.1).  However, as the example shows (Figure 6.1), THP-1 monocytes 
overlap in size and granularity with keratinocytes and fibroblasts.   
 
Figure 6.1.  Separation of THP-1 monocytes from normal oral fibroblasts and H357 
keratinocytes using size and granularity.   THP-1 monocytes cultured in suspension, or 
normal oral fibroblasts (NOF) and oral squamous cell carcinoma cell line, H357, cultured in 
adherent culture were analysed using flow cytometry.  Gates were set to measure forward 
scatter (FSC) and side scatter (SSC), for size and granularity respectively, of THP-1 (A), (NOF 
(B) and H357 (C).  Data are shown for a single experiment (n=1) following dead cell exclusion 
with propium iodide. 
In addition, as macrophages can vary greatly in size depending on environmental cues due 
to their plastic nature, the separation of these immune cells from other cells within the 
model based on FSC and SSC is not suitable.  Therefore, unique markers were required for 
the identification and separation of macrophages from fibroblasts and keratinocytes. 
B A C 
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6.2 Selection of reagents for polychromatic flow cytometry 
The aim of the polychromatic flow cytometry panel was to firstly identify macrophages 
within a co-culture of macrophages, fibroblasts and keratinocytes, and subsequently enable 
characterisation of macrophage phenotype using a range of M1 and M2 markers.  To select 
fluorochromes for serial gating, reagents were given priority ratings in order that the 
brightest fluorochromes could be assigned to the highest prioritised antigens for gating 
purposes (Table 6.1).  Furthermore, the panel was designed so that CD antigens with the 
smallest selection of commercially available antibodies were assigned the most commonly 
available fluorochromes. 
Priority 
Rating 
Category Rationale Reagents 
1 Identification of leukocytes 
and specifically, macrophages 
To remove any cells not 
relevant to the analysis 
CD45, CD14 
2 Viability To exclude dead and highly 
auto-fluorescing cells 
Amine-reactive 
blue 
3 Polarisation 1 Key macrophage protein 
involved in oral cancer 
CD163 
4 Polarisation 2 Further polarisation markers 
to characterise the 
macrophage population 
CD36, CD80, 
CD86, CD206 
Table 6.1.  Development strategy of the multi-colour flow cytometry panel. 
For the identification of macrophages from fibroblasts and keratinocytes, CD14 and pan-
leukocyte marker CD45 were selected.  Due to its emerging role as a marker for poor 
prognosis in oral cancer (Balermpas et al., 2014; Fujii et al., 2012; Fujita et al., 2014; He et 
al., 2014; Mori et al., 2011; Weber et al., 2014; Wehrhan et al., 2014), CD163 was selected 
as the highest prioritised macrophage polarisation marker, followed by CD80 and CD86 (M1 
markers), and CD36 and CD206 (M2 markers).  As with previous work in this thesis, THP-1 
monocytes were initially used for the optimisation of techniques that were later applied to 
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primary human macrophages; following Figure 6.2 and Figure 6.3, all the following data in 
chapter 6 has been collected using primary human MDM based on optimisation of methods 
presented in the preceding chapters. 
 Selection of antibodies for the identification of monocytes  
CD14 is a monocyte and macrophage cell surface marker that is not expressed by NOF.  
Therefore, fluorochrome-conjugated anti-CD14 antibodies were used to separate 
monocytes from fibroblasts using flow cytometry.  As one of the highest prioritised markers, 
CD14 required conjugation to a bright fluorochrome, such as PE, to enable clear separation 
of CD14+ from CD14- events.   
Separation of monocytes from fibroblasts using CD14 expression 
To determine the efficacy of CD14 expression to separate monocytes from NOF, purified 
PBM from healthy volunteers and THP-1 or MM6 monocytes cultured in suspension were 
combined in equal number with NOF cultured in 2D stained with anti-CD14PE antibodies 
(Figure 6.2) and the results analysed using flow cytometry. 
  
 
166 | P a g e  
 
 
Figure 6.2.  Separation of monocytes from normal oral fibroblasts using PE-conjugated 
anti-CD14 antibody.   Peripheral blood monocytes immediately following isolation and 
purification; THP-1 or Mono Mac 6 (MM6) monocytes cultured in suspension; or normal 
oral fibroblasts (NOF) cultured in adherent culture were recovered, mixed and labelled 
using anti-CD14 antibodies and analysed using flow cytometry.  Gates were set based on 
unstained samples of relevant cells to identify CD14+ events in NOF alone (A), and mixtures 
of NOF with peripheral blood monocytes (B), THP-1 (C) or MM6 (D) monocytes.  Data are 
shown for a single experiment (n=1) following dead cell exclusion with propium iodide. 
Dot plots show that NOF alone showed high levels of auto-fluorescence at the same 
wavelength as PE, resulting in a high percentage of events recovered in the CD14+ gate, in 
the absence of monocytes.  As shown previously (Page 87), PBM express higher levels of 
CD14 than both THP-1 or MM6 monocytes, and the three cell types differ in size and 
granularity (Page 85).  Dot plots here show that the high expression of CD14 on PBM and 
the difference in size of PBM and NOF, enabled the two cell types to be clearly separated.  
THP-1 monocytes, although larger than PBM and expressing lower levels of CD14, could still 
A B 
C D 
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be separated from NOF by size and CD14 expression.  However, due their larger size and 
markedly lower levels of CD14 expression, MM6 and NOF could not be clearly segregated. 
In parallel, it was observed that the expression of CD14 decreased during monocyte to 
macrophage differentiation in both primary cells and THP-1 cell line (Page 93).  Therefore, 
the additional use of CD45 leukocyte marker was assessed for the separation of monocytes 
and macrophages from NOF by flow cytometry.   
Separation of THP-1 from normal oral fibroblasts and H357 using CD45 expression 
As an alternative to anti-CD14 antibodies, anti-CD45FITC antibodies were explored to enable 
the identification of the THP-1 monocytes from NOF and keratinocytes used within the 
tissue-engineered oral mucosa developed in parallel (Page 137).  THP-1, NOF and H357 cells 
were cultured individually in 2D or in various combinations of 3D co-cultures using a 
collagen hydrogel.  Hydrogels were cultured at an air-to-liquid interface for 14 days and 
models processed into single-cell suspensions using collagenase IV and a cell strainer.  
Viable cells were selected using Topro3, which contains a carbocyanine dye that enters dead 
cells through compromised cell membranes, causing them to fluoresce.  The expression of 
CD45FITC was analysed using flow cytometry (Figure 6.3). 
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Figure 6.3.  Separation of THP-1 monocytes from normal oral fibroblasts and H357 
keratinocytes, in 2D and 3D using FITC-conjugated anti-CD45 antibody.   THP-1 monocytes 
cultured in suspension, or normal oral fibroblasts (NOF) and oral squamous cell carcinoma 
cell line, H357, cultured in adherent culture, were retrieved and used, unstained, to set 
gates (A-C) respectively.  Samples labelled with anti-CD45FITC were analysed for each cell 
type individually (D-F) for THP-1, NOF and H357 respectively.  Additionally, cells were 
cultured within a collagen hydrogel for 14 days either individually (G-I) for THP-1, NOF and 
H357 respectively, or in co-culture; THP-1 with NOF (G) or THP-1, NOF and H357 (H).  Data 
are shown for a single experiment (n=1) following dead cell exclusion using propium iodide. 
E D F 
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THP-1 monocytes expressed high levels of CD45, with >99 % of THP-1 cells cultured alone 
in 2D appearing in the CD45+ gate.  In contrast, NOF and H357 keratinocytes cultured alone 
in 2D showed no expression of CD45 and hence <1 % of events appeared in the CD45+ gate.  
However, once cultured alone within a collagen hydrogel, 31.7 % NOFs and 92.4 % H357 
cells appeared within the CD45+ gate.  This resulted in a high percentage of CD45+ events 
appearing in 3D co-cultures omitting THP-1 cells and poor separation of THP-1 monocytes 
from H357 cells and NOFs in 3D tri-cultures. 
Parallel experiments enabling the viable culture of MDM in 3D (Page 124) resulted in the 
3D culture of THP-1 being discarded; all subsequent experiments use MDM and data from 
experiments using THP-1 monocytes were used to inform future experimental design. 
 Selection of viable monocyte-derived macrophages  
MDM auto-fluoresce in every laser channel, and as cells die, the membrane becomes 
permeable allowing antibodies to penetrate the cell resulting in auto-fluorescence which 
may be detected as a false positive signal.  In addition, MDM require processing in order to 
produce a single-cell suspension suitable for flow cytometry that can lead to a decrease in 
cell viability over time.  Therefore, a suitable reagent for the gating of viable cells was 
required.  Reagents using Lightwave Xcyte™ laser in the UV detection range were chosen, 
as this would not affect the selection of other fluorochrome reagents.   
Amine dyes are available in a wide choice of colours, including those excited with a UV laser.  
These dyes bind amine groups which are only accessible once the cell membrane has 
become permeable.  Only a few amine groups are present on the surface of viable cells with 
intact membranes, therefore these dyes can penetrate non-viable cells to bind the amine 
groups on proteins inside the cell, resulting in a brighter fluorescence of non-viable cells 
than those that are viable.   
Treatment of viable MDM with saponin or ethanol, heat-shock or freeze-thaw cycles for cell 
permeabilisation were tested in order to produce a positive control for non-viable cells.  
Treatment with 100% ethanol for 15 minutes at room temperature enabled clear separation 
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of viable and non-viable MDM.  Fixable Viability Dye eFluor® 455UV (eBioscience, USA) was 
compared to LIVE/DEAD® Fixable Blue Dead Cell Stain (Life Technologies, UK) using viable 
and ethanol-treated non-viable macrophages (1:1 v/v ratio) to determine dye efficacy 
(Figure 6.4).   
 
Figure 6.4.  Viability stain comparison.   Monocyte-derived macrophages (MDM) were 
adherently cultured for 7 days, retrieved using cell scraping and analysed using flow 
cytometry.  LIVE/DEAD® Fixable Blue Dead Cell Stain (Life Technologies, B) and Fixable 
Viability Dye eFluor® 455UV (eBioscience, C) were used to detect viable and ethanol-treated 
non-viable macrophages mixed in a 1:1 (v/v) ratio to examine reagent performance.  
Unstained cells, treated under the same conditions as sample cells, were used to set viability 
gates (A).  Data representative of three independent experiments (n=3).  Gates were set 
using unstained cells treated with ethanol (A). 
A gate was set based on unstained cells treated with ethanol, and used to compare the 
separation of viable and ethanol-treated non-viable MDM.  LIVE/DEAD® Fixable Blue Dead 
cell stain showed a sharp peak of 61.4 ± 2.8 % of cells within the left-hand viable gate with 
an MFI of 95.8 ± 2.7, and a second peak of 38.33 ± 1.1 % of cells was visible distinctly 
separated from the first with an MFI of 3094 ± 591.2.  Alternatively, Fixable Viability Dye 
eFluor® 455UV showed a shift in the whole population of cells beyond the left-hand viable 
gate, where only 9.5 ± 0.5 % of cells were found.  Two peaks could be identified with this 
dye (the first with an MFI of 268.3 ± 49.19 and the second with an MFI of 1688 ± 195.1), 
however, there was overlap between the two peaks and no clear distinction could be made 
between the viable and non-viable cell populations.  Of the two stains used, LIVE/DEAD® 
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Fixable Blue Dead Cell Stain showed superior separation of viable and non-viable 
macrophages and was consequently used in ensuing experiments.   
 Selection of antibodies for identification of monocyte-derived 
macrophages 
A limiting feature of macrophages, in polychromatic flow cytometry panel design, is their 
high level of auto-fluorescence that limits the choice of fluorochromes that can be used.  In 
particular, FITC and PE fluorochromes should be avoided for the initial separation of MDM 
from other cell types as MDM are highly auto-fluorescent at the same wavelength as these 
fluorochromes.   
Selection of anti-CD14 antibodies for polychromatic analysis of monocyte-derived 
macrophages 
To enable separation of MDM from fibroblasts and keratinocytes in co-culture, a suitable 
anti-CD14 antibody was required.  MDM cultured in 2D were stained with anti-CD14 
antibodies conjugated to PE, eFluor450 and Alexa Fluor 700 and compared to unstained 
samples.  The normalised median fluorescence intensity (nMFI) for the three antibodies was 
compared (Figure 6.5). 
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Figure 6.5.  Selection of anti-CD14 antibody.   Monocyte-derived macrophages (MDM) 
were cultured for 7 days, retrieved using cell scraping and CD14 expression analysed using 
flow cytometry.  Anti-CD14 antibodies conjugated to PE (A), eFluor 450 (B) and Alexa Fluor 
700 (C) were tested and compared using normalised median fluorescence.  Filled (grey) 
histograms show unstained cells, and open histograms show single-stained cells.  Data are 
from a single experiment (n=1) and gates were set based on unstained cells following dead 
cell exclusion. 
Anti-CD14PE displayed the highest MFI (110.14) compared to anti-CD14Alexa Fluor® 700 (7.88) 
and CD14eFluor® 450 (1.39).  In addition, both anti-CD14PE and anti-CD14Alexa Fluor® 700 showed a 
CD14low and CD14high population that was not visible with the less bright eFluor 450 
fluorochrome. 
Selection of anti-CD45 antibodies for polychromatic analysis of monocyte-derived 
macrophages  
Previous data demonstrated that during monocyte to macrophage differentiation, the 
expression of CD14 decreased.  Therefore, the use of both CD14 and CD45 may be used to 
identify MDM from fibroblasts and keratinocytes in a mixed co-culture.  MDM cultured in 
2D were stained with anti-CD45 antibodies conjugated to PE eFluor 610 and FITC, and 
compared to unstained samples.  The normalised median fluorescence intensity (nMFI) for 
the two antibodies was compared (Figure 6.6). 
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Figure 6.6.  Selection of anti-CD45 antibody.   Monocyte-derived macrophages (MDM) 
were cultured for 7 days, retrieved using cell scraping and CD45 expression analysed using 
flow cytometry.  Anti-CD45 antibodies conjugated to PE eFluor 610 (A) and FITC (B) were 
tested and compared using normalised median fluorescence.  Filled (grey) histograms show 
unstained cells, and open histograms show single-stained cells.  Data are from a single 
experiment (n=1) and gates were set based on unstained cells following dead cell exclusion. 
The use of both anti-CD45PE eFluor® 610 and anti-CD45FITC clearly identified CD45+ events 
compared to unstained cells, although the MFI of anti-CD45PE eFluor® 610 was higher at 79.56 
compared to 1.41 for anti-CD45FITC.  In addition, anti-CD45PE eFluor® 610 was able to distinguish 
between CD45high and CD45low events, and FITC had previously been shown to be unsuitable 
for use in detecting MDM cultured within a highly auto-fluorescent collagen hydrogel.   
Separation of monocyte-derived macrophages from normal oral fibroblasts cultured in 
3D 
To retrieve cells from the collagen hydrogel, methods using collagenase IV had previously 
been optimised.  However, previously published literature suggested that collagenase IV 
may cleave cell surface proteins of interest.  Therefore, the expression of CD45 and CD14 in 
MDM cultured in 2D with and without additional treatment with collagenase IV were 
compared using nMFI to quantify any differences in expression measured by flow cytometry 
(Figure 6.7). 
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Figure 6.7.  Collagenase IV does not affect the expression of CD14 and CD45.   Monocyte-
derived macrophages (MDM) were adherently cultured for 7 days, and retrieved using cell 
scraping before analysis using flow cytometry.  The expression of CD14 (A and C) and CD45 
(B and D) by MDM was unaffected by treatment with (+ coll., dotted line) and without (- 
coll., solid line) collagenase IV.  Data are compared as histograms (A and B) and column 
charts (C and D).  Grey, filled histograms represent unstained MDM, error bars show 
standard error mean and significance was determined using an unpaired two-tailed T-test.  
Data are representative of three independent experiments (n=3). 
Histograms showed very similar expression levels of CD14 and CD45 by MDM cultured in 
2D either with or without additional treatment with collagenase IV; 9.4 ± 2.2 and 8.3 ± 1.8 
for CD14, and 167.5 ± 7.3 and 193.9 ± 8.7 for CD45 in the absence or presence of collagenase 
treatment, respectively.  An unpaired two-tailed T-test showed that MDM treated with 
collagenase IV displayed no significant difference in the expression of CD14 (p=0.7165) or 
CD45 (p=0.0578).   
As there was no apparent decrease in expression of CD14 or CD45 by MDM following 
treatment with collagenase IV, MDM and NOF co-cultured within a collagen hydrogel for 14 
ns 
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days at ALI were stained with both anti-CD14Alexa Fluor® 700 and CD45PE eFluor® 610 to enable 
separation of MDM from NOF (Figure 6.8). 
 
Figure 6.8.  Separation of monocyte-derived macrophages from normal oral fibroblasts 
cultured in 3D.   Monocyte-derived macrophages (MDM) cultured for 7 days in adherent 
culture were retrieved using cell scraping and co-cultured for an additional 14 days with 
normal oral fibroblasts (NOF) within a collagen hydrogel.  Identification of CD14+ (A and D), 
CD45+ (B and E) and CD14+CD45+ (C and F) cells in 3D collagen hydrogels containing normal 
oral fibroblasts in the absence (A-C) or presence (D-F) of MDM.  Gates were set based on 
fluorescence-minus-one controls following dead cell exclusion.  Dot plots are representative 
of three independent experiments (n=3).  
Collagen hydrogels devoid of MDM showed 1.8 % of events in the CD14+ gate and 0.6 % of 
events in the CD45+ gate.  In addition, 2.4 % of events appeared in the CD14+CD45+ gate.  
In contrast, hydrogels containing MDM showed a clear population of cells in both the CD14+ 
gate (representing 27.5 % of events) and CD45+ gate (representing 41.1 % of events).  
Analysis of MDM-containing hydrogels showed 68.8 % of events in the CD14+CD45+ gate, 
that were not present in the hydrogels devoid of MDM. 
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 Polarisation of monocyte-derived macrophages 
A huge variety of macrophage polarisation markers have been identified in the literature.  
In this study, CD80, CD86, CD163 and CD206 were selected as they were the most highly 
cited and due to antibody availability.  In order to generate positive controls for the selected 
proteins, the use of various exogenous stimuli was required.  The published literature cites 
a variety of different combinations of cytokines to stimulate high expression of CD80, CD86, 
CD163 and CD206.  Therefore, a variety of polarisation protocols were followed, and for 
many, results did not confirm published data. 
Selection of polarisation stimuli 
Of the published polarisation protocols, the use of GM-CSF, M-CSF, IL-4, IL-10, LPS and IFNγ 
appeared frequently.  MDM were cultured in 2D for 7 days with the additional presence of 
GM-CSF combined with LPS and IFNγ for the final 24 hours to induce high expression of 
CD80 and CD86, and M-CSF combined with either IL-4 or IL-10 to induce high expression of 
CD163 and CD206.  The expression of the selected markers was compared between MDM 
cultured with different cytokine stimulation, including MDM cultured in the absence of any 
cytokine stimulation (control, M0) and compared to unstained cells to determine nMFI 
(Figure 6.9).   
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Figure 6.9.  Expression of key macrophage polarisation markers following exogenous cytokine stimulation.  Monocyte-derived 
macrophages (MDM) were adherently cultured for 7 days in the absence (control) or presence of M1 (GM-CSF, IFNγ and LPS; green line) or 
M2 (M-CSF combined with either IL-4 (red line) or IL-10 (blue line) cytokines.  The expression of M1 markers, CD80 (A, E and I) and CD86 (B, 
F and J), and M2 markers, CD163 (C, G and K) and CD206 (D, H and L) on MDM were compared. Dot plots represent M1-stimulated MDM 
(A-C) or M-CSF/IL-10-stimulated MDM (D).  Stained samples are compared to an unstained control (grey, filled histogram). Histograms (E-H) 
are summarised as bar charts (I-L).  Data are representative of two independent experiments (n=2).  Gates were set based on unstained 
samples treated under the same conditions following dead cell exclusion. 
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Dot plots show the percentage expression of the selected marker under conditions to 
stimulate a positive control, with gates set compared to an unstained sample.  These show 
that after stimulation with GM-CSF, LPS and IFNγ, a high percentage of MDM expressed 
CD80 and CD86 (37.7 % and 77.9 % respectively).  In addition, the levels of CD80 and CD86 
expression by the whole MDM population increased resulting in a shift in MFI beyond that 
of MDM stimulated with M-CSF with IL-4 or IL-10.  Stimulation of MDM with M-CSF and IL-
10 resulted in 11.4 % of cells expressing CD163, and a small increase in nMFI compared to 
MDM stimulated with GM-CSF, LPS and IFNγ or M-CSF with IL-4.  Stimulation of MDM with 
M-CSF and IL-4 resulted in 88.1 % of cells expressing CD206, however, the overlay histogram 
and nMFI values showed that MDM stimulated with GM-CSF, LPS and IFNγ expressed higher 
levels of CD206 when MDM were stimulated with M-CSF and IL-4.  Consequently, CD36 was 
selected to confirm an M2 phenotype in addition to CD163 in later experiments. 
Selection of polarisation marker antibodies 
MDM were cultured in 2D for 7 days with the additional presence of GM-CSF combined with 
LPS and IFNγ for the final 24 hours to induce high expression of CD80, CD86 and CD206, and 
M-CSF combined with IL-10 to induce high expression of CD36 and CD163.  MDM were 
stained with anti-CD80 antibodies conjugated to FITC; anti-CD163 antibodies conjugated to 
PE and APC; anti-CD36 antibodies conjugated to PE and APC; anti-CD86 antibody conjugated 
to PE Cyanine 7; and anti-CD206 antibodies conjugated to eFluor 450 and PE.  The 
expression of marker and fluorochrome combinations was compared to an unstained 
sample and the nMFI determined (Figure 6.10).  
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Figure 6.10.  Selection of antibodies targeting macrophage polarisation markers.   Monocyte-derived macrophages (MDM) were cultured 
for 14 days, retrieved using cell scraping and CD36, CD80, CD86, CD163 and CD206 expression analysed using flow cytometry.  Anti-CD80 
antibodies conjugated to FITC, clones MEM-233 (A) and 2D10.4 (B); anti-CD163 antibodies conjugated to PE (C) and APC (D); anti-CD36 
antibodies conjugated to PE (E) and APC (F); anti-CD86 antibody conjugated to PE Cyanine7 (G); anti-CD206 antibodies conjugated to eFluor 
450 (H) and PE (I) were tested and compared using normalised median fluorescence.  Filled (grey) histograms show unstained cells, and open 
histograms show single-stained cells.  Gates were based on unstained cells, following dead cell exclusion.  Data are from a single experiment 
(n=1).   
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CD163PE displayed a higher nMFI (1.58) than CD163APC (1.36) and as a key marker in this 
panel, the brightest fluorochrome was allocated to CD163 (Figure 6.10).  By this stage, 
further choices were very limited and fluorochromes were selected according to availability 
(CD86PE Cyanine7 and CD80FITC); clone 2D10.4 showed a higher nMFI (2.54) than clone MEM-
233 (1.07) for CD80FITC and so was selected in preference.  CD36APC showed a lower nMFI 
(49.93) than CD36PE (70.67), however with PE required for CD163, CD36APC was added to 
the panel.  The nMFI of CD86PE Cyanine7 was 47.39.  Although CD206PE showed a higher MFI 
(19.87) than CD206eFluor® 450 (2.01) the latter was selected as the PE fluorochrome was 
required for CD163.   
6.3 Optimisation of FcγR blocking methods 
Macrophages express many Fcγ receptors (FcγR) which enable them to recognize and 
internalize foreign antigens in order to perform their role in antigen presentation to cells of 
the adaptive immune system.  However, the abundance of FcγR present on macrophages 
results in non-specific (non-epitope) binding of flow cytometry antibodies.  In addition, 
antibodies can penetrate the membrane of non-viable cells and non-specifically bind 
intracellular targets.  For these reasons, it was vital to use FcγR blocking prior to flow 
cytometry staining of MDM.  In order to detect non-specific binding, selected isotype 
controls were used with the same fluorochrome (at the same F:P ratio), and at the same 
concentration as the antibody targeted to antigens of interest.  FcR blocking reagent was 
tested at two different concentrations and incubations were performed at 4 °C or on ice for 
15 minutes (Figure 6.11). 
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Figure 6.11.  Optimisation of FcγR blocking methods.   Monocyte-derived macrophages (MDM) were cultured for 14 days, retrieved using 
cell scraping and analysed using flow cytometry.  The fluorescence from an unstained sample is compared to that of a sample stained with 
isotype control for FITC (A), PE eFluor 610 (B), PE (C), PE Cyanine7 (D), APC (E), eFluor 450 (F) and Alexa Fluor 700 (G).  Data are representative 
of three independent experiments (n=3). 
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Ten microliters of FcR blocking reagent incubated at 4 °C demonstrated improved blocking 
of non-specific binding of isotype controls, to levels comparable to unstained samples.  No 
difference in nMFI was measured or visible differences in histograms could be visualized 
between unstained samples and those stained with isotype controls for antibodies 
conjugated to FITC, PE eFluor 610, PE, APC or eFluor 450.  However, a small increase nMFI 
was observed for PE Cyanine 7 (1.25) and Alexa Fluor 700 (1.47) in isotype-stained samples. 
6.4 Phenotypic characterisation of polarised monocyte-derived macrophages cultured 
in 2D 
The fully optimised polychromatic flow cytometry panel could now be used to characterise 
and compare the expression of key macrophage markers by MDM cultured under the 
stimulation of various polarising cytokines.  MDM were cultured in 2D without additional 
stimulation or with the addition of GM-CSF with LPS and IFNγ, or M-CSF with IL-10.   
 Fewer M1 monocyte-derived macrophages are CD14+ compared to M2 
monocyte-derived macrophages 
The morphological changes of unstimulated MDM and MDM polarised to M1 or M2 
phenotypes were compared using light microscopy (Figure 6.12), and changes in size and 
granularity were measured using flow cytometry for CD14+CD45+ (Figure 6.13) and CD45+ 
(Figure 6.14) events.   
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Figure 6.12.  Polarised monocyte-derived macrophages undergo morphological changes in 2D.   Monocyte-derived macrophages (MDM) 
cultured for 7 days in the absence of exogenous stimuli (A) or in the presence of M1-polarising cytokines GM-CSF, LPS and IFNγ (B) or M2-
polarising cytokines M-CSF and IL-10 (C) were imaged using light microscopy.  Data are representative of three independent experiments 
(n=3) and scale bars indicate 50 µm.  White arrows highlight rounded cells, and black arrows highlight spindle-shaped cells.
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Unstimulated MDM and those stimulated with M2 cytokines showed a high proportion of 
flat, round cells (white arrows) compared to spindle-shaped fibroblastoid cells (black 
arrows).  In contrast, those stimulated with M1 cytokines showed an increased 
representation of fibroblastoid-like cells similar to results described previously (Cassol et 
al., 2009).   
 
Figure 6.13.  Polarised CD14+CD45+ monocyte-derived macrophages undergo physical 
changes in 2D.   Monocyte-derived macrophages (MDM) cultured for 7 days in the absence 
of exogenous stimuli (A and D) or in the presence of M1-polarising cytokines GM-CSF, LPS 
and IFNγ (B and E) or M2-polarising cytokines M-CSF and IL-10 (C and F) were analysed using 
flow cytometry.  CD14+CD45+ (A-C) events were selected following dead cell exclusion and 
their size and granularity compared (D-F). 
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Measurements of FSC and SSC of CD14+CD45+ events to examine changes in size and 
granularity were 80213 ± 4268 and 48021 ± 3484 (M0), 85184 ± 7829 and 78485 ± 9093 
(M1), 78059 ± 4950 and 51371 ± 3824 (M2) respectively.  This data indicates that MDM 
stimulated with M1 cytokines were larger and more granular than both those unstimulated 
and those stimulated with M2 cytokines, with much smaller differences in FSC and SSC 
observed between the latter. Of the un-stimulated MDM, 40.1 ± 1.2 % were CD14+CD45+ 
compared to 7.6 ± 0.6 % of M1-stimulated and 51.3 ± 1.9 % of M2-stimulated.  However, in 
all samples, >90 % of events were CD45+, therefore, changes in size and granularity of 
CD45+ were also compared (Figure 6.14). 
 
Figure 6.14.  Polarised CD45+ monocyte-derived macrophages undergo physical changes 
in 2D.   Monocyte-derived macrophages (MDM) cultured for 7 days in the absence of 
exogenous stimuli (A and D) or in the presence of M1-polarising cytokines GM-CSF, LPS and 
IFNγ (B and E) or M2-polarising cytokines M-CSF and IL-10 (C and F) were analysed using 
flow cytometry.  CD45+ (A-C) events were selected following dead cell exclusion and their 
size and granularity compared (D-F). 
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Measurements of FSC and SSC of CD45+ events to examine changes in size and granularity were 
65408 ± 10240 and 46176 ± 2400 (M0), 34240 ± 9600 and 57888 ± 9504 (M1), 60768 ± 10080 
and 47744 ± 1408 (M2) respectively. This data indicates that M1-stimulated MDM are smaller 
and more granular than those unstimulated or stimulated with M2 polarising cytokines.  This is 
comparable to data analysed CD14+CD45+ MDM.  Interestingly, FSC and SSC dot plots of CD45+ 
MDM showed two different populations, as opposed to the single, homogeneous population of 
CD14+CD45+ MDM seen previously. 
 M1 monocyte-derived macrophages appear to express CD80, CD86 and 
CD206, whilst M2 monocyte-derived macrophages express CD36 and 
CD163 
The expression of CD36, CD80, CD86, CD163 and CD206 of un-stimulated and M1 or M2-
polarised MDM was compared using percentage expression and nMFI for CD14+CD45+ 
(Figure 6.15) events and CD45+ events (Figure 6.16).   
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Figure 6.15.  Differences in expression of key monocyte and macrophage markers in unstimulated, M1 and M2 CD14+CD45+ monocyte-
derived macrophages.   Monocyte-derived macrophages (MDM) were adherently cultured for 14 days in the absence (M0) or presence of 
GM-CSF, IFNγ and LPS (M1), or stimulated with M-CSF and IL-10 (M2). The percentage of CD14+CD45+ events expressing CD80, CD163, CD86, 
CD206 and CD36 respectively (A), the normalised median fluorescence (nMFI, B) and nMFI data summarised as column charts (C) are shown. 
Grey, filled histograms represent un-stimulated MDM, green line depicts M1-stimulated and blue line depicts M2-stimulated macrophages. 
Gates were set based on fluorescence-minus one controls and CD14+CD45+ events were selected as in Figure 6.13, following dead cell 
exclusion. Data are representative of two independent experiments (n=2).     
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M1-stimulated MDM displayed a higher expression of CD80 (68.2 %), CD86 (69.4 %) and 
CD206 (88.1 %), compared to un-stimulated MDM (1.4 %, 18.1 % and 34.6 % respectively) 
and M2-stimulated MDM (0.7 %, 3.3 % and 40.6 % respectively).  In addition, M1-stimulated 
MDM displayed higher average nMFI values for CD80 (2.2), CD86 (6.0) and CD206 (5.8) 
compared to un-stimulated MDM (1.0, 2.4 and 1.9 respectively) and M2-stimulated MDM 
(1.1, 5.4 and 1.5 respectively). 
A slightly increased percentage of M2-stimulated MDM expressed CD36 (99.6 %) and CD163 
(21.7 %) compared to un-stimulated MDM (99.5 % and 6.3 % respectively) and M1-
stimulated MDM (92.9 % and 3.2 % respectively).  In addition, M2-stimulated MDM 
displayed higher average nMFI values for CD36 (9.9) and CD163 (1.4) compared to un-
stimulated MDM (6.2 and 1.2 respectively) and M1-stimulated MDM (4.7 and 1.2 
respectively).  Whilst changes in the percentage expression and nMFI were observed 
through the different polarization stimuli, these changes represented the cell population as 
a whole, as opposed to the segregation of separate populations of cells. 
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Figure 6.16.  Differences in expression of key monocyte and macrophage markers in unstimulated, M1 and M2 CD45+ monocyte-derived 
macrophages.   Monocyte-derived macrophages (MDM) were adherently cultured for 14 days in the absence (M0) or presence of GM-CSF, 
IFNγ and LPS (M1), or stimulated with M-CSF and IL-10 (M2). The percentage of CD45+ events expressing CD80, CD163, CD86, CD206 and 
CD36 respectively (A), the normalised median fluorescence (nMFI, B) and nMFI data summarised as column charts (C) are shown. Grey, filled 
histograms represent un-stimulated MDM, green line depicts M1-stimulated and blue line depicts M2-stimulated macrophages. Gates were 
set based on fluorescence-minus one controls and CD45+ events were selected as in Figure 6.14, following dead cell exclusion. Data are 
representative of two independent experiments (n=2). 
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M1-stimulated MDM displayed a higher expression of CD80 (26.1 %), CD86 (97.6 %), CD206 
(40.6 %), compared to un-stimulated MDM (0.8 %, 95.7 %, and 8.6 % respectively) and M2-
stimulated MDM (0.5 %, 91.1 %, and 13.3 % respectively).  In addition, M1-stimulated MDM 
displayed higher average nMFI values for CD80 (2.4), CD86 (210.0) and CD206 (5.9), 
compared to un-stimulated MDM (1.1, 81.7, and 1.9 respectively) and M2-stimulated MDM 
(1.1, 40.4, and 2.4 respectively).  This is comparable to analysis of CD14+CD45+ MDM. 
A slightly increased percentage of M2-stimulated MDM expressed CD36 (96.7 %) but not 
CD163 (5.2 %) compared to un-stimulated MDM (96.3 % and 7.3 % respectively) and M1-
stimulated MDM (69.2 % and 0.74 % respectively).  In addition, M2-stimulated MDM 
displayed higher average nMFI values for CD36 (60.4) and CD163 (0.3) compared to M1-
stimulated MDM (12.7 and 0.1 respectively) but not un-stimulated MDM (72.5 and 0.1 
respectively). 
6.5 Discussion 
To date, no single polychromatic flow cytometry panels have been developed for the 
quantitative characterisation of human MDM polarization status.  Since the start of 
development of this panel, Tarique et al., published a series of three panels that could be 
used in parallel to measure various features of classically and alternatively activated 
macrophages (Tarique et al., 2015).  In common with the panel presented here, published 
work used CD80, CD206 and CD163 to distinguish M1 from M2 macrophages.  However, 
only 2 of the 3 panels used an antigen to distinguish macrophages, CD68, and therefore 
cannot be used to identify macrophages in a co-culture environment.  In addition, the use 
of intracellular markers limits the use of these panels for live cell sorting.  Whilst a 10-colour 
flow cytometry panel has been previously published to characterise macrophages and 
dendritic cells in the normal mouse lung (Misharin et al., 2013) and a 6-colour panel for the 
analysis of mouse adipose tissue macrophages (Cho et al., 2014), there are no multi-colour 
flow cytometry panels available for the characterisation of human macrophages from in 
vitro 3D culture or patient tissue samples.  The polychromatic flow cytometry panel 
presented here is an essential tool for developing an understanding of the changes in 
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expression of key macrophage markers in response to changes in culture environment.  The 
development of the panel is discussed below. 
 Reagent selection 
Fibroblasts are required within a tissue engineered oral mucosa model as they enable the 
adherence and proliferation of keratinocytes to the simulated connective tissue in order to 
form an epithelium (Latkowski et al., 1995).  However, to identify the macrophage 
population for accurate analysis of cell surface protein expression, both fibroblasts and 
keratinocytes need to be separated from macrophages prior to analysis by flow cytometry.  
Typically, a ‘dump-channel’ would be used to remove cells irrelevant to the analysis, such 
as fibroblasts and keratinocytes.  Increasingly, CD90 has been used as a fibroblast marker in 
flow cytometry experiments.  However, CD90 is also expressed by many other cell types, 
including some T lymphocytes and blast cells signifying poor prognosis in AML (Buccisano 
et al., 2004; Guillot-Delost et al., 2012; Zhou and Chng, 2014).  In addition, previously 
published data has isolated stromal cells from lymphnodes, and showed the challenges in 
specifically selecting these for analysis using flow cytometry as a whole range of markers 
was required (Fletcher et al., 2011).  In particular, this paper cites the challenges posed by 
the highly auto-fluorescence extra-cellular matrix in tissues.  Therefore, CD90 alone may 
not be a suitable dump channel marker for fibroblasts in flow cytometry.  Alternative 
markers include αSMA and vimentin, although these are intracellular markers and their 
expression varies markedly under different conditions (Gedye et al., 2014; Hsia et al., 2016).  
The use of PDGFRα has also been explored to isolate cancer-associated fibroblasts from 
patient samples and may be useful in isolating fibroblasts that are both αSMA positive and 
negative (Sharon et al., 2013).  Regarding keratinocytes, these cells express many different 
markers, but no examples of optimised keratinocyte markers suitable for use in a ‘dump 
channel’ could be found. 
CD14 is typically regarded as a monocyte- and macrophage-specific marker, although 
evidence has shown that CD14 may also be expressed by non-myeloid cells (Jersmann, 
2005).  CD45, otherwise known as leukocyte common antigen, is expressed by all 
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leukocytes, including macrophages.  Neither fibroblasts or keratinocytes are CD14+CD45+ 
and thus the panel presented here used positive selection for CD14+CD45+ dual positive 
cells in order to identify macrophages within co-culture with keratinocytes and fibroblasts.   
Fluorochrome selection 
Macrophages are a highly auto-fluorescent cell type, to such an extent that this has 
previously been used to identify these cells during in vitro generation from PBM using flow 
cytometry (Njoroge et al., 2001).  Cellular auto-fluorescence in animals is mostly derived 
from chromophores such as flavins, enzymes such as NADH and NADPH and extracellular 
matrix components such as collagen and elastin (Billinton and Knight, 2001).  Initially, anti-
CD14 and anti-CD45 antibodies conjugated to FITC and PE were examined for the 
identification of macrophages from other cell types.  However, fibroblasts contain large 
amounts of collagen which auto-fluoresces around 520nm; within the emission spectra of 
FITC.  Due to the large amounts of overlap in emission spectra of FITC and PE, auto-
fluorescence from fibroblasts resulted in both of these fluorochromes proving unsuitable 
for the separation of macrophages from fibroblasts.   
A wide variety of fluorochromes are available for use in flow cytometry experiments; these 
can vary in brightness and excitation or emission wavelengths, and they can be used alone 
or in tandem.  The brightest fluorochromes (those with the highest stain index) were 
reserved for the highest prioritised antigens, such as CD14, CD45 and CD163 that were 
assigned to Alexa Fluor 700, PE eFluor 610 and PE respectively.  Directly-conjugated anti-
CD14 and anti-CD45 antibodies are commonly used in research, and thus a wide choice of 
fluorochromes are available.  Therefore, the selection of fluorochromes for these antibodies 
was postponed until fluorochromes had been selected for less commonly available 
antibodies.  Fluorochromes were selected in order to reduce the amount of compensation 
required to minimize the effects of spectral overlap.  However, there was considerable 
spectral overlap of FITC in the blue 575/26 and blue 610/20 channels; PE into blue 610/20; 
PE eFluor 610 into blue 530/30 and blue 575/26; and Alexa Fluor 700 into red 660/20 
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although this never exceeded >50%.  Due to spectral overlap, the use of fluorochromes 
detected by blue 660/20 laser are not recommended for additions to this panel. 
Non-viable cells non-specifically bind free antibodies in a staining solution.  Therefore, it is 
essential to use a viability dye during flow cytometry analysis to remove non-viable cells 
from the analysis that may otherwise be measured as a false-positive result (Tung 2007).  
The LIVE/DEAD® Fixable Blue Dead Cell Stain used here demonstrated favourable 
separation of viable and non-viable cells compared to a Fixable Viability Dye eFluor® 455UV.  
Both these dyes are excited by the Lightwave Xcyte™ laser, for which very few 
fluorochromes are available.  This ensured that as many fluorochromes remained available 
for the selected markers.  
 Polarisation of monocyte-derived macrophages 
Macrophages are a highly pleiotropic cell type, responding to various environmental stimuli 
by changing gene and protein expression, as well as shape and size.  As macrophages alter 
their protein expression so rapidly to changes in their environment, there is a need for tools 
to enable characterisation of macrophages isolated from animals and humans with limited 
in vitro manipulation to further understand their role in disease progression.  In vitro 
experiments have shown that the gene expression profile of MDM stimulated with one 
cocktail of cytokines can rapidly change if a second cocktail of cytokines is added (Murray 
and Wynn, 2011).  Therefore, polychromatic flow cytometry panels are rapidly emerging as 
promising tools to characterise macrophages isolated from various disease models, 
however none exist for the characterisation of human macrophages. 
There are many different published protocols for the polarisation of MDM using several 
different cytokines and varying antigens used to measure the direction of polarisation.  
Typically, changes in protein expression measured by flow cytometry are reported as 
changes in nMFI (Chan et al., 2013) and will therefore be discussed here, in addition to 
changes in percentage expression.   
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It was previously observed that MDM cultures were >95 % CD14+ after 7 days, therefore 
protocols for polarising MDM over 7 days were used.  The most commonly used markers 
were selected for assessment of macrophage polarisation (Table 1.1).  Gene and protein 
expression do not often correlate, but similarly to experiments analysing protein 
expression, many different combinations of cytokines are used to stimulate gene expression 
of MDM polarisation antigens.  These have previously been summarised (Erbel et al., 2013). 
M1 antigens 
T lymphocyte activation antigen, CD80, is often used as a marker of M1 macrophage 
polarisation.  Through culture of MDM for 7 days in the presence of GM-CSF with the 
addition of LPS and IFNγ, expression of CD80 increased compared to MDM cultured without 
stimulation or in the presence of M2 cytokines, providing similar results to those previously 
published (Jaguin et al., 2013).  However, in this published study, stimulation of MDM by 
GM-CSF alone, resulted in no significant increase in CD80 observed (Jaguin et al., 2013).  
This is in direct contrast to Ambarus et al., who found that GM-CSF or IFNγ alone could 
stimulate an increased expression of CD80 (Ambarus et al., 2012).  Whilst the increase in 
CD80 expression by nMFI was modestly in favour of M1-stimulated MDM, 70 % of cells were 
found to be CD80+ compared to unstimulated and M2-stimulated MDM that showed 1.4 % 
and 0.7 % CD80+ cells respectively.  
CD86 is a common antigen used for identifying M1 macrophages.  In the absence of GM-
CSF, but presence of LPS and IFNγ, or IFNγ alone, Vogel et al., found no significant increase 
in CD86 expression compared to control or M2 polarised MDM (Vogel et al., 2013).  As in 
other previously published protocols (Mia et al., 2014; Zhang et al., 2013), it was found here 
that CD86 expression could be induced by the culture of MDM for 6 days in the presence of 
GM-CSF, with an additional 24 hours in the presence of GM-CSF, LPS and IFNγ.  This 
treatment resulted in a similar pattern of increase in both nMFI and percentage expression 
of CD86+ cells.  
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During the activation of innate immunity, the binding of LPS to TLR4 leads to a signal 
transduction pathway that culminates with activation of iNOS and expression of co-
stimulatory molecules such as CD80, CD86 and CD40 that results in the activation of T 
lymphocytes (Iwasaki and Medzhitov, 2004).  Activated T lymphocytes and natural killer 
cells, attracted by IL-12 released by macrophages, secrete IFNγ that binds IFNGR1 resulting 
in the upregulation of pro-inflammatory cytokines such as TNF and IL-1β whilst increasing 
the expression of IFNGR1 in a positive feedback loop (Biswas and Mantovani, 2010; Chavez-
Galan et al., 2015).  Additionally, the binding of LPS to CD14, via the action of LPS binding 
protein and GM-CSF to GMCSFR results in further upregulation of pro-inflammatory 
cytokines (Duque and Descoteaux, 2014). 
Following stimulation of MDM with GM-CSF, LPS and IFNγ, data showed a decrease in the 
expression of CD14+ events.  This resulted in a decrease in the number of macrophages 
selected as they were no longer selected in the CD14+CD45+ gate.  Previous data showed a 
decrease in membrane CD14 expression by alveolar macrophages in response to E.coli and 
extracted LPS both in vivo and in vitro (Lin et al., 2004).  With the aid of LPS binding protein 
(LBP), LPS binds CD14 for internalisation.  Whilst there is evidence to support the 
internalisation of CD14 with LPS (Poussin et al., 1998), there is also evidence to suggest that 
CD14 does not accompany LPS during internalisation (Vasselon et al., 1999).  During 
inflammation, LBP is secreted from the liver and increases in concentration in peripheral 
blood.  This aids in activating cells devoid of CD14 to respond to exposure to LPS (Fenton 
and Golenbock, 1998).  Whilst many researchers add exogenous LBP to in vitro cultures of 
macrophages to stimulate a response to LPS, CD14 can bind LPS in the absence of LBP, albeit 
at a very low rate (Fenton and Golenbock, 1998). 
M2 antigens 
CD36 is a scavenger receptor that is increasingly used to identify M2 macrophages.  It is 
considered essential for the activation of macrophages to an M2 phenotype (Huang et al., 
2014).  Although its gene expression is commonly measured in macrophage polarising 
experiments to indicate M2 polarisation, no examples of flow cytometry analysis of CD36 
  
 
196 | P a g e  
 
under different polarising conditions could be found.  Data showed that MDM stimulated 
with M-CSF combined with IL-10 expressed higher levels of CD36 compared to both un-
stimulated and M1-stimulated MDM.  Here, M1-stimulated MDM expressed the lowest 
levels of CD36, determined by both percentage expression and nMFI, in a similar pattern to 
previously published gene expression data (Jaguin et al., 2013).  However, while nMFI data 
showed a marked increase in CD36 expression compared to both unstimulated and M1-
stimulated MDM, similar percentages of MDM were CD36+ in both un-stimulated and M2-
stimulated MDM. 
Scavenger receptor CD163 is often used to identify M2 macrophages.  In addition, CD163 
has been shown in the literature to have an important role in the progression of oral cancer, 
and can be used as a determinant of poor prognosis (Balermpas et al., 2014; Fujii et al., 
2012; Fujita et al., 2014; He et al., 2014; Mori et al., 2011; Weber et al., 2014; Wehrhan et 
al., 2014).  An increase in the expression of CD163 has previously been observed following 
culture of MDM for 6 days in the presence of M-CSF with an additional 24 hours in the 
presence of IL-4 (Zhang et al., 2013).  This is in direct contrast to research by another group 
that found no significant increase in CD163 expression by MDM following stimulation with 
IL-4 (Vogel et al., 2013).  In fact, it was found that there was a slight increase in the 
expression of CD163 in the presence of M1 polarising cytokines.  Of note, the use of M-CSF 
alone has been found to increase the expression of CD163 (Ambarus et al., 2012).  In 
addition, this work showed that CD163 expression was observed to increase in response to 
stimulation of MDM with M-CSF or IL-10 either alone or in combination (Ambarus et al., 
2012).  Research presented in this thesis found that the culture of MDM with M-CSF in 
combination with IL-10 resulted in an increase in CD163 expression compared to un-
stimulated MDM and those stimulated with GM-CSF, LPS and IFNγ.  The use of M-CSF 
combined with IL-4 did not result in an increase in expression of CD163 compared to un-
stimulated MDM.  Whilst a modest increase in nMFI of M2-stimulated MDM was observed, 
the percentage of CD163+ cells increased by more than 3-fold compared to un-stimulated 
MDM and more than 7-fold compared to M1-stimulated MDM. 
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Mannose receptor type 1, otherwise known as CD206, has been well characterised and has 
many roles in macrophage function.  It is often used to identify M2 macrophages, however 
this study found its expression to increase during polarisation with M1 cytokines.  Previous 
literature has shown that the use of IL-4 can significantly increase the expression of CD206 
to demonstrate polarisation of MDM to M2 status (Ambarus et al., 2012; Vogel et al., 2013).  
However, other research groups found no significant difference in CD206 expression after 
stimulation of MDM with M-CSF and IL-4 compared to MDM stimulated with M0 or M1 
polarising cytokines (Jaguin et al., 2013).  However, this was not replicated by their gene 
expression data that showed a significant increase in CD206 transcription in the presence 
of IL-4 compared to un-stimulated MDM or those cultured with M1-polarising cytokines.  
An alternative approach is the use of IL-4 combined with IL-10 or with the further addition 
of TGFβ that displayed a significant increase in CD206 expression compared to un-
stimulated MDM and those stimulated with various combinations of IL-4, IL-10, IL-13, TGFβ, 
LPS and IFNγ (Mia et al., 2014).  In this published study, the use of IL-4 and IL-10 in the 
absence of TGFβ resulted in the largest increase in CD206 expression.  The study presented 
in this thesis was unable to reproduce these results, and consistently found that CD206 
expression increased in the presence of M1 polarising cytokines, as reported by both nMFI 
and percentage expression. 
Of note, data showed that changes in expression of polarisation antigens by MDM was 
shared by the population as a whole, with shifts in nMFI observed.  No evidence of discrete 
populations of cells emerging as CD36+, CD80+, CD86+, CD163+ or CD206+ was observed.  
The combination of nMFI and percentage expression was found to provide further insight 
into the changes in protein expression reported. 
Whilst there are many studies analysing the signalling pathways involved in M1 macrophage 
activation, less information is available for M2 macrophages.  IL-10 is an anti-inflammatory 
cytokine, and the binding of this to its receptor, IL-10R, leads to a signal transduction 
cascade that culminates in the transcription of anti-inflammatory genes and scavenger 
receptors CD36 and CD163, and CD206 (Chavez-Galan et al., 2015; Duque and Descoteaux, 
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2014).  Further IL-10 is secreted, and attracts B cells and Treg cells that release more IL-10 
in a positive feedback loop (Biswas and Mantovani, 2010).  The increased expression of 
CD36, CD163 and CD206 enables macrophages to bind and scavenge increased amounts of 
oxidised LDL, hapto-haemoglobin complexes and bacterial carbohydrates resulting from the 
inflammatory response, respectively (Duque and Descoteaux, 2014).  As part of the anti-
inflammatory response of M2 macrophages, LPS-dependent pro-inflammatory responses 
are inhibited (Biswas and Mantovani, 2010). 
 Flow cytometry controls 
There are many studies using flow cytometry that have not been found to be reproducible, 
particularly in the case of large clinical trials with some studies showing more than 20 % 
variance in results, typically from variation in gating strategies (Maecker et al., 2010).  
Hence, there has been a focussed effort to raise awareness of the correct controls and 
approaches to gating to ensure that more data can be reproduced (Alvarez et al., 2010).  
Consequently, guidelines were developed for the minimum information to be reported 
alongside published flow cytometry data (Lee et al., 2008).  By incorporating suitable 
controls, accurate gating and data compensation into a study, reproducible data may be 
achieved.  The data presented in this work has followed all published flow cytometry 
guidelines and used the following controls and quality control steps. 
Compensation is used to account for spectral overlap between different fluorochromes.  It 
estimates and subtracts the spectral overlap from the detected signal to estimate the actual 
signal (Herzenberg et al., 2006).  Most software associated with a flow cytometers compute 
complex algorithms for quantifying spectral overlap using positive controls such as 
compensation beads (Tung et al., 2007).  The fluorochromes selected in the polychromatic 
panel presented here required compensation due to overlap between the emission spectra.  
Compensation corrects for reagent spillover, and the gold-standard method combines the 
use of compensation beads which are always brighter, more accurate and more 
reproducible than the cells of interest with automatic compensation algorithms (Bagwell 
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and Adams, 1993).  This ensures that only the fluorochrome of interest is measured at any 
given time, rather than spillover from other fluorochromes (Roederer, 2001). 
Compensation beads were used in this thesis to provide maximally bright and maximally 
dim signals to calculate accurate compensation.  Anti-mouse CompBeads and ArC amine 
reactive beads were used according to the manufacturer’s instructions with the selected, 
titrated fluorochrome-conjugated antibodies.  Compensation (Table 2.10) was applied by 
FACSDiva software and applied to all ensuing samples.  All compensated samples were 
manually checked to ensure the median values of negative and positive populations were 
equal. 
Whilst compensation minimises the amount of spectral overlap between different 
fluorochromes, FMO controls are used to ensure that gates are set to eliminate any 
fluorescence spread.  This is particularly important in the case of highly auto-fluorescent 
cells, such as macrophages.  Each FMO control contains all the panel reagents, except the 
reagent of interest.  Gates can then be applied that ensure only truly positive events are 
measured (Roederer, 2001; Tung et al., 2007).   
Macrophages express many Fcγ receptors (FcγR) which enable them to recognize and 
internalize foreign antigens in order to perform their role in antigen presentation to cells of 
the adaptive immune system (Guilliams et al., 2014).  However, the abundance of FcγR 
present on macrophages results in non-specific (non-epitope) binding of flow cytometry 
antibodies (Andersen et al., 2016).  In addition, antibodies can penetrate the membrane of 
non-viable cells and non-specifically bind intracellular targets.  For these reasons, it was vital 
to use FcγR blocking prior to flow cytometry staining of MDM.  MDM bind strongly to IgG1 
and IgG2a, but not to IgG2b.  However, even this strong binding can be blocked by using an 
FcγR blocking reagent (Andersen et al., 2016).  Isotype controls are typically used to ensure 
that FcγR blocking methods successfully block non-specific antibody binding.  In this work, 
all flow cytometry reagents were titrated in order to avoid high levels of background 
staining.  In addition, isotype antibodies matched the isotype of the test antibody and both 
antibodies were purchased from the same vendor to ensure matching F:P ratios.  It was 
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ensured that the background staining of the isotype antibody matched an unstained sample 
(Maecker and Trotter, 2006). 
In some studies, samples stained with isotype controls are used to set gates and as a 
reference in comparison to stained samples.  However, an increasing body of literature 
advises against the use of isotype controls for this purpose, and instead advises the use of 
unstained and unstimulated samples as comparisons and FMO controls for setting gates 
(Andersen et al., 2016; Keeney et al., 1998; Maecker and Trotter, 2006).  The use of an 
isotype control to set gates in a polychromatic flow cytometry experiment does not allow 
for fluorescence spill over, hence FMO controls are recommended for this purpose 
(Herzenberg et al., 2006). 
6.6 Conclusion 
The fully optimised polychromatic flow cytometry panel presented here not only describes 
a tool that may be used reproducibly to gain further understanding in the expression of 
specific antigens by MDM cultured under various conditions, the exclusive use of cell 
surface markers in this panel enables its use for live cell sorting.  Whilst the panel has been 
developed for use on in vitro cultured MDM in 2D and 3D, the panel may be further 
optimised for use on patient biopsies.  In any case, the panel provides the opportunity to 
analyse MDM antigen expression in detail that has not previously been possible. 
  
  
 
201 | P a g e  
 
 Chapter 7: Preliminary Analysis of an In Vitro 
3D Model of the Oral Mucosa Using 
Polychromatic Flow Cytometry 
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7.1 Introduction 
Macrophages have been shown to have an increasingly important role in oral cancer 
progression.  However, the tools available to establish the molecular interactions between 
primary human macrophages and other cells of the tumour microenvironment have 
previously been limited to IHC of patient biopsies (Bagul et al., 2016; Balermpas et al., 2014; 
Boas et al., 2013; Li et al., 2002; Lu et al., 2010; Mori et al., 2011).  However, whilst 
histological analysis provides some detailed information, it only provides a snapshot.  The 
tissue-engineered oral mucosa model containing human MDM developed previously in 
Chapter 5 may be used to investigate the role that TAM play in oral cancer progression.  In 
this model, the interactions of MDM with fibroblasts and keratinocytes can be explored.  
The array of tools, such as polychromatic flow cytometry panel and rheometry, optimised 
in previous chapters may now be optimised and applied specifically to analyse changes in 
MDM within the tissue-engineered model.   
Macrophages are highly plastic and adjust their function in response to environmental 
stimuli.  In the tumour microenvironment, previous data has shown that macrophages 
change expression of markers in response to cytokines released by tumour cells to promote 
a tumour-supportive environment.  In particular, CD163 is emerging as a potential 
prognostic marker for oral cancer as its expression has correlated with poor patient survival 
in a number of studies (Balermpas et al., 2014; Fujii et al., 2012; Fujita et al., 2014; He et al., 
2014; Mori et al., 2011; Weber et al., 2014; Wehrhan et al., 2014). 
In order to gain an understanding of the changes that macrophages undergo in response to 
oral cancer cells and consequences to cancer progression, a collagen hydrogel containing 
fibroblasts with and without MDM was seeded with NOK, FNB6 or H357 keratinocytes.  
Alternatively, to further understanding of the effects polarised macrophages have on the 
oral mucosa, hydrogels populated with M0, M1 and M2 MDM were cultured with an FNB6 
epithelium in the presence of continuous cytokine stimulation as previously described 
(Linde et al., 2012).  Models were cultured at ALI for 14 days and analysed using an 8-colour 
flow cytometry panel for the identification of MDM from fibroblasts and characterisation 
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of macrophage polarisation status, rheometry to measure changes in tissue stiffness and 
histology to analyse changes in tissue architecture.   
7.2 Optimisation of flow cytometry panel for use on tissue-engineered models of the 
oral mucosa 
Chapter 6 of this thesis described the optimisation of a multi-colour flow cytometry panel 
suitable to quantitatively analyse the expression of CD36, CD80, CD86, CD163 and CD206 
on CD14+CD45+ macrophages.  To be used on MDM co-cultured in 3D with fibroblasts and 
a variety of epithelial cells, further methods for the disaggregation of models and analysis 
of MDM were required.   
 Effect of collagenase IV on the expression of cell surface markers by 3D-
cultured monocyte-derived macrophages 
The polychromatic flow cytometry panel presented in this thesis has so far been optimized 
for use on 2D in vitro generated MDM, however, its purpose is to interrogate the expression 
of key macrophage markers on MDM cultured in 3D, which requires further optimisation.  
Retrieval of MDM from 3D cultures was previously optimized using collagenase IV and 
therefore it was essential to ensure that the use of this enzyme did not affect the expression 
of the selected markers of interest. 
MDM were cultured in 2D either un-stimulated or in the presence of M1 or M2 polarising 
cytokines in order to stimulate the expression of chosen markers of interest.  MDM were 
washed and scraped into fresh IMDM using cell scrapers and expression of markers was 
compared between MDM treated with collagenase IV and those without treatment.  Data 
are presented as overlay histograms and the nMFI of CD80FITC, CD163PE, CD86PE Cyanine7, 
CD206eFluor450 and CD36APC with and without collagenase IV treatment were compared using 
an unpaired two-tailed T-test (Figure 7.1).   
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Figure 7.1.  Disaggregation of collagen hydrogel using collagenase IV does not affect the expression of macrophage polarisation markers.   
Monocyte-derived macrophages (MDM) were adherently cultured for 7 days, retrieved using cell scraping and analysed using flow cytometry 
in the absence or presence of collagenase treatment. The differential expression of CD80 (A and F), CD163 (B and G), CD86 (C and H), CD206 
(D and I) and CD36 (E and J) by macrophages cultured with (+ coll., dotted line) and without (- coll., solid line) collagenase IV treatment is 
compared as histograms (A-E) and column charts (F-J). Grey, filled histograms represent un-stimulated macrophages, error bars show 
standard error mean and significance was determined using an unpaired two-tailed T-test. Data are representative of three independent 
experiments (n=3). 
ns ns ns ns ns 
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Following treatment with collagenase IV, expression levels of CD36, CD80, CD86, CD163 and 
CD206 by MDM were similar to those of un-treated MDM; 26.6 ± 0.4 and 24.4 ± 1.9 for 
CD36, 4.0 ± 2.0 and 4.3 ± 0.27 for CD80, 344.1 ± 25.37 and 261.6 ± 62.0 for CD86, 29.0 ± 4.3 
and 29.0 ± 5.1 for CD163, and 8.0 ± 0.7 and 8.8 ± 0.3 for CD206, in the absence or presence 
of collagenase treatment, respectively.  An unpaired two-tailed T-test showed that MDM 
treated with collagenase IV displayed no significant difference in the expression of CD80 
(p=0.5251), CD163 (p=0.9941), CD86 (p=0.2855), CD206 (p=0.3325) or CD36 (p=0.2536).  
Some cells were lost during the additional processing of samples treated with collagenase, 
resulting in reduced cell counts. 
 Use of additional controls 
In chapter 6, a polychromatic flow cytometry panel was developed to enable analysis of 
polarisation status of MDM cultured within the tissue-engineered model of the oral mucosa 
presented in Chapter 5.  In order for this panel to be used to analyse the changes in 
expression of key macrophage polarisation markers, CD36, CD80, CD86, CD163 and CD206, 
in response to MDM culture with NOK, FNB6 or H357 keratinocytes.  However, additional 
controls may be required to accurately interpret results. 
Monocyte-derived macrophages appear to change in morphology and expression of 
CD14 and CD45 in response to co-culture with normal oral keratinocytes, FNB6 and H357 
cells 
After 14 days of culture at ALI, hydrogels were disaggregated using collagenase IV, samples 
were processed into a single cell suspension using a cell strainer and stained using the multi-
colour flow cytometry panel developed in chapter 6.  Gates were set using FMO controls to 
measure percentages of cell expression and nMFI calculated (Equation 2.1).  The FSC, SSC 
and expression of CD14 and CD45 was compared using flow cytometry (Figure 7.2). 
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Figure 7.2.  Monocyte-derived macrophages appear to undergo morphological changes 
and differentially express CD14 and CD45 within tissue-engineered oral mucosa 
containing normal oral keratinocytes, immortalised FNB6 keratinocytes or oral squamous 
cell carcinoma cell line, H357.  Monocyte-derived macrophages (MDM) following 7 days of 
adherent culture were retrieved using cell scraping and additionally cultured within tissue-
engineered oral mucosa containing normal oral fibroblasts in addition to normal oral 
keratinocytes (NOK, A-B), immortalised FNB6 keratinocytes (C-D) or oral squamous cell 
carcinoma cell line, H357 (E-F) for 14 days at air-liquid interface. MDM showed differences 
in size and granularity (A, C and E) and expression of key macrophage markers, CD14 and 
CD45 (B, D and F), following co-culture with the different keratinocytes. Gates were set 
based on fluorescence-minus-one controls following dead cell exclusion. Data shown are 
for a single experiment (n=1). 
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Following culture of MDM within a tissue-engineered model of the oral mucosa in the 
presence of NOK, FNB6 and H357, changes in MDM size and granularity were observed.  
MDM cultured in the presence of NOK had the highest measured FSC and SSC at 87 360 and 
84 544 respectively, and those cultured with FNB6 cells had the lowest values at 65 408 and 
68 544 respectively.  MDM cultured in the presence of H357 keratinocytes has FSC and SSC 
values of 79 552 and 82 816 respectively.   
Monocyte-derived macrophages appear to express altered levels of background auto-
fluorescence in response to co-culture with different cells 
The background fluorescence of MDM was altered following co-culture with NOK, FNB6 and 
H357 cells.  Therefore, the detection of CD45PE eFluor 610 and CD14Alexa Fluor 700 was affected.  
Consequently, gates were required based on individual FMO controls for each model type.  
In models containing NOK, 44.0 % of events were CD14+CD45+ compared to 25.0 % in 
models containing FNB6 cells and 21.4 % in models containing H357 cells.  However, as the 
percentages of CD14-CD45- varied between samples, a ratio was also produced to 
determine the ratio of CD14+CD45+ events compared to CD14-CD45+ events by dividing 
CD14+CD45+ events by CD14-CD45+ events.  This ratio was found to 4.5 for NOK, 3.4 for 
FNB6 and 2.3 for H357 containing models.  This indicates an increased ratio of CD14+CD45+ 
MDM in NOK-containing models compared to both FNB6 and H357 containing models. 
The viability of cells was >90 % in all cases.  In order to visualise the differences in auto-
fluorescence of MDM co-cultured with NOK, FNB6 and H357 cells, the fluorescence of 
unstained MDM retrieved from collagen hydrogels was compared in all channels of interest 
(Figure 7.3). 
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Figure 7.3.  Background fluorescence of monocyte-derived macrophages appears to 
change in response to culture with normal oral keratinocytes, immortalised FNB6 
keratinocytes and oral squamous cell carcinoma cell line, H357s.  Monocyte-derived 
macrophages (MDM) cultured within tissue-engineered oral mucosa containing normal oral 
fibroblasts in addition to normal oral keratinocytes (NOK, dashed line), immortalised 
keratinocytes, FNB6 (dotted line) or oral squamous cell line, H357 (unbroken line) showed 
differences in background fluorescence of unstained samples at the wavelengths used to 
measure CD36APC (A), CD80FITC (B), CD86PE Cyanine7 (C), CD163PE (D) and CD206eFluor 450 (E). Data 
shown are for a single experiment (n=1).  
In response to co-culture with NOK, FNB6 and H357 keratinocytes, in addition to changes in 
the expression of CD14 and CD45 and changes in FSC and SSC, the background fluorescence 
of MDM in FMO controls at wavelengths measuring the expression of key macrophages 
markers was also altered.  The measured background MFI measured using a blue 530/30 
laser (FITC) was 418 (FNB6), 540 (NOK), 460 (H357); for the blue 575/26 laser (PE) was 196 
(FNB6), 253 (NOK), 188 (H357); for the blue 780/60 laser (PE Cyanine7) was 1201 (FNB6), 
1467 (NOK), 1165 (H357); for the red 660/20 laser (APC) was 316 (FNB6), 340 (NOK), 318 
(H357); and for the violet 450/50 laser (eFluor 450) was 866 (FNB6), 1253 (NOK), 702 
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(H357).  MDM cultured with NOK expressed higher levels of background fluorescence at the 
same wavelength as FITC, PE, eFluor 450 and expressed a slightly higher MFI at the same 
wavelength as PE Cyanine 7 compared to those cultured with both FNB6 and H357.  The 
background fluorescence of MDM at the same wavelength as APC remained unchanged. 
7.3 The interaction of monocyte-derived macrophages with normal oral keratinocytes, 
FNB6 and H357 epithelia 
Tissue-engineered oral mucosa models containing fibroblasts either in the presence or 
absence of MDM were cultured with an epithelium containing NOK, FNB6 or H357 cells.  
After 14 days of culture at ALI, models were formalin-fixed, paraffin-embedded and sections 
were stained with H&E (Figure 7.4).   
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Figure 7.4.  Histology of models containing normal oral keratinocytes, immortalised keratinocyte cell line, FNB6, or oral squamous cell 
carcinoma cell line, H357, in the absence or presence of monocyte-derived macrophages.  Tissue engineered oral mucosa models 
containing normal oral fibroblasts (NOF) in addition to normal oral keratinocytes (NOK, A and D), immortalised keratinocytes, FNB6, (B and 
E) or oral squamous cell line, H357, (C and F) in the absence (A-C) or presence (D-E) of monocyte-derived macrophages (MDM) were cultured 
at air-liquid interface for 14 days. Models were formalin fixed, sectioned and stained with H&E. Data are representative of two independent 
experiments using NOK from different patients (n=2). Scale bars indicates 200 μm. 
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Models containing NOK demonstrated a thin epithelium compared to those containing 
FNB6 or H357 cells.  In those models containing FNB6 cells, a thick, multi-layered epithelium 
could be observed with apical-basal polarity, forming a stratified epithelium.  Whilst models 
containing an H357 epithelium were also several layers thick, no stratification was 
observed, instead the epithelium was disordered with evidence of some epithelial invasion 
into the connective tissue.  Within the connective tissue, cells were evenly distributed and 
the ECM itself stained pink indicating matrix deposition by fibroblasts. 
 Monocyte-derived macrophages appear to express key macrophage 
markers at varying levels in response to co-culture with normal oral 
keratinocytes, FNB6 or H357 cells 
Following the optimisation of controls required for the analysis of MDM cultured within a 
collagen hydrogel, the multi-colour flow cytometry panel developed in Chapter 6 was used 
to quantitatively measure differences in the expression of CD36, CD80, CD86, CD163 and 
CD206.  Models containing MDM with either a NOK, FNB6 or H357 epithelium were cultured 
at ALI for 14 days.  Models were disaggregated using collagenase IV, prepared into a single-
cell suspension using a cell strainer and stained using the multi-colour flow cytometry panel 
developed in chapter 6.  To analyse the differences in expression of the selected markers, 
gates to select CD14+ and CD45+ cells were set using FMO controls, and the MFI determined 
using separate FMO controls for each model type.  The expression of CD36, CD80, CD86, 
CD163 and CD206 is presented as histograms Figure 7.5 and summarised in bar charts 
displaying nMFI and % cells expressing each marker Figure 7.6.  
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Figure 7.5.  Differential expression of key markers by monocyte-derived macrophages in co-culture with normal oral keratinocytes, 
FNB6 and H357.  Monocyte-derived macrophages (MDM) were cultured within tissue-engineered oral mucosa containing normal oral 
fibroblasts, in addition to normal oral keratinocytes (NOK), immortalised keratinocyte cell line, FNB6, and oral squamous cell line, H357. 
Following 14 days of culture at air-liquid interface, MDM were retrieved using collagenase and analysed using flow cytometry. 
CD14+CD45+ MDM were selected, following dead cell exclusion and the differential expression of CD36 (A, F and K), CD80 (B, G and L), 
CD86 (C, H and M), CD163 (D, I and N) and CD206 (E, J and O) in response to co-culture with normal oral keratinocytes (NOK, A-E), FNB6 
(F-J) and H357 (K-O) was determined. Data shown are for a single experiment (n=1). 
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Figure 7.6.  Protein expression of monocyte-derived macrophages isolated from engineered oral mucosa models containing normal oral 
keratinocyte, immortalized keratinocytes, FNB6, and oral squamous cell line, H357, epithelia.  Monocyte-derived macrophages (MDM) 
were cultured within tissue-engineered oral mucosa containing normal oral fibroblasts, in addition to normal oral keratinocytes (NOK), 
immortalised keratinocyte cell line, FNB6, and oral squamous cell line, H357. Following 14 days of culture at air-liquid interface, MDM 
were retrieved using collagenase and analysed using flow cytometry. CD14+CD45+ MDM were selected, following dead cell exclusion and 
the differential expression of CD36 (A and F), CD80 (B and G), CD86 (C and H), CD163 (D and I) and CD206 (E and J) in response to co-
culture with normal oral keratinocytes (NOK, A-E), FNB6 (F-J) and H357 (K-O) was determined as normalized median fluorescence intensity 
(nMFI) and percentage cell expressing the selected marker. Data are summarised from a single experiment (n=1).  
A B C D E 
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Following co-culture of MDM with NOK, FNB6 and H357 keratinocytes, changes in the 
expression of key macrophage markers were observed.  Models containing NOK contained 
a higher percentage of MDM expressing CD36 at 97.0 % compared to 37.3 % in FNB6 models 
and 90.4 % in H357 models.  Similarly, the nMFI of CD36 expression was highest in NOK-
containing models at 15.8 compared to 5.1 for FNB6 models and 10.0 for H357 models.  
Models containing H357 keratinocytes showed the highest percentage expression of CD80 
with 7.6 % of cells expressing this antigen compared to 1.5 % in NOK models and 1.4 % in 
FNB6 models.  This was reflected in nMFI data that showed the highest nMFI for H357 
containing models at 1.4 compared to models containing NOK and FNB6 keratinocytes that 
both showed an nMFI of 1.1.  Similarly, the highest percentage of CD86+ cells was found in 
models containing H357 cells as these made up 91.6 % of the cells compared to 46.8 % in 
NOK models and 17.8 % in FNB6 models.  The nMFI for CD86PE Cyanine7 was also highest in 
models containing H357 at 13.2 compared to 3.3 for NOK-containing models and 2.4 in 
FNB6-containing models.  MDM cultured with H357 keratinocytes included the most 
CD163+ cells at 74.1 % compared to 41.5 % in NOK-containing models and 39.8 % in FNB6-
containing models.  Whilst the percentage expression of CD163 was much higher for H357 
models, the nMFI of CD163PE measured for MDM cultured in the presence of NOK and H357 
was very similar at 9.4 and 9.9 respectively, compared to 3.5 for MDM cultured with FNB6.  
The expression of CD206 increased from NOK to FNB6 to H357 models, with nMFI increasing 
from 1.4 to 2.5 to 2.7 respectively and the percentage of CD206+ cells increasing from 6.1 
% to 30.4 % to 36.4 % respectively. 
 Contraction of tissue-engineered models containing monocyte-derived 
macrophages and either normal oral keratinocytes, FNB6 or H357 cells 
Following 14 days of culture at ALI of models containing NOF with NOK, FNB6 or H357 
keratinocytes in the presence or absence of MDM, the surface area of each model was 
measured to determine amount of contraction using ImageJ (Figure 7.7).  This variation of 
a collagen contraction may provide an indication of the activation of fibroblasts within the 
co-culture. 
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Figure 7.7. Contraction of hydrogels incorporating monocyte-derived macrophages, 
normal oral keratinocytes, immortalised keratinocytes, FNB6, and oral squamous cell line, 
H357.  Monocyte-derived macrophages (MDM) were cultured within tissue-engineered oral 
mucosa containing normal oral fibroblasts, in addition to normal oral keratinocytes (NOK, 
A and D), immortalised keratinocyte cell line, FNB6 (B and E), and oral squamous cell line, 
H357 (C and F). Following 14 days of culture at air-liquid interface, hydrogels were analysed 
using a contraction assay. Images show contracted hydrogels (A-F) for models devoid of 
MDM (A-C) or containing MDM (D-F). Images are representative of two independent 
experiments, using different patient NOK, measured in duplicate (n=2). Column chart 
summarises the area of each model (G). 
All models were set in a 24-well plate with surface area of 20.0 mm2.  Following culture for 
14 days, models containing NOK had contracted the most, with the surface area decreasing 
to 8.2 mm2 and 10.5 mm2, in both the absence and presence of MDM, respectively.  Models 
containing FNB6 cells were 23.6 mm2 and 18.4 mm2 after 14 days and models containing 
H357 keratinocytes were the largest at 37.8 mm2 and 36.8 mm2 in the absence and presence 
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of MDM respectively.  The presence of MDM did not appear to affect the contraction of 
models. 
 The stiffness of tissue-engineered oral mucosa containing monocyte-
derived macrophages, normal oral keratinocytes, FNB6 and H357 cells 
Following culture of tissue-engineered models with NOF and NOK, FNB6 or H357 epithelium 
in the absence or presence of MDM, models were analysed using rheometry to determine 
whether changes in the epithelial cell type may be linked to matrix stiffness.  Samples were 
analysed between parallel plates in a humidified environment and the elastic modulus at 
0.1 Hz was measured to determine tissue stiffness (Figure 7.8). 
 
Figure 7.8.  Differences in the stiffness of tissue-engineered oral mucosa containing 
normal oral keratinocytes, immortalised keratinocyte cell line, FNB6, and oral squamous 
cell line, H357.   Monocyte-derived macrophages (MDM) were cultured within tissue-
engineered oral mucosa containing normal oral fibroblasts, in addition to normal oral 
keratinocytes (NOK, A and D), immortalised keratinocyte cell line, FNB6 (B and E), and oral 
squamous cell line, H357 (C and F). Following 14 days of culture at air-liquid interface, 
hydrogels were analysed using rheometry.  The elastic modulus (stiffness) of tissue-
engineered oral mucosa containing NOK, FNB6 and H357 in the presence or absence of 
MDM was measured.  Data are representative of two independent experiments (n=2).   
    NOK    FNB6     H357 NOK    FNB6     H357 
                  -MDM                 +MDM 
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Models containing H357 displayed a higher elastic modulus at 884 Pa and 868 Pa in the 
absence and presence of MDM respectively compared to models containing both NOK and 
H357.  In the absence of MDM, models containing FNB6 displayed the lowest elastic 
modulus at 373 Pa compared to 432 Pa for models containing NOK.  However, in the 
presence of MDM, models containing NOK displayed the smallest elastic modulus at 653 Pa 
compared to 797 Pa for models containing FNB6 keratinocytes.  Additionally, all models 
containing MDM appeared to display an increase in stiffness compared to their MDM-free 
equivalents. 
7.4 The interaction of polarised monocyte-derived macrophages on models containing 
an FNB6 epithelium 
A previously published model of human skin SCC showed an increase in the invasion of 
epithelial cells in response to polarised macrophages (Linde et al., 2012).  Polarised MDM, 
added to tissue-engineered models containing FNB6 cells, were cultured in the presence of 
additional polarising cytokines as previously described (Linde et al., 2012).   
Initial experiments to incorporate polarised macrophages into the 3D tissue-engineered 
model of oral mucosa developed in this work, involved the polarising of MDM in 2D using 
polarising cytokines described in Table 2.3.  The addition of these cytokines was maintained 
once models containing FNB6 cells and polarised MDM were established.  The data 
presented here is very preliminary, as appropriate FMO controls could not be performed 
due to a lack of MDM.  Following 14 days of culture, separate tissue-engineered models 
were analysed using histology (Figure 7.9), flow cytometry (Figure 7.10 and Figure 7.12), 
rheometry (Figure 7.14), and a contraction assay (Figure 7.15). 
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Figure 7.9.  Invasion of immortalised FNB6 cell line into tissue engineered models containing polarised monocyte-derived macrophages.  
Tissue engineered oral mucosa containing immortalised keratinocyte cell line, FNB6, and normal oral fibroblasts, in the absence (A-C) or 
presence (D-E) of monocyte-derived macrophages (MDM) were cultured in the absence (A and D) or presence of M1 cytokines (B and E) or 
M2 cytokines (C and F) at air-liquid interface.  Following 14 days of culture, models were formalin fixed, sectioned and stained with H&E.  
Data are representative of a single experiment (n=1).  Arrows indicate areas of epithelial invasion and scale bars indicate 200 µm.
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Histological analysis of tissue-engineered models of the oral mucosa containing polarised 
MDM co-cultured with an FNB6 epithelium indicates that the presence of GM-CSF, IFNγ and 
LPS induces higher levels of invasion (arrows) compared to the incorporation of both M0 
and M2-polarised macrophages.  Interestingly, the M1 cocktail of cytokines promotes 
epithelial invasion in the absence of MDM, but is noticeably more prominent in the 
presence of MDM.   
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Figure 7.10.  Monocyte-derived macrophages change in morphology and expression of 
CD14 and CD45 in response to M1 or M2 polarisation when cultured within tissue-
engineered oral mucosa models containing immortalised keratinocyte cell line, FNB6.  
Tissue engineered oral mucosa containing immortalised keratinocyte cell line, FNB6, and 
normal oral fibroblasts, in addition to monocyte-derived macrophages (MDM) were 
cultured in the absence (A-B) or presence of M1 cytokines (C-D) or M2 cytokines (E-F) at air-
liquid interface.  Following 14 days of culture, MDM were retrieved using collagenase IV and 
analysed using flow cytometry.  MDM showed differences in CD14 and CD45 expression (A, 
C and E) and changes in size (FSC) and granularity (SSC, B, D and F) in response to 
polarisation cytokines.  Data shown are for a single experiment (n=1) and gates were based 
on unstained samples in the absence of fluorescence-minus-one controls. 
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The use of the multi-colour flow cytometry panel developed in Chapter 6 enabled polarised 
MDM to be selected using CD14 and CD45 and separated from FNB6 and NOF for analysis.  
In models containing M0 and M2 MDM, higher percentages of CD14+CD45+ cells were 
selected (49.2 % and 40.1 % respectively) compared to 17.4 % in models containing M1 
MDM.  Of these CD14+CD45+ events, differences were observed in the FSC and SSC.  In 
models containing M0 MDM, FSC was 68352 and SSC was 66560.  In models containing M1 
MDM, FSC was 80320 and SSC was 109312.  In models containing M2 MDM, FSC was 63360 
and SSC was 61312.  This could be visualised in dot plots which showed that M1 MDM 
isolated from the model were larger and more granular than those from M0 and M2 
polarised MDM models. 
Due to the reduced percentage of CD14+CD45+ events in M1 polarised MDM, the 
expression of markers was also assessed for CD45+ events (Figure 7.11). 
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Figure 7.11.  CD45+ monocyte-derived macrophages change in morphology and 
expression of CD14 and CD45 of monocyte-derived macrophages polarised in 3D culture 
models containing immortalised keratinocyte cell line, FNB6.  Tissue engineered oral 
mucosa containing immortalised keratinocyte cell line, FNB6, and normal oral fibroblasts, 
in addition to monocyte-derived macrophages (MDM) were cultured in the absence (A-B) 
or presence of M1 cytokines (C-D) or M2 cytokines (E-F) at air-liquid interface.  Following 
14 days of culture, MDM were retrieved using collagenase IV and analysed using flow 
cytometry.  MDM showed differences in CD45 expression (A, C and E) and changes in size 
(FSC) and granularity (SSC, B, D and F) in response to polarisation cytokines.  Data shown 
are for a single experiment (n=1) and gates were based on unstained samples in the absence 
of fluorescence-minus-one controls. 
A B 
C D 
E F 
  
 
223 | P a g e  
 
Due to the reduced percentage of CD14+CD45+ events in M1 polarised MDM, the 
expression of macrophages polarisation markers was also assessed for CD45+ events.    In 
models containing M0 MDM, FSC was 61376 and SSC was 61696.  In models containing M1 
MDM, FSC was 41280 and SSC was 68992.  In models containing M2 MDM, FSC was 57172 
and SSC was 57536.  This could be visualised in dot plots which showed that M1 MDM 
isolated from the model were more granular than those from M0 and M2 polarised MDM 
models.  This is comparable to data analysed from CD14+CD45+ events, and from MDM 
cultured in 2D.
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Figure 7.12. The differential expression of macrophage markers by CD14+CD45+ monocyte-derived macrophages within oral mucosa 
models containing immortalised keratinocyte cell line, FNB6, in response to polarisation cytokines.   Tissue engineered oral mucosa 
containing immortalised keratinocyte cell line, FNB6, and normal oral fibroblasts, in addition to monocyte-derived macrophages (MDM) 
were cultured in the absence (M0, black line) or presence of M1 cytokines (green line) or M2 cytokines (blue line) at air-liquid interface.  
Following 14 days of culture, MDM were retrieved from the collagen hydrogels using collagenase IV and their expression of CD36 (A and F), 
CD80 (B and G), CD86 (C and H), CD163 (D and I) and CD206 (E and J) was measured using flow cytometry.  Samples were compared to an 
unstained sample (grey, filled histogram) and median fluorescence measured (A-E).  Gates to determine percentage expression (F-J) were 
set compared to an unstained sample in the absence of fluorescence-minus-one controls.  Data are representative of a single experiment 
measured (n=1).   
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Using multi-colour flow cytometry, the expression of CD36, CD80, CD86, CD163 and CD206 
could be measured on CD14+CD45+ events retrieved from models containing FNB6 cells 
and polarised MDM.  The nMFI of CD36 was very similar in M0 and M2 MDM at 1394 and 
1330, respectively, compared to 421 for M1 MDM.  A similar pattern was observed in the 
percentage of cells expressing CD36 which was measured as 90.3 %, 40.3 % and 89.4 % 
respectively for M0, M1 and M2 MDM.  M1 MDM displayed the highest expression of CD80 
with an nMFI of 748 compared to 516 and 513 for M0 and M2 MDM.  A similar pattern was 
also observed for the percentage of cells expressing CD80, which was 0.8 % for M0, 8.0 % 
for M1 and 0.8 % for M2 MDM.  The nMFI for CD86 expression in M0, M1 and M2 MDM 
respectively was 460, 441 and 503.  The percentage of cells expressing CD86 was 3.6 %, 4.4 
% and 7.0 % respectively for M0, M1 and M2 MDM.  The highest percentage of CD163+ cells 
were identified in M2 MDM-containing models with 41.5 % identified compared to 32.8 % 
in M0 MDM and 35.6 % in M1 MDM models.  The nMFI representing CD163 expression was 
similar between M0 and M2 MDM at 1394 and 1330 respectively, compared to 421 in 
models containing M1 MDM.  The expression of CD206 was very similar in all 3 culture 
conditions, with nMFI measured as 1101, 1600 and 914 for M0, M1 and M2 MDM 
respectively.  The percentage of cells expressing CD206 was 76.4 %, 92.3 % and 68.8 % for 
M0, M1 and M2 respectively.  
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Figure 7.13.  The differential expression of macrophage markers by CD45+ monocyte-derived macrophages within oral mucosa models 
containing immortalised keratinocyte cell line, FNB6, in response to polarisation cytokines.   Tissue engineered oral mucosa containing 
immortalised keratinocyte cell line, FNB6, and normal oral fibroblasts, in addition to monocyte-derived macrophages (MDM) were cultured 
in the absence (M0, black line) or presence of M1 cytokines (green line) or M2 cytokines (blue line) at air-liquid interface.  Following 14 days 
of culture, MDM were retrieved from the collagen hydrogels using collagenase IV and their expression of CD36 (A and F), CD80 (B and G), 
CD86 (C and H), CD163 (D and I) and CD206 (E and J) was measured using flow cytometry.  Samples were compared to an unstained sample 
(grey, filled histogram) and median fluorescence measured (A-E).  Gates to determine percentage expression (F-J) were set compared to an 
unstained sample in the absence of fluorescence-minus-one controls.  Data are representative of a single experiment measured (n=1).   
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The expression of CD36, CD80, CD86, CD163 and CD206 was also measured on CD45+ MDM 
retrieved from models containing FNB6 cells and polarised MDM.  The nMFI of CD36 was 
9.9, 2.2 and 9.3 for M0, M1 and M2 MDM respectively.  The nMFI of CD80 was 1.2, 1.1 and 
1.2 for M0, M1 and M2 MDM respectively.  The nMFI of CD86 was 1.5, 1.1 and 4.2 for M0, 
M1 and M2 MDM respectively.  The nMFI of CD163 was 1.0, 1.1 and 2.3 for M0, M1 and M2 
MDM respectively.  The nMFI of CD206 was 5.8, 2.0 and 4.8 respectively for M0, M1 and 
M2 MDM respectively. 
In addition, 81.0 %, 21.3 %, 78.2 % of MDM were CD36+ in M0, M1 and M2 MDM 
respectively.  For CD80, 0.7 %, 2.5 % and 1.0 % of events were CD80+ for M0, M1 and M2 
MDM respectively.  Of the 45 + event, 2.9 %, 4.2 % and 5.7 % were CD86+ in M0, M1 and 
M2 stimulated MDM respectively.  For CD163, 26.2 %, 11.4 % and 34.0 % were CD163+ in 
M0, M1 and M2 stimulated samples respectively.  Lastly, 62.6 %, 39.8 % and 55.9 % of 
events were CD206+ in M0, M1, and M2 stimulated MDM respectively.  Whilst the 
expression patterns for CD36, CD80 and CD86 were similar in CD14+CD45+ and CD45+ 
events, the expression patterns for CD163 and CD206 varied slightly.  
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Figure 7.14.  Hydrogel stiffness may be linked to macrophage polarisation.  Tissue 
engineered oral mucosa containing immortalised keratinocyte cell line, FNB6, and normal 
oral fibroblasts, in the absence (-) or presence (+) of monocyte-derived macrophages 
(MDM) were cultured in the absence (C = control) or presence of M1 cytokines or M2 
cytokines at air-liquid interface.  Following 14 days of culture, collagen hydrogels were 
analysed using rheometry and the elastic modulus (stiffness) measured.  Data are 
representative of a single experiment measured in duplicate (n=1).   
The addition of M2-polarised macrophages appeared to have very little effect on the 
stiffness of the engineered tissue compared to the inclusion of un-stimulated macrophages.  
However, the addition of M1-stimulated macrophages and the addition of M1-polarising 
cytokines resulted in an increase in the stiffness of tissues both containing and devoid of 
macrophages. 
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Figure 7.15.  Contraction of tissue-engineered oral mucosa model containing FNB6 and 
polarised monocyte-derived macrophages.  Tissue engineered oral mucosa containing 
immortalised keratinocyte cell line, FNB6, and normal oral fibroblasts, in the absence (-) or 
presence (+) of monocyte-derived macrophages (MDM) were cultured in the absence (C = 
control) or presence of M1 cytokines or M2 cytokines at air-liquid interface.  Following 14 
days of culture, collagen hydrogels were analysed using a contraction assay.  Data are 
representative of a single experiment measured in duplicate (n=1).  Images show models 
cultured alone (A and D) or with M1-stimulation (B and E) or M2-stimulation (C and F) either 
in the absence (A-C) or presence (D-F) of monocyte-derived macrophages (MDM).  Images 
are representative of a single experiment, measured in duplicate (n=1).  Column chart 
summarises the area of each model (G). 
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All models were set in a 24-well plate with surface area measuring 20 mm2.  During 14 days 
of culture, models containing un-stimulated MDM (M0) contracted the most, with surface 
area decreasing to 12.07 mm2 and 10.00 mm2 in models devoid or containing MDM, 
respectively.  Models containing M1 polarised MDM were measured as 19.57 mm2 and 
18.69 mm2 in the absence or presence of MDM respectively, and those models containing 
M2 polarised MDM were measured as 16.47 mm2 and 17.05 mm2 in the absence or 
presence of MDM respectively. 
7.5 Discussion 
Whilst much of the work described in this chapter is very preliminary, it demonstrates that 
the tissue-engineered model of the oral mucosa containing MDM developed in chapter 5 
may be analysed using the multi-colour flow cytometry panel developed in chapter 6.   
Effects of collagenase treatment on macrophage marker expression 
Collagenases cleave helical regions of collagens at specific sites and were first prepared for 
research use in 1953 (Mandl et al., 1953).  Collagenase IV is often used in the disaggregation 
of human tissue and has been shown to offer improved disaggregation compared to other 
collagenases (Crabbe et al., 1997).  In particular, collagenase IV has a low tryptic value 
compared to other collagenases and therefore is more suited for use on cells analysed by 
flow cytometry as damage to membrane receptors is limited.  Previous data has shown that 
collagenase type I decreased the expression of various surface markers on lymphocytes 
analysed using flow cytometry (Abuzakouk et al., 1996).  Therefore, the expression of the 
markers selected for analysis on 3D-cultured MDM was compared with and without 
additional treatment with collagenase IV.  No significant difference in the expression of 
these antigens was observed, suggesting that disaggregation of tissue-engineered models 
could be achieved using collagenase IV without affecting marker expression. 
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 Oral mucosa models containing monocyte-derived macrophages in the 
presence of normal oral keratinocytes, FNB6 and H357 
During cancer progression, invasion of the epithelium into the connective tissue is 
characteristic of malignant transformation.  Here, epithelial cells breach the basement 
membrane and begin to form clusters within the connective tissue (Bradley et al., 2010).  
Preliminary data in chapter 5 showed an increase in the invasion of H357 cells into the 
connective tissue of models containing THP-1 monocytes, which was not observed in their 
absence, but was also demonstrated in models containing FNB6 cells.  Therefore, it was 
hypothesised that macrophages may promote epithelial invasion.   
In this chapter, models containing NOK, FNB6 and H357 cells were cultured for 14 days in 
the presence or absence of MDM and invasion analysed using histology.  Contrary to the 
hypothesis, none of these models showed signs of epithelial invasion.  No other models 
containing MDM comparing invasion in response to different epithelia could be found, 
although differences in epithelial invasion of models containing polarised macrophages are 
discussed below (Page 234). 
A novel multi-colour flow cytometry panel was developed to analyse the expression of a 
range of macrophage polarisation markers on cells cultured within a 3D tissue-engineered 
model containing epithelial cells and fibroblasts.  Previously, it has not been possible to 
quantitatively measure the expression of CD14, CD36, CD45, CD80, CD86, CD163 and CD206 
simultaneously, or from macrophages cultured in 3D.  Although preliminary, this data 
showed differences in the expression of these markers.  Most importantly, the percentage 
of macrophages expressing CD163 increased from 41.5 % in NOK models and 39.8 % in FNB6 
models to 74.1 % in H357 models.  This is in line with previously published literature which 
shows an increase in the expression of CD163 in invasive oral cancers (Fujita et al., 2014; 
Mori et al., 2011; Weber et al., 2014; Wehrhan et al., 2014).  The emerging use of CD163 
for immunostaining of oral cancer biopsies to determine diagnosis and prognosis 
demonstrates the importance of this flow cytometry panel to quantitatively measure the 
changes in level of expression and the percentages of cells expressing this key marker.  
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Additionally, immunohistochemical analysis of OSCC specimens rarely detected CD80+ cells 
in lower grade specimens, and even less in higher grades of tumour (Mori et al., 2011).  The 
ability of this panel to detect even small numbers of cells in a tissue-engineered sample will 
provide a greater understanding of the phenotypes of macrophages found residing within 
tissues. 
Collagen hydrogels are widely used to analyse the contraction of fibroblasts, particularly to 
understand wound healing processes.  During wound healing, inflammation and 
proliferation of cells is followed by tissue remodelling, and wound closure which requires 
tissue deposition, epithelialisation and contraction (Bagul et al., 2015).  Many parallels can 
be drawn between the wound healing and tumour microenvironments, particularly due to 
the activation of fibroblasts to myofibroblasts, matrix remodelling, angiogenesis and the 
release of TGFβ (Kalluri and Zeisberg, 2006).  Myofibroblasts display a highly contractile 
phenotype, which can be induced by TGFβ (Grinnell, 1994).  In the tumour 
microenvironment, TGFβ is released by cancer cells, which activates fibroblasts to adopt a 
contractile phenotype and release further TGFβ to form a positive feedback loop (Comito 
et al., 2014; Kobayashi et al., 2005).  In addition, any changes in the ECM can also activate 
fibroblasts to adopt a more contractile phenotype (Comito et al., 2014).   
Contraction assays relate the activation of fibroblasts with contraction of a collagen 
hydrogel.  Typically, a collagen hydrogel containing the cells of interest is set within a culture 
well, and released once set to float in culture.  Over the culture period, the hydrogel may 
contract and the surface area can be measured to compare between different conditions 
(Ngo et al., 2006).  Measuring the surface area of models following 14 days of culture may 
provide an insight into the activation status of fibroblasts residing within the models.   
Results in Chapter 5 showed that models containing THP-1 monocytes appeared highly 
contracted, with a markedly smaller surface area compared to models devoid of THP-1 cells.  
Therefore, it was hypothesised that immune cells may induce activation of fibroblasts to a 
myofibroblast phenotype.  The overexpression of TGFβ is often observed in OSCC and is 
correlated with poor survival rates (White et al., 2010).  Therefore, it was hypothesised that 
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models containing H357 cells, which release more TGFβ than normal cells, would promote 
activation of fibroblasts to myofibroblasts resulting in increased contraction of the model 
compared to those containing NOK and FNB6 cells.  In addition, models containing MDM 
may experience increased contraction due to cell crosstalk.  To test this hypothesis, the 
contraction of models containing NOK, FNB6 and H357 either in the absence or presence of 
MDM was measured.   
The preliminary results described in this chapter demonstrate that models containing NOK 
contracted more than those containing either FNB6 or H357 cells as a decrease in surface 
area was measured.  In addition, the absence or presence of MDM did not appear to result 
in noticeable difference in contraction.  Previously published data has shown that M2 
macrophages activate fibroblasts to a CAF or myofibroblast phenotype which is linked with 
poor prognosis in prostate cancer (Comito et al., 2014).  Whilst data in this chapter showed 
an increase CD163+ MDM considered to be M2 macrophages in models containing H357 
cells, the contraction associated with fibroblast activation was not observed in these 
models. 
Tissue stiffness varies in response to normal development and disease and can vary 
significantly between tissues of different types (Handorf et al., 2015).  The stiffness of the 
oral mucosa can vary dramatically between different sites of the oral cavity, and between 
patients (Chen et al., 2015).  During the development of cancer, abnormal matrix deposition 
and the degradation of the ECM by MMPs results in an increase in matrix stiffness, which 
can be one of the first indicators of the presence of a tumour, such as in breast cancer, 
(Boyd et al., 2014).  The contraction of myofibroblasts in cancer tissue is responsible for the 
increase in stiffness of these malignancies (Bagul et al., 2015).  In addition to data measuring 
the contraction of tissue-engineered models, comparisons in tissue stiffness may provide 
further insight into the activation of fibroblasts.  Here, a frequency sweep was performed 
using a rheometer to measure the elastic modulus of models containing NOK, FNB6 or H357 
cells in the presence or absence of MDM.   
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Preliminary data showed that models containing H357 cells displayed a higher elastic 
modulus, indicative of an increased tissue stiffness, compared to models containing NOK or 
FNB6 cells.  Data also showed that stiffness may be increased in models containing MDM 
compared to those devoid of MDM.  Whilst previously published literature has measured 
the elastic modulus of a breast cancer cell line cultured within a 3D alginate hydrogel using 
AFM (Cavo et al., 2016) no studies could be found that analysed the stiffness of tissue-
engineered models of the oral mucosa.  
 FNB6 models containing polarised monocyte-derived macrophages 
In the work published by Linde et al., models treated with M-CSF and IL-4 showed increased 
tumour cell invasion and spontaneous polarisation of macrophages to an M2 phenotype 
was observed after 21 days of culture (Linde et al., 2012).  However, in this work, alternative 
polarising cytokines were used to those presented in this thesis, primarily, GM-CSF was not 
used.  In an alternative study, GM-CSF was shown to enhance invasion of a colon 
adenocarcinoma cell line by increasing the prevalence of MMPs, especially MMPs 2, 9 and 
26, present in the collagen hydrogel (Gutschalk et al., 2013).  Blockade of GM-CSF signalling 
by neutralising antibodies reduced the invasion observed (Gutschalk et al., 2013).  
Additionally, models of skin SCC found that IL-6 promotion of invasion was GM-CSF-
dependent and the use of GM-CSF neutralising antibodies drastically reduced the invasion 
of HaCat-ras A-5 cells (Lederle et al., 2011).  This published study also found that IL-6 
induced the release of MCP-1 by fibroblasts and keratinocytes which correlated with an 
increase in MMP2, which resulted in activation of fibroblasts and promotion of invasion. 
The use of HSC-3 tongue carcinoma cells within a 3D co-culture with polarised PMA-treated 
THP-1 cells showed an increase in the invasion of cells in response to M2 polarisation which 
was not observed following M1 polarisation (Pirila et al., 2015).  In this study, macrophages 
migrated towards carcinoma cells and could be found preferentially at the tumour border 
in patient biopsies (Weber et al., 2014).  Additional experiments may use anti-CD68 
antibodies to detect the location of macrophages within the engineered tissue using 
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immunhistochemistry.  Additionally, the release of MMPs could be investigated using 
gelatin zymography.   
7.6 Conclusion 
The work presented in this chapter has optimised the use of the multi-colour flow cytometry 
panel on the tissue engineered model of the oral mucosa developed in chapter 5.  It also 
begins to combine the use of this model with analysis using the multi-colour flow cytometry 
panel developed in chapter 6.  The aim of combining these two novel tools is to gain an 
understanding of the role that macrophages may play in oral cancer progression.  The 
preliminary data displayed in chapter 7 shows that the expression of key macrophage 
markers, including CD163, are altered in response to co-culture with different epithelial 
cells.  Previously, it has not been possible to rapidly isolate macrophages from a 3D culture 
environment and analyse their protein expression using multi-colour flow cytometry to 
measure the expression of key macrophage markers on the same cells.  Whilst the 
combination of flow cytometry, rheometry and histology provide a useful insight into the 
molecular interactions between keratinocytes, fibroblasts and macrophages in the 
engineered tumour microenvironment, the use of additional analyses such as gene 
expression and gelatin zymography, as well as a more detailed immunohistochemical 
analyses could provide valuable information regarding the activation status of the cells 
present.  In particular, IHC using anti-CD163 antibodies may enable comparison between 
the tissue-engineered model presented here and previously published studies using 
primary patient material. 
In conclusion, preliminary data has shown that there is an increase in the percentage of cells 
expressing CD163 in response to co-culture with H357 cells.  Further repeats of this work 
are required to confirm results.  Further investigation could determine whether this is also 
true for other OSCC cell lines, and dysplastic cell lines.   
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 Chapter 8: Conclusions and Future Work 
8.1 Conclusions 
In summary, this thesis has described the development of a 3D tissue engineered model of 
the oral mucosa which contains not only viable macrophages, but macrophages which 
respond to stimulation with LPS by secreting a pro-inflammatory cytokine, IL-6.  This model 
has been characterised using immunohistochemistry and compared to published literature 
describing patient samples of the oral mucosa.  In addition, a multi-colour flow cytometry 
panel has been developed which can quantitatively analyse the expression of CD36, CD80, 
CD86, CD163 and CD206 on CD14+CD45+ macrophages cultured in 3D.  This thesis 
concludes with the optimisation and preliminary use of the multi-colour flow cytometry 
panel to identify CD14+CD45+ macrophages from keratinocytes and fibroblasts present in 
the 3D co-culture.  Therefore, the data presented in this thesis provides tools necessary to 
improve understanding of the role macrophages play in oral cancer progression.   
The interactions of the different cells of the tumour microenvironment are complex and 
variable.  Whilst two novel tools for the analysis of the role macrophages play in oral cancer 
progression are presented in this thesis, further experiments would provide further insight 
in to the details of the mechanisms involved. 
8.2 Future work 
The fully optimised 3D tissue-engineered model of the oral mucosa and multi-colour flow 
cytometry panel specifically designed for use on this model, could be used to address a huge 
variety of questions.  In addition to the preliminary experiments described in chapter 7 that 
require further investigation, the following section describes possible future work. 
 Comparison of tissue resident macrophages in healthy and malignant 
tissue to those in engineered oral mucosa 
The ability to quantitatively analyse the expression of macrophage polarisation markers on 
macrophages isolated from primary patient tissues could have real value in improving 
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understanding of the role macrophages play in oral cancer progression.  In particular, the 
methods developed in this thesis provide rapid isolation of macrophages from 3D tissue to 
preserve the expression of selected markers. 
Methods for the isolation of macrophages from primary tissues were preliminarily 
investigated.  In addition to providing us with a deeper understanding of the molecular 
biology of macrophage residing within oral cancer tissues, this would enable the model 
developed in this thesis to be compared and validated against primary tissue. 
Methods were developed according to the previously published protocols (Donnenberg and 
Donnenberg, 2011; Fletcher et al., 2011; Misharin et al., 2013);).  Primary oral biopsies were 
collected from healthy volunteers (09/H1308/66) or obtained during surgical procedures 
with written, informed consent (13/NS/0120, STH17021) and stored in transport media 
overnight at 4°C.  The following day, the tissue sample was dissected into pieces 2-4 mm in 
size.  An enzyme mix containing 0.5 % collagenase A (Sigma Aldrich, Dorset, UK) and 0.1 
mg/mL DNAse (Sigma Aldrich, Dorset UK) was prepared in DMEM and tissue disaggregation 
was initiated using a gentleMACS C tube (Miltenyi, Cologne, Germany).  A 40 µm cell strainer 
was used to separate larger pieces from the single cell suspension and FACS Lyse (BD 
Biosciences, Oxford, UK).  The resulting cell suspension was stained using the 8-colour multi-
colour flow cytometry panel presented in this thesis. 
Unfortunately, no cells could be identified during flow cytometry analysis and the lack of 
availability of primary patient tissue prevented this work from being repeated.  In order for 
the flow cytometry panel to successfully identify macrophage within the mixture of cells 
present in an oral cancer biopsy, further dump channels may be required to be added to 
the panel, such as for the elimination of dendritic cells which may be CD14+CD45+, and the 
elimination of fibroblasts and keratinocytes as previously described.  For the elimination of 
dendritic cells, not present in the co-culture model developed in this thesis, CD208 may be 
used (Allaoui et al., 2016). 
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With increased availability of both normal and malignant primary tissue, the validation of 
the tissue-engineered model presented here could be achieved.   
 Towards an animal-free tissue-engineered model of the oral mucosa  
Whilst 3D tissue-engineered models offer benefits to in vivo experiments due to reduced 
costs, increased simplicity and reproducibility, the model presented here is not entirely 
animal-free.  Rat tail collagen was used to generate the collagen hydrogel, and although rat 
tails were discarded from other research studies, alternative forms of collagen are available 
that are animal-free.  For example, plant-derived human collagen can be produced in the 
tobacco plant using recombinant human collagen type I.  This collagen is homogenic, well-
organised, mechanically strong, and provides an excellent model of the ECM (Shoseyov et 
al., 2013).  A tissue-engineered model of the skin has been developed using plant-derived 
human collagen which includes PMA-treated THP-1 cells (Willard et al., 2013). 
Alternatively, MAPTrix (Amsbio, Oxon, UK) is a commercially available animal-free ECM 
which combines synthetic ECM peptides within mussel adhesive protein.  MAPTrix HyGel™ 
(Amsbio, Oxon, UK) is specifically designed for use in 3D culture and can easily be adapted 
to alter elasticity and pore size.  Despite the availability of MAPTrix containing a huge variety 
of ECM proteins, such as collagen, fibronetctin, laminin, vitronectin and cadherin, no 
published examples of use of this matrix could be found.  As well as a reducing the use of 
animal components, both of these matrices offer improved batch-to-batch reproducibility, 
and most importantly, reduced immunogenicity.   
Perhaps the most biologically relevant, animal-free matrix may be achieved by using a 
fibroblast-derived matrix which has previously been shown to accurately represent in vivo 
dermal architecture (Berning et al., 2015).  Whilst this matrix contains native proteoglycans 
and glycoproteins, the long culture periods and numbers of cells required to generate this 
fibroblast-derived matrix may be limiting for some applications.  
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 Chapter 10: Appendix 
 
Appendix Figure 1.  Melt curve for primers targeted to carboxypeptidase M gene.  M = -
2.835. 
Primer efficiency (E) was calculated using the following equation: 
 E = 10(-1/-2.835) = 2.253 
Primer percentage efficiency (% E) was calculated using the following equation: 
 % E = (2.253-1) x 100% = 125.26 % 
 
 
 
 
 
 
 
